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Abstract 
 
In humans, exercise capacity strongly associates with morbidity, mortality, and 
disease-risk. Maximal exercise capacity is a heritable trait, and rats selectively bred 
for high and low exercise capacity mimic phenotypes observed in humans: high 
capacity running rats (HCR) have lower metabolic-disease risk and increased 
longevity compared to low capacity running rats (LCR). In prior in vitro studies HCR 
skeletal muscle was shown to have higher fatty acid (FA) oxidizing capacity than 
LCR. We hypothesized that HCR would have enhanced FA utilization during in vivo 
exercise. In this study we use metabolomics and proteomics approaches to test this 
hypothesis and to explore metabolic differences between HCR and LCR during an 
increasing-intensity treadmill protocol (speed increasing 1 m/min every 2 min). Using 
indirect calorimetry, we found that during exercise HCR maintain high FA utilization, 
while LCR primarily utilize carbohydrates. Skeletal muscle and plasma were 
collected at rest, at 10 min of exercise (near exhaustion for LCR), and at 45 min of 
exercise (near exhaustion for HCR). Metabolite profiles showed HCR have increased 
muscle long-chain acyl-carnitines from rest to 10 min of exercise, indicating 
increased FA entry into the mitochondria of HCR. In contrast, LCR showed 
accumulation of short- and medium-chain muscle acylcarnitines from rest to 10 min 
of exercise, indicating inefficient substrate metabolism. We quantified muscle 
mitochondrial proteins and protein post-translational modifications (phosphorylation 
and acetylation) at rest and at 10 min of exercise. At rest, HCR have greater 
expression of enzymes within FA and branched-chain amino acid (BCAA) metabolic 
pathways than LCR. Compared to LCR, HCR have lower mitochondrial protein 
acetylation at rest and show protein deacetylation with 10 min of exercise, 
specifically in oxidative phosphorylation, citric acid cycle, FA and BCAA metabolic 
pathways. Consistent with a functional role of increased protein expression and 
lower protein acetylation within the BCAA pathway, HCR have greater BCAA 
metabolism during 10 min of exercise as measured by flux of intraperitoneally 
injected U-13C15N valine into catabolic intermediates. This study suggests 
xi 
enhanced FA and BCAA metabolism supports high running capacity and provides 
evidence for FA and BCAA pathway protein expression and acetylation in mediating 
enhanced fuel utilization.
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Chapter 1 
Introduction 
 
How well an individual performs on a maximal exercise test can predict longevity 
and risk for disease. This might seem intuitive; an endurance trained athlete is likely 
healthier than someone who starts breathing hard after jogging only a few meters. 
But training to run long-distances takes months, and the training effect on metabolic 
processes can be lost within a matter of weeks. So although training can improve 
one's immediate health outlook, much of what determines performance during a 
maximal exercise test — and long-term health prospects — is genetically 
predetermined.  
The genetics and underlying molecular mechanisms of exercise capacity are 
unknown. Certain medical conditions, like asthma and anemia, can impair delivery of 
oxygen to working muscle and thus limit exercise capacity. Similarly, mutations 
within genes involved in energy metabolism, for example glycogen phosphorylase, 
can limit energy production for contracting muscle. However, what yields Olympic-
level exercise capacity, and associated longevity, or even more subtle differences in 
exercise capacity, are less well understood.  
This is an important problem to address. We can imagine that someday, having 
this knowledge of exercise capacity and how it associates with health and longevity 
will lead to targeted and/or therapeutic approaches to maximize the number of 
healthy years we can enjoy.  
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1.1  Aim and Scope 
My thesis focuses on understanding this intrinsic (non-trained) component of 
exercise capacity. In this study, I aim to better understand the underlying physiology 
of animals divergent for intrinsic exercise capacity. The implication is that the 
physiological mechanisms that differ with running capacity likely impact overall 
health. Although there are many potential mechanisms for increased exercise 
capacity, I will focus on the concept of fuel preference: selectively utilizing fatty acids 
or carbohydrates for energy production.  
Preference towards fat utilization during exercise is linked to better exercise 
capacity. Trained long-distance athletes use fat more efficiently. This is due to a 
coordinated, physiological response to the stress of exercise and involves up-
regulation of specific genes related to fat metabolism. In contrast, an individual with 
poor metabolic health uses fats inefficiently during exercise and even at rest, has 
impaired switching between fats and carbohydrates for energy production. Thus, fuel 
preference appears to relate to both exercise capacity and overall health.  
The original research presented in this thesis is focused specifically on fuel use 
during a maximal exercise test on a treadmill. During this test, the speed increases 
at regular intervals until individuals exhaust. As you might imagine, fuel preference is 
dynamic and changes depending on the intensity of activity. At rest, roughly 85% of 
energy comes from fatty acids. As intensity increases, an individual a) needs more 
fuel to meet increasing energy demands and b) changes fuel preference, shifting 
towards greater carbohydrate use as speed increases. We take advantage of this 
shift in fuel preference as intensity increases to examine possible underlying factors 
for fuel preference. 
My study uses rats bred for high and low intrinsic running capacity. The rats have 
a heterogeneous genetic background and are the product of selective breeding for 
intrinsic exercise capacity. This rat model mimics the associated health aspects of 
exercise capacity that we see in humans: the high capacity rats are lean, less 
susceptible to diet induced obesity and insulin resistance, and longer lived. By using 
a rat model, we can control for environmental factors, such as diet and physical 
activity, that can be more difficult to control for in human studies. 
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1.2  Study overview 
This thesis focuses on how mechanisms for fuel preference might support 
increased exercise capacity and overall health. To achieve this aim, the following 
chapters are organized around three points: the background and current knowledge 
about fuel selection (Chapter 2), my original research which tests hypotheses about 
fuel utilization in rats bred for high and low running capacity (Chapters 3, 4, 5), and 
implications of the current study and future directions (Chapter 6).  
In the second chapter, I will go through some of the key evidence linking fuel 
preference to exercise capacity and metabolic health. I will discuss some potential 
mechanisms for adaptive fuel preference, and when and why these mechanisms fail 
to adequately explain fuel preference. Then I will end this chapter by talking about 
the rat model for high and low exercise capacity and why it is a good model for 
uncovering mechanisms of fuel preference and exercise capacity. This chapter will 
set up the rationale and motivation for the original research that follows.  
Chapters 3, 4, and 5 describe a series of experiments to understand fuel 
utilization in rats bred for high and low exercise capacity. In Chapter 3, I use 
metabolomic profiling to define fuel use in high and low capacity running rats. These 
data led to the hypothesis that exhaustive exercise induces changes in enzyme 
acetylation, a post-translation modification that affects enzyme activity. In Chapter 4, 
I use proteomic analysis to investigate post-translational modifications that occur 
with exercise in high and low capacity running rats, and I compare changes in 
protein acetylation vs. changes in protein phosphorylation with exercise. Data in 
Chapters 3 and 4 give evidence for the importance of two key metabolic pathways: 
fatty acid oxidation and branched-chain amino acid oxidation. In Chapter 5, I will 
describe my study using a stable isotope tracer to investigate in vivo flux of the 
branched-chain amino acid valine.  
The final chapter, Chapter 6, I will highlight conclusions, implications, and future 
directions of the study. In particular, I will discuss the importance of fatty acid and 
branched-chain amino acid metabolism to exercise capacity and metabolic health 
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and the need for continued research to better understand the role of post-translation 
modifications like acetylation in supporting fuel preference.  
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Chapter 2 
Importance of fuel preference 
 
The previous chapter gave a brief introduction and overview of the study. This 
next chapter will highlight the current knowledge about fuel preference, first focusing 
on why fuel preference is linked to exercise capacity and health, second focusing on 
how fuel preference might be regulated, and third explaining the advantage of using 
a genetically complex animal model to better understand high running capacity.  
 
2.1  A brief history 
The earliest studies to understand fuel use start with Antoine-Laurent de 
Lavoisier. His work in the late 1700s provided the first strides towards understanding 
respiration and metabolism. Lavoisier was a French chemist interested in animal 
respiration and the phenomenon of heat production. He designed an ice-calorimeter 
to demonstrate that heat produced per unit of CO2 was the same for both a candle 
flame and a live guinea pig, and with these results he famously claimed 'respiration 
is combustion'. Lavoisier was the first to recognize that the inspired air, 'oxygine' as 
he named it, was consumed in both combustion and respiration. Further, when 
Lavoisier measured respiration and pulse in a human volunteer, he showed that 
oxygen consumption varied based on activity, with exercise requiring more oxygen 
than resting, and eating more than fasting (Karamanou and Androutsos, 2013; West, 
2013).  
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An important concept derived from the measurement of oxygen consumption and 
CO2 production is the respiratory quotient (RQ; CO2/O2). In the mid-1800s French 
chemists Regnault and Reiset recognized that the ratio of CO2 produced and O2 
consumed was dynamic with different diets (Wilder, 1959). This fluctuation in the RQ 
stems from the differences in O2 required for combustion of different chemical fuels 
(glucose, fatty acids, proteins). A glucose molecule (C6H12O2) will require 6 O2 to 
produce 6 CO2 and 6 H2O resulting in a ratio of 1:1 of CO2:O2 (RQ = 1). While a 
molecule of fat, for example palmitic acid (C16H32O2), will require 23 O2 to produce 
16 CO2 and 16 H2O resulting in a ratio of 16:23 of CO2:O2 (RQ = 0.7) (Wilmore and 
Costill, 2004). For whole-body respiration, the RQ provides an estimate of relative 
carbohydrate vs. fat oxidation: lower RQ values indicate higher fat use, while higher 
RQ values indicate greater carbohydrate use.  
Since Lavoisier's work and the development of calorimetry techniques to study 
fuel use, scientists have continued to use this knowledge to understand oxidation of 
fat, carbohydrates and protein for energy. Another founder of metabolic research, 
Carl von Voit, combined measurements of nitrogen with RQ to begin expressing 
metabolism in terms of the amount of protein, carbohydrate and fat stored and 
oxidized (Mitchell, 1937). Voit's students Rubner, Atwater, and Lusk each continued 
work on fuel use and metabolism. Rubner and Atwater used a bomb calorimeter to 
measure combustion of fat, protein and carbohydrate (Buchholz and Schoeller, 
2004), and they established how much metabolic energy was produced from fat (8.9 
kcal/g), carbohydrates (4 kcal/g), and protein (4 kcal/g) (Widdowson, 1955). And 
Lusk advanced the knowledge of diabetic, exercise, and intermediary metabolism 
using indirect calorimetry (Du Bois, 1933). These scientists stemming from the 
lineage of Lavoisier laid down the foundation for the study of fuel use in exercise, 
health, and longevity.  
 
2.1.1 Studies linking fuel use and high exercise capacity 
Respiration during exercise has been of interest ever since Lavoisier first 
demonstrated respiration increases with work. In 1923, Hill and Lupton showed that 
O2 respiration increases proportionally with increasing speed of running until a 
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maximum limit is reached, that is, when increasing work does not produce an 
increase in oxygen consumption (Hill and Lupton, 1923). Hill believed this maximal 
oxygen consumption could be used to assess exercise capacity of individuals with 
metabolic, cardiac, or other conditions that limited long-duration exercise. Within the 
last 20 years, several large-scale studies have found that maximal oxygen 
consumption strongly associates with morbidity and mortality in humans (Blair et al., 
1996; Church et al., 2004; Lee et al., 2010). In addition, it also associates with risk 
for metabolic syndrome (Whaley et al., 1999), insulin resistance and diabetes 
(Larsen et al., 2012; Leite et al., 2009; Wei et al., 1999), cancer (Peel et al., 2009), 
and heart disease (Kodama et al., 2009).  
Beyond assessing maximal oxygen consumption, Hill and his contemporaries 
focused on fuel use during exercise. Moderate intensity exercise leads in increased 
fat oxidation (decreasing RQ) and high intensity exercise leads to greater 
carbohydrate oxidation (increasing RQ) (Hill and Lupton, 1923; Romijn et al., 1993). 
By the 1920s, researchers understood that high-intensity exercise, which would elicit 
maximum oxygen consumption, was associated with high carbohydrate use, 
breakdown of glycogen and accumulation of blood lactate. Hill (1923) writes, "the 
very great rise of the R.Q., during and after violent effort, is a sign that the acid 
production is considerable." For nearly a century, researchers have been developing 
techniques to better understand the decreased fat use and increased carbohydrate 
use during high intensity exercise, and it remains an unsolved problem in exercise 
physiology (Jeppesen and Kiens, 2012).  
The problem of fuel selection is important because fuel preference directly relates 
to exercise capacity and maximal oxygen consumption. Maximum oxygen 
consumption occurs when carbohydrate use is high, but it is significantly correlated 
with maximal fat oxidation during an increasing-intensity bout of exercise (Nordby et 
al., 2006; Venables et al., 2005). By using fat for fuel, instead of carbohydrate, the 
limited glycogen stores are spared, and thus exhaustion is delayed. Animal models 
with lower fat oxidation have faster glycogen breakdown during exercise and lower 
exercise capacity (Fernandez et al., 2008; Huijsman et al., 2009). In contrast, animal 
models with high exercise capacity have increased daily fat oxidation (Narkar et al., 
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2011; Perez-Schindler et al., 2012; Quinn et al., 2013; Rogowski et al., 2013; 
Yamamoto et al., 2011), or greater fat oxidation during an increasing-intensity bout 
of exercise compared to control animals (Hakimi et al., 2007). Exercise training, 
which often yields increases in exercise capacity, also leads to increased fat 
oxidation during exercise (Coggan et al., 2000; Helge et al., 2007; Schrauwen et al., 
2002; Tunstall et al., 2002). Given this evidence, we can conclude that fat oxidation 
during increasing-intensity exercise is critical for high oxygen consumption and 
exercise capacity.  
We have focused primarily on fat and carbohydrate use because these fuels 
account for 85-95% of the total fuel used during exercise (Wagenmakers et al., 
1991). However, amino acids can contribute a small percentage to energy 
production. In particular, branched-chain amino acids (BCAA) — valine, leucine, and 
isoleucine — contribute the most towards energy production in skeletal muscle 
(Wagenmakers et al., 1991). BCAA metabolism increases with onset of exercise 
(van Hall et al., 1996; Wagenmakers et al., 1989), and training leads to increases in 
muscle BCAA enzyme activity (Fujii et al., 1995; Shimomura et al., 1995). Gene 
expression of BCAA enzymes appear to be co-regulated with genes for fat oxidation: 
both pathways are increased in active vs. inactive twins (Leskinen et al., 2010; 
Pietilainen et al., 2008) and in high-capacity running rats vs. low-capacity running 
rats (Kivela et al., 2010). Dietary BCAA supplementation does not substantially alter 
exercise capacity (Blomstrand et al., 1991; MacLean and Graham, 1993), but 
knocking out muscle-specific branched-chain aminotransferase in mice significantly 
reduces exercise capacity (She et al., 2010). This evidence gives importance to the 
role of BCAA metabolism in exercise, even though BCAA contribute only a minor 
amount to overall energy production. 
 
2.1.2  Fuel selection and metabolic health 
In addition to fuel selection being important for exercise capacity, fuel selection is 
a critical component of metabolic health. Pathophysiological states such as diabetes 
and insulin resistance are characterized by metabolic inflexibility - the failure to 
appropriately switch between glucose and fat oxidation (Kelley and Mandarino, 2000; 
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Thyfault et al., 2006). In normal individuals, fat oxidation is high in the fasted state 
and declines with insulin stimulation. However, in individuals with insulin resistance, 
the transition from high fat to high carbohydrate oxidation is blunted (Galgani et al., 
2008). This disruption in metabolic flexibility is also associated with accumulation of 
lipid species within liver and muscle tissues (Kelley and Mandarino, 2000). In insulin 
resistance there is greater flux of fatty acids into the tissue (Bonen et al., 2004) but 
also greater incomplete fat oxidation, which might support insulin resistance (Koves 
et al., 2008; Muoio and Koves, 2007). 
Studies have shown that manipulation of fat and glucose metabolism can lead to 
increased insulin sensitivity. Carnitine palmitoyl transferase I (CPTI) is essential for 
long-chain fatty acid entry into the mitochondria. Inhibiting fat oxidation with CPTI 
inhibitors (Oxfenicine, etomoxir, or excess malonyl-CoA) can improve insulin 
sensitivity (Bouzakri et al., 2008; Keung et al., 2013; Koves et al., 2008; Timmers et 
al., 2012). This improvement in insulin sensitivity occurs despite increased 
accumulation of lipid species within skeletal muscle and decreased fat oxidation. 
This data might seem counterintuitive, but it highlights the importance of matching 
fuel income with fuel oxidation. In cases when fuel requirements are low (at rest) 
increasing fat uptake relative to oxidation has negative consequences, and limiting 
fat oxidation can improve balance between fat and carbohydrate oxidation. In the 
case of exercise, when fuel requirements are high, increased fat uptake and 
oxidation is beneficial. Restoring the balance between fuel uptake and fuel use might 
underlie part of insulin-sensitizing benefits of exercise (Goodpaster and Brown, 
2005). As mentioned in the previous section, fat use during exercise is critical to 
exercise capacity and positively correlates with insulin sensitivity (Hall et al., 2010).  
In addition to disruption in fat and glucose metabolism, insulin resistance is 
associated with changes in BCAA utilization. BCAA pathway enzyme expression 
decreases with diabetes (Mullen and Ohlendieck, 2010), and BCAA enzyme gene 
expression positively correlates with insulin sensitivity (Pietilainen et al., 2008; Sears 
et al., 2009). In insulin resistance, circulating BCAA are elevated (Batch et al., 2013; 
Huffman et al., 2009; Wang et al., 2011). These elevated levels of BCAA correlate 
with insulin resistance (Fiehn et al., 2010; Menni et al., 2013; Xu et al., 2013) and 
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are predictive of development of diabetes (Wang et al., 2011). Weight loss 
improvement of insulin resistance associates with decreased circulating BCAA levels 
(Magkos et al., 2013; Shah et al., 2012).  
The dynamics of BCAA metabolism with insulin resistance is not well understood. 
It could be that BCAA metabolism is increased with insulin resistance, as both BCAA 
and downstream metabolites are elevated in diabetes/insulin resistance (Batch et al., 
2013; Fiehn et al., 2010; Menni et al., 2013; Newgard et al., 2009; Xu et al., 2013). 
However, it is more likely that BCAA metabolism is decreased in insulin resistance. 
Elevated BCAA coincides with decreased BCAA-related enzyme activity in animal 
models of insulin resistance (Doisaki et al., 2010). The mRNA expression of BCAA 
metabolic enzymes decreases with insulin resistance and is restored with insulin 
sensitizing thiazolidinedione (TZD) treatment (Sears et al., 2009). The elevation of 
BCAA and intermediary metabolites in insulin resistance might also indicate an 
imbalance of input and oxidation.  
 
2.1.3  Fuel selection and longevity 
Exercise capacity is strongly associated with morbidity and mortality and is one of 
the best predictors of healthspan in humans (Blair et al., 1996; Church et al., 2004; 
Kodama et al., 2009; Lee et al., 2010). As expected from this relationship, VO2max, 
a measurement of exercise capacity, decreases with age (Hollenberg et al., 1998; 
Hollenberg et al., 2006). Notably, aging is also associated with changes in lipid 
metabolism (Houtkooper et al., 2011; Tomas-Loba et al., 2013) and down-regulation 
of genes involved in mitochondrial metabolism and electron-transport chain (de 
Magalhaes et al., 2009; Zahn and Kim, 2007).  
In recent years, modulations in diet and gene expression have been shown to 
increase lifespan in model organisms; importantly several of these manipulations 
target nutrient signaling and metabolism: IGF-1, mTOR, sirtuins, growth hormone, 
and calorie restriction (Giblin et al., 2014; Lopez-Otin et al., 2013). The metabolic 
response to these manipulations is thought to be an integral to the extension of 
lifespan (Anderson and Weindruch, 2010).  
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In a number of these long-lived organisms, there is elevated fat oxidation. The 
long-lived Ames dwarf mice and growth hormone receptor knockout mice have 
substantially lower 24-hr RQ measurements than control mice, indicating greater 
fatty acid oxidation (Westbrook et al., 2009). Long-lived mitochondrial mutations (in 
C. elegans) have elevated FA utilization and display upregulation of energy 
producing pathways (Munkacsy and Rea, 2014). Caloric restriction, which extends 
life and prevents much of the age-related decline in metabolic gene expression (Park 
and Prolla, 2005) also leads to increased fat oxidation in Drosophila (Katewa et al., 
2012), mice (Bruss et al., 2010) and humans (Huffman et al., 2012). Consistent with 
a role of lipid metabolism in longevity, long-lived mice (calorie restriction, Irs1 -/-, and 
Ames dwarf) show elevations in plasma lipids (Wijeyesekera et al., 2012). 
In addition to alterations in fat oxidation in long-lived models, there also appear to 
be modifications in BCAA metabolism; however this relationship is more complex. 
Long-lived Ames dwarf mice have lower circulating BCAA, which might indicate 
greater utilization (Eto, 2013; Wijeyesekera et al., 2012). Calorie restriction also 
leads to lower levels of plasma BCAA in dogs (Richards et al., 2013). However, long-
lived daf-2 mutants (C. elegans) with disrupted insulin/insulin-like signaling pathway 
have elevated BCAA and lower expression of BCAA metabolic enzymes (Fuchs et 
al., 2010; Martin et al., 2011). The inconsistency of BCAA metabolism among long-
lived mutants might depend on whether insulin signaling is disrupted. As we 
discussed in the previous section BCAA are elevated with increasing insulin 
resistance (Fiehn et al., 2010; Menni et al., 2013; Xu et al., 2013). We conclude that 
while BCAA metabolism is modulated in some of the long-lived models, up- or down-
regulation of BCAA metabolism does not consistently track with increased or 
decreased lifespan.  
 
2.2  Mechanisms for adaptive fuel selection 
In the previous section, we reviewed the historical interest in fuel selection, and 
the strong association between fuel selection and exercise capacity, metabolic 
health, and longevity. Together, this knowledge motivates the continued study of fuel 
selection and mechanisms for adaptive fuel selection in response to environmental 
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changes. Regulation of fuel selection is an integrated process that allows for energy 
supply to meet energy demand despite, and in response to, environmental instability. 
In fact, metabolic health depends on appropriate changes in fat, glucose, and protein 
use in response to fasting, feeding, and exercise. These dynamic changes in fuel 
use aid in our understanding of the various levels of control that drive fuel selection. 
Given the complexity of the regulation, I will focus our attention to some of the 
best explanations for fuel selection, starting with regulation of fuel availability, fuel 
entry into the cell, glycogenolysis and glycolysis, substrate entry into the 
mitochondria, and mitochondrial enzyme activity.  
 
2.2.1  Fuel availability 
Fuel availability is probably one of the largest contributors to fuel selection. 
Intermittent food uptake maintains fuel availability. Incoming fuel (food) can be used 
immediately for energy production or stored and used later during fasting or starving 
conditions. The system is regulated in a way that minimizes large sustained changes 
in glucose availability, which serves the purpose of maintaining glucose for the brain. 
Circulating hormones like insulin and glucagon augment glucose control. Insulin 
signaling after feeding leads to increased glucose uptake in peripheral tissues 
(muscle, adipose, and liver) and increased fatty acid storage in adipose tissue, while 
glucagon signaling during fasting leads to increased glucose production from the 
liver and stimulates fatty acid release from adipose tissue.  
What results from this system is a see-saw between fat and glucose availability 
and utilization during periods of fasting and feeding (Figure 2.1). The key 
modulators of circulating fuel availability are 1) fuel uptake, which will be discussed 
in the next section, and 2) fuel release from stored sources, which will be the main 
focus of this section.  
In the fasted condition, glucose supply is primarily regulated by the liver 
(Ramnanan et al., 2011). The liver will synthesize glucose in times of fasting and 
under exercise. This process utilizes stored forms of carbohydrate (glycogen) to form 
glucose, which is then released into circulation. The process of glycogen breakdown 
in the liver is mediated by glucagon (Ramnanan et al., 2011).  
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Fat is primarily stored as triglyceride (3 fatty acid chains + a glycerol backbone) in 
the adipose tissue and within skeletal muscle. Triglyceride storage accounts for the 
most dense and largest fuel reserve in the body (Horowitz, 2003). In times of energy 
need, triglycerides are broken down to yield free fatty acids and glycerol. These free 
fatty acids can then be oxidized for energy production. Triglyceride breakdown is 
catalyzed by lipases: hormone sensitive lipase (HSL) and adipose triglyceride lipase 
(ATGL) in tissue (Lass et al., 2011), and lipoprotein lipase in blood vessels 
(Horowitz, 2003). 
HSL hydrolyzes many lipid types (triglycerol, diacylglycerol, cholesterylester) 
(Lass et al., 2011). As the name implies, HSL is acutely regulated by hormones. 
Insulin can suppress HSL activity (Campbell et al., 1992), and β-adrenergic 
stimulation by catecholamines can activate HSL (Clifford et al., 2000). During 
exercise, HSL can be activated both by increased catecholamine levels and by 
decreased circulating insulin (Horowitz, 2003). Mice with HSL-null mutation have 
decreased plasma fatty acids under fasting and moderate intensity exercise, and 
because fatty acids are an important source of fuel during exercise, these animals 
have lower running capacity (Fernandez et al., 2008). HSL is also present in skeletal 
muscle and likely mediates the breakdown of intramuscular triglycerides (IMTG) 
(Horowitz, 2003). Although catecholamines can increase muscle HSL activity, 
calcium can also play a role in HSL stimulation (Horowitz, 2003).  
ATGL, identified in 2004, specifically catalyzes reaction of triacylglcyrol into 
diacylglycerol and a fatty acid (Lass et al., 2011). Like HSL, ATGL is also stimulated 
by β-adrenergic activity (Haemmerle et al., 2006). Increased lipid oxidation under 
fasting and exercise conditions does not occur in ATGL-null mice and these null-
animals have proportionally greater carbohydrate oxidation (Huijsman et al., 2009; 
Schoiswohl et al., 2010). Together, ATGL and HSL activity accounts for greater than 
95% of the lipolysis in adipose (Schweiger et al., 2006) and skeletal muscle (Alsted 
et al., 2013). 
How much does fuel availability control fuel utilization? If a substrate supply is 
limited, as is the case in for glucose under fasting conditions or fatty acids in ATGL- 
or HSL-null mice, then energy demand will be met with the alternative substrate. 
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Increasing fuel availability by direct infusion of lipid, glucose, or amino acids will lead 
to increased oxidation of those substrates (Coyle et al., 1997; Horowitz et al., 1997; 
Odland et al., 1998a; White and Brooks, 1981). But even at high availability there is 
substrate competition leading to shifts in fuel preference (Coyle et al., 1997; 
Horowitz et al., 1997) suggesting some further cellular or mitochondrial regulation of 
fuel selection.  
Further evidence for cellular regulation of fuel selection is the fact that exercise 
training leads to greater fat oxidation during exercise, but does not lead to 
substantial increases in lipolysis (Klein et al., 1994). Horowitz (2003) explains that 
trained individuals have a better balance between fat availability and utilization than 
untrained, and in both, fat supply is not limiting. Fat supply is also not limiting at high 
exercise intensity, when carbohydrate oxidation increases and fat oxidation declines 
(Jeppesen and Kiens, 2012). Infusion of fatty acids was unable to prevent the 
decline in fat oxidation at higher exercise intensities (Romijn et al., 1995), again 
giving importance to a cellular/mitochondrial regulation of fuel selection. 
 
  
 
Figure 2.1 Fuel shift with fasting and feeding. With food, glucose and fat become 
plentiful, both are stored (although glucose is stored to a smaller degree) and 
primarily glucose is oxidized for energy production. During fasting, blood glucose is 
maintained by glucose production from the liver. Glucose is primarily reserved for 
oxidation in the brain, and lipids are released from the adipose tissue to supply fat as 
a fuel source for energy production in the peripheral tissues (muscle, liver, etc.). 
Hormones insulin and glucagon secreted from the pancreas augment changes in fuel 
availability.  
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2.2.2  Substrate entry into the cell 
Increasing fuel availability can increase fuel uptake, but this is through regulated 
transporters that facilitate fuel uptake. Because skeletal muscle is a primary 
consumer of these fuels (Turner et al., 2014), we will focus on regulation of glucose 
and fatty acid entry into the skeletal muscle.  
Glucose enters skeletal muscle through glucose transporters GLUT1 and GLUT4. 
GLUT1 is found at low levels in skeletal muscle, whereas GLUT4 is acutely 
regulated by insulin and contractions (Richter and Hargreaves, 2013). GLUT4 is 
maintained in intracellular vesicles; upon insulin- or contraction-stimulation, GLUT4 
translocates to the sarcolemma and t-tubules (Lauritzen et al., 2008; Lauritzen et al., 
2010). Deletion of GLUT4 from skeletal muscle results in decreased stimulated 
glucose uptake (Zisman et al., 2000). Under non-stimulated conditions, glucose 
transport into cells is limiting and thus shifts fuel selection away from glucose 
oxidation; however, under fed or exercise conditions glucose transport is sufficient 
and glucose phosphorylation inside the cell is more rate-limiting for glucose 
utilization (Wasserman and Ayala, 2005). 
Fatty acid entry into skeletal muscle is regulated by fatty acid transporter 
(FAT/CD36), fatty acid binding proteins (FABPpm and FABP4), and fatty acid 
transport protein 1 (FATP1) (Kiens, 2006; Nickerson et al., 2009). FAT/CD36, 
FABPpm and FABP4, but not FATP1, are more directly associated with increases in 
lipid oxidation (Jeppesen et al., 2012; Yoshida et al., 2013). Like GLUT4, FAT/CD36 
is translocated to the sarcolemma under insulin and contraction stimulated 
conditions (Bonen et al., 2004). Overexpression of FAT/CD36 in skeletal muscle 
increases fat-oxidation during exercise (Ibrahimi et al., 1999; Yoshida et al., 2013). 
However, insulin-stimulated translocation (Luiken et al., 2002) and overexpression of 
FAT/CD36 in myocytes increased triglyceride synthesis and not fat oxidation 
(Garcia-Martinez et al., 2005). Though overexpression of fatty acid transports tends 
to lead to increased lipid uptake and oxidation (Nickerson et al., 2009), the possibility 
of increased triglyceride synthesis suggests other intracellular mechanisms help 
direct fatty acids towards oxidation or triglyceride synthesis.  
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These fatty acid transporters might also facilitate lipid entry into the mitochondria. 
FAT/CD36, FABPpm, and FATP1 have been found in mitochondria fractions (Guitart 
et al., 2014; Smith et al., 2011; Stump et al., 1993). FAT/CD36 appears to facilitate 
palmitate, but not palmityol-CoA transport into mitochondria (Smith et al., 2011). This 
distinction might suggest a role for this protein in supporting IMTG generated fatty 
acid entry into the mitochondria. FATP1 overexpression also leads to increased 
palmitate oxidation, but mitochondrial specificity of FATP1 action is less well 
understood (Guitart et al., 2014). Unlike FAT/CD36, FABPpm mitochondrial function 
is not related to fat oxidation. FABPpm has sequence homology with mitochondrial 
aspartate aminotransferase (gene name: GOT2) (Stump et al., 1993). This protein 
has two distinct functions depending on subcellular localization; the mitochondrial 
localized protein is specific to amino acid metabolism (Holloway et al., 2007). 
Like increases in fuel availability, increases in substrate transport into the cell can 
support higher oxidation rates. However, other downstream enzymes, like 
hexokinase or mitochondrial fat oxidizing genes, might also regulate fuel selection 
and utilization, and these will be discussed next. 
 
2.2.3  Glycogenolysis and glycolysis 
As mentioned in the previous section, hexokinase (HK) activity can be rate-
limiting for glucose utilization, especially during high intensity exercise (Wasserman 
and Ayala, 2005). HK is the first enzyme in glycolysis (Figure 2.2), a process that 
produces energy equivalents and pyruvate, which can enter the mitochondria and 
support oxidative phosphorylation. Inhibition or activation of key enzymes in 
glycolysis and glycogenolysis (glycogen breakdown) are important for modulating 
fuel selection. This concept of glycolysis inhibition underlies a well-cited explanation 
for fuel selection, the glucose fatty-acid cycle presented by Randle (1963). The 
glucose-fatty acid cycle explains fuel selection through fatty acid availability and 
subsequent biochemical inhibition of glucose oxidation: increased availability of fatty 
acids will yield increased fat oxidation, which in turn leads to metabolite changes that 
allosterically down-regulate glucose oxidation.  
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HK catalyzes the phosphorylation of glucose. Both HK isoforms I and II are 
present in skeletal muscle, but HK II is more prevalent and accounts for 80% of the 
activity (John et al., 2011). Overexpression of HK II leads to greater glucose update 
under insulin- and contraction- stimulated conditions (Wasserman and Ayala, 2005). 
HK II activity is negatively regulated by glucose 6-phosphate (Richter and 
Hargreaves, 2013), and additionally, HK activity is modulated by transient 
association with the outer mitochondrial membrane (John et al., 2011). 
Disassociation of HK II from the mitochondria increases glucose uptake in a manner 
that is less tightly coupled to mitochondrial ATP production (Mailloux et al., 2011; 
Neary and Pastorino, 2013). HK II dissociation from the mitochondria occurs under 
high glucose 6-phosphate, particularly glucose 6-phosphate generated from 
glycogen breakdown (John et al., 2011). This transient association of HK II with the 
mitochondria is speculated to facilitate channeling of substrate down specific 
metabolic pathways (John et al., 2011).  
6-Phosphofructokinase (PFK) catalyzes the reaction of fructose 6-phosphate to 
fructose 1,6 bisphoshate and is inhibited by citrate (Randle, 1998). In the glucose-
fatty acid cycle, increasing fatty acid oxidation was linked to elevations in 
NADH/NAD and Acetyl-CoA/CoA. The accumulation of acetyl-CoA would lead to 
increased production of citrate, which would inhibit PFK. Inhibition of PFK would lead 
to accumulation of upstream glucose 6-phosphate and inhibition of HK (Randle, 
1998). The citrate-mediated inhibition of PFK in skeletal muscle is not well supported 
by in vivo results (Jeukendrup, 2002; Randle, 1998). However, PFK is also activated 
by AMP and inhibited by AMP-kinase (AMPK) activation and these mechanisms 
might also be important regulators of PFK (Hue and Taegtmeyer, 2009).  
 Though not incorporated in the glucose-fatty acid cycle, glycogen breakdown 
(glycogenolysis) is relevant to glucose uptake and fuel selection under fasting and 
exercise. Glucagon signaling (in liver), beta adrenergic signaling and muscle 
contraction can stimulate glycogenolysis (Jensen et al., 2011). Rapid glycogenolysis 
that occurs with increasing intensity exercise (Gollnick et al., 1974) will lead to 
elevations of glucose 6-phosphate and inhibition of hexokinase (Richter and 
Hargreaves, 2013). Additionally, rapid glycogen breakdown is associated with 
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decreased fat oxidation (Jeppesen and Kiens, 2012); while low glycogen content or 
the inability to break down glycogen is associated with increased fat utilization 
(Orngreen et al., 2009; Roepstorff et al., 2005). Glycogen phosphorylase (GP) 
regulates glycogenolysis, and GP activity is modulated by allosteric inhibitors and 
activators, phosphorylation, and acetylation (Jensen et al., 2011; Zhang et al., 2012). 
Allosteric activators of GP include AMP and IMP, and allosteric inhibitors are ATP, 
glucose 6-phosphate, and FAD+. This allosteric regulation makes glycogen 
phosphorylase responsive to the energy state of the cell (Chebotareva et al., 2005; 
Jensen et al., 2011). 
In summary, regulation of glycolysis and glycogenolysis are important for fuel 
selection and maintained energy supply during exercise. Inhibition of HK, PFK, or 
GP lead to impaired exercise capacity and greater fat oxidation (Fueger et al., 2003; 
Haller and Vissing, 2004; Wasserman and Ayala, 2005). In the next sections we will 
cover regulation of metabolite entry into the mitochondria and mitochondrial enzyme 
activity.  
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Figure 2.2 Glycolysis and glycogenolysis. Glucose and glycogen are broken down 
to pyruvate through several enzyme-catalyzed reactions, and produces a net 2 ATP 
and 2 NADH and 2 pyruvate molecules. Important regulated enzymes are highlighted 
in blue: hexokinase (HK), phosphofructokinase (PFK), and glycogen phosphorylase 
(GP).  
 
2.2.4  Substrate entry into the mitochondria 
Entry of fatty acids into mitochondria is yet another site of fuel regulation. Long-
chain fatty acids or fatty-acyl CoAs enter the mitochondria via specific transporters. 
We have already discussed the potential role of CD36 in mediating fatty acid 
(palmitate) entry into the mitochondria and now will focus on long-chain fatty acyl-
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transporters carnitine palmitoyltransferase I and II (CPTI/CPTII). CPTI is located on 
the outer mitochondrial membrane, while CPTII is located on the inner mitochondrial 
membrane. CPTI reacts with long-chain acyl-CoA in the cytosol and replaces the 
CoA moiety with carnitine, forming an acyl-carnitine and allowing the acyl group to 
pass through the mitochondrial membrane (Ramsay and Zammit, 2004). CPTII 
converts the fatty-acyl carnitine back to fatty-acyl CoA, which can then undergo beta-
oxidation in the mitochondria.  
CPTI activity is inhibited by malonyl-CoA (Ramsay and Zammit, 2004), and CPTI 
activity can be further reduced under conditions of lower pH (Starritt et al., 2000). 
The inhibition of CPTI by malonyl-CoA provides a mechanism by which cells can 
modulate between fatty acid oxidation and fatty acid synthesis. Malonyl-CoA is 
generated from acetyl-CoA by the enzyme Acetyl-CoA carboxylase (ACC), and 
malonyl-CoA can serve as a precursor for fatty acid elongation (Kerner et al., 2014). 
Consistently, inhibition of CPTI, with chemical inhibitor etomoxir, leads to decreased 
fat oxidation and increased glucose oxidation and fatty acid synthesis (Schrauwen et 
al., 2013). However, muscle malonyl-CoA concentrations in vivo are fairly constant in 
humans under different exercise intensities despite changes in fuel selection (Odland 
et al., 1998b), suggesting that malonyl-CoA availability is not modulating exercise-
induced changes in fuel selection. 
CPTI catalyzes the addition of a carnitine moiety onto fatty acyl-groups. Reduced 
carnitine levels with increasing intensity exercise is associated with lower fatty acid 
oxidation (van Loon et al., 2001), and is suggestive that carnitine availability is 
limiting for fatty acid oxidation (Jeppesen and Kiens, 2012). Supplementation with L-
carnitine can improve metabolic flexibility (Noland et al., 2009; Power et al., 2007), 
but there is only indirect evidence that L-carnitine supplementation improves fat 
oxidation during exercise (Wall et al., 2011). Furthermore, even at reduced levels, 
carnitine concentrations are well above the Km for CPTI (0.2 - 0.5 mM) and thus 
changes in free-carnitine with exercise should have minimal effect on CPTI activity 
(Sahlin et al., 2008).  
 
2.2.5  Mitochondrial enzyme activity 
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Mitochondrial enzyme activity is the final regulatory step in fuel selection. 
Glucose-derived carbons, fatty acids, and amino acids all enter the mitochondria and 
broken down to produce NADH and FADH2. Which are then passed to the electron 
transport chain for oxidative phosphorylation.  
Glucose oxidation can be tightly controlled through mitochondrial pyruvate 
dehydrogenase complex (PDHc) and this control is one of the main mechanisms of 
the glucose-fatty acid cycle (Randle, 1998). Pyruvate generated from glycolysis is 
converted to acetyl-CoA by PDHc. PDHc is inactive when phosphorylated and 
allosterically inhibited by acetyl-CoA and NADH (Hue and Taegtmeyer, 2009). 
Increased fatty acid derived acetyl-CoA and NADH will inhibit PDHc and thus limit 
glucose derived carbons from entering the citric acid cycle through acetyl-CoA. 
PDHc activity increases with increasing intensity exercise (Constantin-Teodosiu et 
al., 1991; Howlett et al., 1998), and is modulated primarily by changes in 
phosphorylation status.  
Fatty oxidation in the mitochondria occurs first through beta-oxidation to produce 
acetyl-CoA, which can enter the citric acid cycle. Beta-oxidation is catalyzed by acyl-
CoA dehydrogenase and the trifunctional protein. The acyl-CoA dehydrogenase 
reaction produces one FADH2, and the trifunctional protein produces one NADH and 
acetyl-CoA. Together, these molecules shorten the fatty acid chain by 2 carbons with 
each cycle. The activity of beta-hydroxyacyl-CoA dehydrogenase, a component of 
the trifunctional protein, is positively correlated with fat oxidation during exercise 
(Kiens, 2006). Additionally training increases in fatty acid oxidation are associated 
with the upregulation of mitochondrial components of fatty acid oxidation (Holloszy 
and Coyle, 1984).  
 
2.3  Model for high and low exercise capacity 
In the last section we discussed the importance of fuel preference and 
mechanisms that might regulate fuel preference at rest and during exercise. In this 
section we will discuss the advantages of a genetically complex animal model that 
has been artificially selected for high and low running capacity (HCR and LCR). This 
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animal model provides the advantage of controlled diet and environment while 
capturing some of the important phenotypes observed in humans.  
 
2.3.1  Beginnings of the HCR-LCR model 
In the late-1990's, Steve Britton and Lauren Koch began developing an animal 
model that could be used to model complex disease. They began with the 
understanding that no single genetic mutation could mimic the effect of diseases like 
type II diabetes, heart disease, or high blood pressure, which are known to be multi-
factorial in origin. Instead, they began with the premise that a model that had genetic 
complexity, as well as healthy and non-healthy spectrums, would be more 
appropriate for the study of complex disease. Using a similar principle as used in the 
Dahl-salt model for high- and low- salt tolerance (Rapp, 1982), Britton and Koch 
latched on to the idea of selective breeding for healthy and unhealthy rats.  
Although there are a variety of phenotypes considered to be healthy and 
unhealthy, a large-scale study concluded that cardiovascular fitness (VO2max) was 
more strongly predictive of morbidity and mortality than measurements like abnormal 
electrocardiogram, chronic illness, high cholesterol or high blood pressure (Blair et 
al., 1996). Because VO2max is closely associated with maximum work performed 
during an increasing intensity protocol, cardiovascular fitness can be approximated 
by maximal running distance during an increasing intensity exercise test. Thus, 
Britton and Koch began to test the hypothesis that rats bred for high and low running 
capacity would diverge in traits for health and longevity (Koch and Britton, 2001).  
The initial test for inheritance of exercise capacity was performed using an 
outbred strain of Sprague-Dawley rats, consisting of 18 male and 24 females as 
breeding pairs (Koch et al., 1998). Rats were introduced to the treadmill once a day 
for 5 days. The first two days on introduction, rats were placed on a moving treadmill 
(less than 10 m/min on at 15° incline) and assisted by hand if they did not keep on 
the treadmill. On the third through fifth days of introduction, the rats were allowed to 
fall onto a shock grid (1.2 mA of current at 3 Hz) if they did not keep up with the 
treadmill speed. The speed and time on the treadmill was minimal to reduce any 
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exercise training effect, but only animals that met the minimum 5 min at 10 m/min 
were subsequently tested for exercise capacity. 
After being introduced to the treadmill, rats were tested for exercise capacity 
once a day for 5 days. Rats were run at a constant 15° incline at 10 m/min with 
speed increasing 1 m/min every 2 min. Rats were run until they exhausted. 
Exhaustion was defined as the third time a rat could no longer sustain treadmill 
running and would rather sustain 2s of shock than continue on the treadmill. At 
exhaustion, animals were removed from the treadmill. The best performance (in 
distance) over the 5-day testing period was used as the measure of maximal running 
capacity.  
For the selective breeding, the best runners were bred together and the worst 
runners were bred together. In the initial test of inheritance with the Sprague-Dawley 
outbred strain, running capacity of the high-selected line was 70% greater than the 
low-selected line after 3 generations of selection (Koch et al., 1998). The 
segregation of running capacity with selective breeding suggested that running 
capacity is a heritable trait. Thus, Lauren Koch and Steven Britton decided to initiate 
a larger-scale selective breeding program for high and low running capacity (Koch 
and Britton, 2005).  
For the larger-scale selection, Koch and Britton chose to begin with a 
heterogeneous founder population, N:NIH rats (Koch and Britton, 2001). The N:NIH 
outbred population began from intercrossing 8 inbred rat strains: Maudsely reactor, 
Wistar, Wistar Kyoto, Marshall 520, Fischer, A x C 9935 Irish, Brown Norway, and 
Buffalo (Hansen and Spuhler, 1984), and this population was maintained with 60 
outcross families. Koch and Britton began with 96 male and 96 female non-sibling 
N:NIH rats for the initial selection based on high and low exercise capacity (Koch 
and Britton, 2001). Rats were introduced to the treadmill and tested in a similar 
manner as described above. Based on maximal running capacity, the top-performing 
13 males and females were bred together to initiate the high capacity running (HCR) 
line, and the bottom-performing 13 males and females were bred together to initiate 
the low capacity running (LCR) line. These initial breeding pairs were the first of a 
rotational within-family selective breeding scheme. In this breeding scheme each of 
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the 13 families contributes one male and one female to the next generation and are 
rotationally bred with another pre-arranged family. By using a rotational breeding 
scheme, the rate of inbreeding per generation is estimated to be less than 1% (Koch 
and Britton, 2005). By 10 generations of selective breeding for high and low running 
capacity, the HCR and LCR diverged in running capacity by 3.1-fold (females) and 
3.2-fold (males) (Koch and Britton, 2005).  
 
2.3.2  Fuel selection in HCR and LCR 
The rat model for high and low running capacity (HCR-LCR) has been selectively 
bred now for over 35 generations. Running capacity was found to be a heritable trait 
that has continued to diverge in this rat model since the initial heterogeneous found 
population (N:NIH stock) (Ren et al., 2013). Numerous studies have explored the 
physiological differences that occur with divergence of running capacity (Koch and 
Britton, 2005, 2008). Importantly, the divergence in exercise capacity was associated 
with the divergence in lean mass, body weight, metabolic disease risk, and lifespan 
(Koch et al., 2011; Naples et al., 2010; Noland et al., 2007; Novak et al., 2010; 
Wisloff et al., 2005).  
Accumulated evidence from this rat model suggests high capacity running rats 
(HCR) have higher fat oxidation than the low capacity running rats (LCR). Gene 
expression pathway analysis shows that HCR have increased gene expression 
within lipid metabolism, oxidative phosphorylation, citric acid cycle, and BCAA 
metabolism pathways (Kivela et al., 2010). Consistent with changes in mRNA, 
Lessard, et al (2011) showed increased protein expression of CD36 in skeletal 
muscle. 
In vitro studies using isolated skeletal muscle demonstrate that HCR muscle has 
greater fat oxidation capacity than LCR (Lessard et al., 2011). Increased fat 
oxidation in HCR vs. LCR was also demonstrated in perfused skeletal muscle (Rivas 
et al., 2011) and isolated mitochondria (Thyfault et al., 2009), but not in perfused 
hearts (Schwarzer et al., 2010). The relationship between higher oxidative capacity 
and fuel selection in the isolated tissue models is promising. However, better 
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characterization of in vivo fuel selection, and specifically exercise-induced changes 
in fuel selection are needed. 
 
2.4  Summary 
• Fuel selection, or the primary fuel used for energy, changes with food intake 
and exercise. 
• Increased fat oxidation is associated with greater exercise capacity, better 
metabolic health, and longevity.  
• A number of enzymes and transports help regulate fuel selection by 
controlling fuel availability, uptake into the cells, and metabolism.  
• The HCR/LCR animal model was developed to better understand the genetic 
link between metabolic health and high exercise capacity, and this model is 
valuable for understanding the underlying physiology of exercise capacity and 
fuel use.  
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Chapter 3 
Metabolomics to define fuel use during exercise 
 
In the previous chapter, we discussed the potential mechanisms of fuel selection. 
For the study discussed in this chapter, we used a metabolomics platform to 
understand exercise fuel use in the HCR-LCR model. This study demonstrates that 
HCR have higher fat oxidation during exercise and the data allow for speculation on 
why and how fat might be preferentially utilized. This chapter sets the groundwork for 
the experiments described in Chapters 4 and 5.  
 
3.1  Introduction 
Exercise capacity and cardiovascular fitness predict health and mortality (Blair et 
al., 1996; Church et al., 2004; Kodama et al., 2009), and yet the mechanisms 
supporting these associations are not fully understood. Fuel selection is a critical 
component to both exercise capacity and overall metabolic health. Higher exercise 
capacity associates with increased fat oxidation during exercise (Hall et al., 2010; 
Morris et al., 2013; Nordby et al., 2006; Venables et al., 2005), and poor metabolic 
health associates with impaired fuel switching (Kelley and Mandarino, 2000). The 
glucose-fatty acid cycle described by Randle et al. (1963) states that fat availability 
will drive fat oxidation and reciprocally lead to decreased glucose oxidation; however 
this theory cannot explain instances when fat availability is high, but carbohydrate is 
preferentially used, as is the case during high-intensity exercise and diabetes (Kelley 
and Mandarino, 2000; Mittendorfer and Klein, 2001; Sidossis et al., 1997). We 
  
27 
employ a metabolomics approach to examine the physiology underlying fuel 
preference during exercise.   
Metabolomics is a growing field of study that employs liquid chromatography or 
gas chromatography coupled to mass spectrometry (LC-MS or GC-MS) or nuclear 
magnetic resonance spectroscopy (NMR) to quantitate tens to thousands of 
metabolites in a single sample. This approach allows for a system wide snapshot of 
a metabolic state. Previous metabolomics approaches have used to study exercise 
have focused on changes in serum (Pohjanen et al., 2007), plasma (Lehmann et al., 
2010; Lewis et al., 2010), and urine (Enea et al., 2010). Additionally, all but one of 
these earlier studies (Enea et al., 2010) have focused on trained individuals or 
individuals with high VO2max. Metabolomics approaches comparing both high and 
low exercise capacity mice (Wone et al., 2011) and humans (Lustgarten et al., 2013; 
Morris et al., 2013) have focused on the phenotype at rest rather than the response 
to exercise. 
The current study uses a metabolomics approach to understand exercise-induced 
changes in fuel use in rats with high and low intrinsic running capacity (HCR and 
LCR). We focus not only on changes in plasma, but also changes in muscle, as 
muscle is the main site of fuel utilization during exercise (Egan and Zierath, 2013). 
By understanding the metabolic effects that differ between HCR and LCR during 
exercise, we gain insight into possible mechanisms of exercise capacity and fuel 
selection. Additionally by studying both lines at exhaustion, we can find metabolic 
profiles that associate with fatigue regardless of running capacity. We find that HCR 
preferentially use fatty acids for fuel, and exhaustion is associated with accumulation 
of metabolic intermediates, short- and medium-chain acyl-carnitines. 
 
3.2  Methods 
 
3.2.1  Animal protocol and study design 
HCR and LCR male rats (generation 26, age 4.5 months) were housed at the 
University of Michigan, and the University Committee on Use and Care of Animals, 
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Ann Arbor Michigan approved the study. All procedures were in compliance with 
University guidelines and state and federal regulations.  
Exercise capacity was determined on a motorized treadmill (Columbus 
Instruments, Columbus, OH) with an increasing-intensity protocol, starting at 10 
m/min and increasing 1 m/min every 2 min, with a constant 15° incline.  
The study design is presented in Figure 3.1. We first conducted whole-body 
indirect calorimetry during the increasing-intensity exercise protocol. These same 
rats were then divided into groups (n=5-6) and were run for 0, 10 min, 45 min (HCR 
only), or to exhaustion followed by a 30 min recovery (Rec). At these time points, we 
immediately euthanized by decapitation and collected trunk blood and tissue. Trunk 
blood was used for preparing plasma and for immediate quantitation of blood 
glucose and lactate (Accu-Check Aviva meter and Nova Biomedical Lactate Plus 
meter). Tissues were immediately frozen in liquid nitrogen and stored at −80℃. For 
subsequent assays, frozen tissues were pulverized in liquid-nitrogen with a pre-
chilled bio-pulverizer or mortar and pestle. 
 
Figure 3.1 Study design. HCR and LCR were run on the treadmill for 0 min, 10 min, 
or 45 min (HCR only). At these time points, animals were euthanized and plasma and 
tissues were collected. During the protocol, the treadmill speed begins at 10 m/min 
and increases 1 m/min every 2 min.  
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3.2.2  Indirect calorimetry 
Animals were run to exhaustion in sealed treadmill chambers. VO2 and VCO2 
were sampled every 2 min for 5 s and were recorded using a Comprehensive 
Laboratory Animal Monitoring System (CLAMS, Columbus Instruments). 
Measurements were scaled to body mass and lean body mass, which was 
determined using an NMR-based analyzer (Minispec LF90II, Bruker Optics, Billerica, 
MA).  
Non-protein RQ was used to estimate whole body carbohydrate and fat oxidation 
(Peronnet and Massicotte, 1991), and we adjusted estimates of carbohydrate 
oxidation to account for increased glycogen utilization as intensity increases 
(Jeukendrup and Wallis, 2005), see Equations 1-4.  
 
Equation 1. Estimates for whole body fat oxidation. 
 Fat oxidation (g/kg/min) = 1.695 ⨉ VO2 − 1.701 ⨉ VCO2  
 
Equation 2. Estimates for whole body carbohydrate oxidation at 0-40% VO2max.  
 Carbohydrate oxidation (g/kg/min) = 4.585 ⨉ VCO2 − 3.226 ⨉ VO2 
 
Equation 3. Estimates for whole body carbohydrate oxidation at 40-50% VO2max. 
 Carbohydrate oxidation (g/kg/min) = 4.585 ⨉ VCO2 − 3.061 ⨉ VO2 
 
Equation 4. Estimates for whole body carbohydrate oxidation at 50-100% 
VO2max. 
 Carbohydrate oxidation (g/kg/min) = 4.585 ⨉ VCO2 − 2.962 ⨉ VO2 
 
3.2.3  Muscle glycogen 
Frozen gastrocnemius muscle (~50 mg) was digested in 30% KOH for 15 min at 
37℃. Ethanol and NaSO4 (64% and 0.32%, final) were added to samples and 
allowed to incubate overnight at −20℃ to precipitate glycogen. Glycogen pellets 
were washed twice with 10% KOH and 66% ethanol. Glycogen was dissolved with 4 
N H2SO4 at 100℃ for 2 hr. Samples were neutralized with 4 N NaOH and the 
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resulting glucose concentration was determined with glucose (HK) assay kit from 
Sigma (St. Louis, MO). Glucose concentrations were normalized to starting tissue 
mass.  
 
3.2.4  Western blot for AMPK 
Pulverized frozen gastrocnemius muscle was extracted in buffer containing 1% 
Triton X-100, 20 mM HEPES, 20 mM beta-glycerophosphate, 150 mM NaCl, 10 mM 
NaF, 10 mM Na-Pyrophosphate, 1 mM EDTA, 1 mM Na-Orthovanadate, Roche 
protease inhibitor cocktail (Indianapolis, IN). After 20s sonication, samples were 
centrifuged at 8,000g for 10 min. Protein concentration was determined with Pierce 
BCA kit (Rockford, IL) and was used to normalize sample concentrations prior to 
loading. Sample extracts were separated by SDS-PAGE (Criterion, BioRad) and 
transferred to nitrocellulose membranes. After blocking with 5% non-fat dry milk in 
TBST, membranes were incubated overnight at 4°C with the following primary 
antibodies (1:1000): phospho-AMPK (Cell Signaling, #2531) and AMPK (Cell 
Signaling, #2532). Membranes were washed and incubated for 1 hr at 20°C with 
appropriate secondary antibodies conjugated to horseradish peroxidase (1:2000). 
After final washes, target proteins were detected with Pierce ECL solution (Rockford, 
IL). Band intensities were quantified using NIH ImageJ software (Schneider et al., 
2012).  
 
3.2.5  Confirmation data set 
 For confirming metabolite values that are coincident with exhaustion, we 
exercised male HCR and LCR (Generation 31 at 4.5 months of age) to quarter 
exhaustion (HCR only, ~15 min), half exhaustion (~6 min for LCR, ~30 min for HCR), 
and full exhaustion. At specified time points, animals were anesthetized with 
continuous inhalation of isoflurane. Tissues were collected under anesthesia and 
frozen immediately in liquid nitrogen; removal of heart ensured euthanasia. Tissues 
were stored at -80ºC.  
 
3.2.6  Statistical analysis and graphing 
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The R statistical and graphing environment was used for statistical analysis and 
generating figures (R Core Team, 2013). Data in tables and figures are presented as 
mean ± standard error of the mean (SEM). Comparisons were made between HCR 
and LCR at 0 min, 10 min and Rec and within HCR and LCR between 0 min and 
other time points. Permutation t-tests, implemented in R using the perm package, 
were used for determining p-values (Fay, 2010). Permutation t-tests minimize Type I 
statistical errors (false positives) and are an alternative to False Discovery Rate 
(FDR) correction (Camargo et al., 2008). We use a significance cut-off of p=0.05. 
Heatmaps were plotted using the gplots package "heatmap.2" function (Gregory 
R. Warnes, 2013). 
 
3.2.7  Muscle and plasma metabolites 
Total plasma non-esterified fatty acid (NEFA) was measured using Wako kit for 
NEFA (Richmond, VA). For specific carbon species analysis lipids were extracted 
from plasma using method described by Bligh and Dyer (Bligh and Dyer, 1959). 
Methyl esters were purified by thin layer chromatography and analyzed by gas 
chromatography.  
For measuring glycolytic and citric acid cycle intermediates, weighed, pulverized 
gastrocnemius muscle samples were extracted with a solvent mixture of 8:1:1 of 
HPLC grade methanol:chloroform:water, with a ratio 1 mL solvent per ~30 mg of wet 
tissue mass. Samples were sonicated using a probe sonicator (Branson 450, 40% 
duty cycle, output power 4) for 20 sec and then centrifuged (16,000 x g) to pellet 
proteins and cell debris. Supernatant were analyzed by hydrophilic interaction 
chromatography - electrospray - time-of-flight mass spectroscopy (HILIC-ESI-TOF-
MS) on Agilent 6220 (Santa Clara, CA) as described previously (Lorenz et al., 2011).  
For acylcarnitine analysis, weighed, pulverized gastrocnemius muscle or plasma 
aliquots were extracted with a mixture of 8:2 of HPLC grade acetonitrile:water. 
Samples were probe sonicated for 20 sec (muscle only) and centrifuged (16,000 x 
g). Supernatant were dried by vacuum centrifugation at 45℃ before being 
reconstituted in 9:1 mixture of mobile phases A/B used for the acylcarnitine analysis. 
The samples were analyzed using reversed phase liquid chromatography (RPLC) 
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coupled to an Agilent 6410 tandem quadrupole mass spectometer. The column used 
was a Water Xbridge C18 2.5 µ, 2.1 x 50 mm (Milford, MA); mobile phase A was 5 
mM ammonium acetate in water adjusted to pH 9.9 with ammonium hydroxide and 
mobile phase B was acetonitrile. Elution was performed at a flow rate of 0.25 
mL/min, and the gradient consisted of a 7 min linear ramp from 0 to 80% B, a 3 min 
was at 100% B and a 6-min re-equilibration period at 0% B. Detection was performed 
using multiple reaction monitoring (MRM) in positive ion mode, using 
precursor/product ion transitions specified elsewhere (Ghoshal et al., 2005). Mass 
spectrometer parameters were set to 4000 V capillary voltage, 325℃ gas 
temperature, 10 L/min gas flow, and 40 psi nebulizer pressure.  
For amino acid analysis, weighed, pulverized gastrocnemius or plasma aliquots 
were extracted in 8:1:1 of HPLC grade methanol:chloroform:water. Muscle extracts 
were probe sonicated for 20 sec. Samples were centrifuged (16,000 x g) and 
supernatant were dried by vacuum centrifugation at 45℃. The dried samples were 
then derivatized and analyzed using Phenomenex's EZ-faast kit (Torrance, CA) and 
analyzed using Agilent 6890 GC with a 5973 mass selective detector (Badawy et al., 
2007).  
For branched-chain keto-acid analysis, plasma aliquots were extracted with 8:1:1 
of HPLC grade methanol:chloroform:water and centrifuged (16,000 x g). Supernatant 
were dried by vacuum centrifugation at 45℃ and reconstituted with water. Resulting 
samples were analyzed by reversed phase liquid chromatography coupled to ESI-
TOF-MS in negative ion mode using a Waters Acquity HSS T3 1.8 µ column, with 
chromatographic conditions as described previously (Evans et al., 2013). 
Peak areas were determined using Agilent Masshunter Quantitative Analysis 
software. Authentic standards were used to determine accurate mass and retention 
times. The data is reported as relative peak area, or in some cases, is reported as 
concentration as determined using stable isotope internal standards. For muscle 
metabolites, peak areas or exact concentrations were normalized to starting tissue 
mass.  
 
3.3  Results 
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3.3.1  HCR have greater whole-body fat oxidation 
As in previous studies with HCR and LCR (Koch and Britton, 2001), HCR have 
lower body weight and higher exercise capacity (Table 3.1). On average, LCR ran 
for 10.51 ± 0.79 min while HCR ran 45.11 ± 1.13 min, p<0.0001.  
Oxygen consumption (V02) and carbon dioxide production (VCO2) during 
exercise were used to estimate whole-body carbohydrate and fat oxidation (Figure 
3.2). Amino acids can also contribute a small percentage of total fuel used during 
exercise (Wagenmakers et al., 1991); however, they are poorly accounted for using 
indirect calorimetry without accurate measurements of excreted nitrogen (urine and 
sweat). We will leave the discussion on amino acids for the later section 3.3.4 - 
Changes in amino acids with exercise. 
Both HCR and LCR increase carbohydrate oxidation with onset of exercise, but at 
4 min of exercise HCR and LCR begin to diverge in fuel use (Figure 3.2A). 
Carbohydrate oxidation continues to rise in LCR, but in HCR, carbohydrate use 
plateaus before gradually increasing again as HCR approach exhaustion. In 
reciprocal fashion, fat oxidation rapidly declines in LCR with onset of exercise but is 
maintained in HCR throughout the exercise protocol (Figure 3.2B). Fat oxidation 
begins to decrease as HCR approach exhaustion but does not drop below zero.  
 
Table 3.1 HCR weigh less and run further than LCR. Data are mean ± SEM. 
Asterisks indicate *p<0.0001. 
 
 
Body weight (g)
Percent fat mass (%)
Percent lean mass (%)
Time to exhaustion (min)
Speedmax (m/min)
VO2max (mL/kg/min)
VO2max (mL/kglean/min)
LCR (n=16)
439.0 ± 12.5
15.6 ± 0.6
72.1± 0.6
10.51 ± 0.79
14.63 ± 0.40
26.5 ± 0.8
36.8 ± 1.0
HCR (n=23)
294.2 ± 7.4*
3.9 ± 0.4*
78.9 ± 0.3*
45.11 ± 1.13*
31.83 ± 0.55*
39.4 ± 0.5*
50.0 ± 0.6*
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Figure 3.2 HCR have higher fat oxidation throughout exercise. With an 
increasing intensity exercise protocol, HCR run greater distance than LCR. (A) 
Carbohydrate oxidation and (B) fat oxidation are calculated from VO2 and VCO2 for 
HCR (blue) and LCR (red). Data are presented as mean ± SEM for HCR (n=23) and 
LCR (n=16). Asterisks indicate *p < 0.05 between HCR and LCR.  
 
3.3.2  HCR spare muscle glycogen 
During exercise the major inputs to glycolysis are blood glucose and muscle 
glycogen. As described in the study design, blood and tissues were collected at 0 
min, 10 min and 45 min (Figure 3.1). At rest (0 min), LCR and HCR show no 
difference in blood glucose (Figure 3.3A) or muscle glycogen levels (Figure 3.3B). 
Blood glucose increases in both LCR and HCR at 10 min, while HCR have a 
reduction in blood glucose near exhaustion (45 min). Muscle glycogen is significantly 
depleted near exhaustion in both LCR (10 min) and HCR (45 min), but glycogen 
levels are not significantly changed in HCR from 0 to 10 min of exercise (Figure 
3.3B). These findings are consistent with previous studies that have shown depletion 
of glycogen with exhaustion (Gollnick et al., 1974). These data suggest that muscle 
glycogen utilization, rather than glucose utilization, underlies the higher apparent 
carbohydrate oxidation in LCR during the first 10 min of exercise (Figure 3.2A).  
Although HCR have significantly greater fat oxidation than LCR and maintain high 
fat oxidation throughout exercise, total circulating NEFA levels do not differ between 
HCR and LCR at any time point. Both HCR and LCR have decreased circulating 
NEFA at 10 min of exercise Figure 3.4.  
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Figure 3.3 HCR spare muscle glycogen. Blood glucose (A), muscle glycogen (B), 
and plasma non-esterified fatty acids (NEFA) (C) were measured at 0 min, 10 min, 
and 45 min (HCR only). Values are mean ± SEM for each group (n = 4-6). Asterisks 
indicate * p<0.05 between HCR and LCR at a specific time point. Hashes indicate # 
p<0.05 difference from 0 min. 
 
3.3.3  HCR maintain complete fat oxidation 
To investigate metabolic changes related to fat oxidation, we measured total 
plasma fatty acids (predominately triglycerides), and muscle and plasma acyl-
carnitines (Figure 3.4A-C). Circulating fatty acid species are similar between HCR 
and LCR at rest (Figure 3.4A). However, several muscle acylcarnitine species are 
lower in HCR than LCR at 0 min (Figure 3.4B), and several plasma acylcarnitine 
species are higher in HCR than LCR at 0 min, except for C5 acylcarnitine which is 
lower in HCR at 0 min (Figure 3.4C). 
LCR, on the whole, show fewer changes in fatty acids and muscle acylcarnitines 
with exercise. Plasma 14:0 and 16:0 acylcarnitines are increased in LCR from rest to 
10 min of exercise (Figure 3.4B-C). The increase in plasma acylcarnitines is 
indicative of incomplete fatty acid oxidation and parallels the decrease in fat 
oxidation observed with increasing intensity exercise. HCR have more dynamic 
changes in fatty acid species and acylcarnitines. HCR show decreases in individual 
circulating fatty acid species from rest to 10 min and 45 min of exercise (Figure 
3.4A), but it should be noted that total sum of all fatty acid species do not differ 
between HCR and LCR at 10 min, consistent with total NEFA levels. In parallel to 
decreases in plasma fatty acid species, we observe that HCR have increased long-
chain muscle acylcarnitines from rest to 10 min and 45 min (Figure 3.4B). But 
importantly, medium-chain acyl-carnitines are not increasing at 10 min in HCR, 
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which is an indication that fatty acid flux is uninhibited and efficient. The decreases 
in fatty acid species and increases in muscle acylcarnitines are consistent with 
greater flux of fatty-acyl groups into HCR mitochondria during exercise, but like LCR, 
plasma long-chain acylcarnitines increase in HCR near exhaustion (45 min), 
coincident with decline in fatty acid oxidation.  
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Figure 3.4 HCR have greater changes in acylcarnitines with exercise. The figure 
depicts concentrations of specific plasma fatty-acyl species (A), muscle acylcarnitine 
species (B), plasma acylcarnitine species (C), muscle amino acids (C), plasma amino 
acids (D) and plasma branched-chain keto acids, α-ketoisocaproic acid (KIC), α-
ketoisovaleric acid (KIV), and α-ketomethylvaleric acid (KMV) for each group (n=5-6). 
Values are presented in heat-color with red indicative of high and blue indicative low 
relative to LCR 0 min. Asterisks indicate * p<0.05 between HCR and LCR at a 
specific time point. Hashes indicate # p<0.05 difference from baseline. 
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3.3.4  Changes in amino acids with exercise 
Amino acids represent the third fuel source for energy production. At rest, HCR 
have higher muscle lysine and lower plasma leucine levels than LCR, but all other 
amino acids were similar between HCR and LCR (Figure 3.4D-E). With exercise, 
several amino acids decrease in HCR: muscle and plasma ornithine, plasma aspartic 
acid, glutamine, isoleucine, leucine, proline, threonine, and valine. Additionally, 
muscle branched-chain amino acids (BCAA) — leucine, isoleucine, and valine — are 
lower in HCR than LCR at 10 min (Figure 3.4D). By 45 min, several amino acids are 
elevated above resting levels in HCR: plasma glutamic acid, muscle and plasma 
phenylalanine, tyrosine, and tryptophan.  
BCAA are the predominate amino acids used for fuel during exercise 
(Wagenmakers et al., 1991), and because these amino acids are lower in HCR than 
LCR at 10 min, we measured the downstream keto-acids. Leucine, isoleucine, and 
valine are deaminated (loss of NH3) to yield keto-isocaproic acid (KIC), keto-
methlyvaleric acid (KMV), and keto-isovaleric acid (KIV), respectively. These keto-
acids increase in LCR with exercise and KIV levels are greater in LCR vs. HCR at 10 
min (Figure 3.4F).  
BCAA degradation can also produce the short-chain carnitines propionyl-carnitine 
(C3), isobutyryl-carnitine (C4), and isovaleryl-carnitine/methylbutyryl-carnitine (C5). 
These carnitines increase in muscle and plasma with exercise (Figure 3.4B-C).  
 
3.3.5  AMP kinase phosphorylation 
AMP kinase is a potential mediator of fuel selection and is driven by changes in 
AMP/ATP ratio (Hardie et al., 1999). HCR and LCR both have significant elevations 
in muscle AMP/ATP ratio near exhaustion (Figure 3.5A). Phosphorylation of AMPK 
parallels AMP/ATP and was increased in LCR at 10 min but not in HCR was not 
significantly different between HCR and LCR at 0 min, and LCR have increased 
AMPK phosphorylation at 10 min, whereas HCR have significantly increased AMPK 
phosphorylation at 45 min (Figure 3.5B-C). These data suggest that greater AMPK 
phosphorylation is not mediating increased fat oxidation in HCR during the first 10 
min of exercise.  
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Figure 3.5 Muscle AMPK is phosphorylated near exhaustion. Muscle AMP:ATP 
(A) parallels changes in phosphorylation of AMPK (B). Representative blots for 
phosphorylated and total AMPK are shown in (C). Values are mean ± SEM for each 
group (n = 4-6). Asterisks indicate * p<0.05 between HCR and LCR at a specific time 
point. Hashes indicate # p<0.05 difference from 0 min. 
 
3.3.6  Metabolite changes coincident with exhaustion 
To probe for metabolite changes that are coincident with fuel selection and 
exhaustion, we determined correlation coefficients (Pearson r) of metabolites with 
estimated fat oxidation, estimated carbohydrate oxidation and relative exhaustion 
(time at collection/previous time to exhaustion). We found 19 metabolites to be 
correlated with both fat and carbohydrate oxidation and coincident with exhaustion; 
most of these increased with longer exercise duration (Table 3.2).  
To confirm changes with exhaustion, we compared these results with a second 
metabolomics data set in which HCR and LCR were run to quarter, half, and full 
exhaustion (Appendix B, Table B.1). Five metabolites were confirmed to change 
significantly with exhaustion: muscle glycogen, muscle acetylcarnitine (C2), muscle 
malate, muscle IMP, and plasma C5 carnitine (Table 3.2). Blood lactate was not 
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measured in the confirmation data set, but given the accumulated evidence from 
previous studies (Constantin-Teodosiu et al., 1991; Hill and Lupton, 1923), blood 
lactate is also a consistent marker of exhaustion on an increasing intensity protocol 
and correlated with fuel selection.  
As previously highlighted, muscle glycogen levels decline with approach to 
exhaustion (Figure 3.3B) and this decline is coincident with increased carbohydrate 
use in both HCR and LCR. Muscle malate, a citric acid cycle intermediate, increases 
near exhaustion (Figure 3.6A). The other TCA cycle intermediates also tended to 
increase with exhaustion (Table 3.2), but only malate was found to be coincident 
with exhaustion in both data sets and strongly associated with fuel use. Muscle IMP 
(Figure 3.6B) is significantly lower in HCR at rest (0 min), but IMP values increase 
more than 5-fold in both HCR and LCR near exhaustion. The increase in IMP 
concentration with exhaustive exercise (Rush et al., 1995) occurs through 
deamination of AMP by myoadenylate deaminase (Tarnopolsky et al., 2001). Plasma 
C5 carnitine was also lower in HCR at 0 min (Figure 3.6C). Relative to the other 
metabolites that increased near exhaustion, changes in plasma C5-carnitine were 
smaller. C5-carnitine is an intermediate metabolite produced in the break down of 
isoleucine and/or leucine.  
 Muscle acetylcarnitine levels (Figure 3.4B) were positively correlated with 
carbohydrate oxidation and inversely correlated with fat oxidation (Figure 3.6D-E). A 
correlation between acetylcarnitine levels and fuel selection (RQ) has been reported 
previously (Kiens, 2006), but unlike previous reports (van Loon et al., 2001), we 
found no association between depletion of muscle L-carnitine and the decline in fat 
oxidation (Figure 3.6F), suggesting that in this model, carnitine availability is not 
limiting fat oxidation. Instead, acetylcarnitine accumulation is indicative of 
overproduction of acetyl units relative to downstream utilization through the citric 
acid cycle at exhaustion in both HCR and LCR. The buildup of citric acid cycle 
intermediate, malate, is consistent with this explanation. Finally, the similar pattern of 
change in metabolite levels relative to exhaustion in HCR and LCR suggests that the 
mechanism of exhaustion is similar in both strains, but is simply delayed in HCR. 
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Table 3.2 Metabolites correlated with fuel use and exhaustion. Table contains 
correlation coefficients (Pearson r) of metabolite values with fat oxidation, 
carbohydrate oxidation and percent exhaustion. An independent data set was used 
to confirm metabolites associated with exhaustion. In the independent data set, HCR 
and LCR were run to quarter (HCR only), half, and full exhaustion. 
 
 
 
 
Metabolite Pearson r p-value Pearson r p-value Pearson r p-value Pearson r p-value
Muscle Glycogen * 0.49 0.008 -0.72 <0.001 -0.82 <0.001 -0.69 <0.001
Muscle C2 Carnitine * -0.51 0.006 0.80 <0.001 0.81 <0.001 0.65 <0.001
Muscle Malate * -0.61 0.001 0.82 <0.001 0.87 <0.001 0.58 0.001
Plasma C5:0 Carnitine * -0.41 0.030 0.65 <0.001 0.54 0.002 0.57 0.001
Muscle IMP * -0.47 0.011 0.59 0.001 0.61 <0.001 0.43 0.019
Muscle UDP-D-glucose -0.47 0.011 0.76 <0.001 0.85 <0.001 -0.51 0.005
Muscle Dihydroxy-acetone-phosphate 0.61 0.001 -0.43 0.023 -0.44 0.012 0.43 0.019
Muscle Succinate -0.44 0.018 0.65 <0.001 0.70 <0.001 0.16 0.413
Muscle AMP -0.62 <0.001 0.63 <0.001 0.55 0.001 0.14 0.475
Muscle GDP -0.49 0.008 0.48 0.010 0.37 0.039 0.07 0.737
Muscle GMP -0.60 0.001 0.57 0.002 0.43 0.017 0.02 0.912
Muscle Creatine -0.39 0.041 0.50 0.007 0.60 <0.001 0.01 0.969
Muscle Malonyl-CoA 0.44 0.019 -0.47 0.012 -0.52 0.003 0.00 0.980
Muscle ADP -0.60 0.001 0.61 0.001 0.53 0.002 -0.15 0.442
Muscle IDP -0.59 0.001 0.57 0.001 0.42 0.018 -0.20 0.294
Muscle Creatine-phosphate 0.62 <0.001 -0.59 0.001 -0.63 <0.001 -0.30 0.108
Blood Lactate -0.51 0.007 0.70 <0.001 0.78 <0.001 n.d.
Plasma 14:0 Fatty Acid 0.46 0.016 -0.39 0.042 -0.39 0.035 n.d.
Correlation with Fatty 
Acid oxidation
Correlation with 
Carbohydrate oxidation
Correlation with 
Exhaustion
Independent Data Set: 
Correlation with 
Exhaustion
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Figure 3.6 Metabolites that increase with exhaustion. Muscle malate (A), blood 
lactate (B) and muscle acetylcarnitine (C) values are shown at 0, 10 and 45 min of 
exercise as mean ± SEM for each group (n = 4-6). Muscle acetylcarnitine (C2) is also 
strongly correlated with previous estimates of carbohydrate oxidation (D) and fat 
oxidation (E) at 0, 10, and 45 min of exercise. Muscle L-carnitine (F) was not 
correlated with fat oxidation. * p<0.05 between HCR and LCR at a specific time point; 
# p<0.05 difference from baseline. 
 
3.4  Discussion  
In this study we use indirect calorimetry and metabolomics to define fuel use 
during an increasing-intensity exercise protocol. These data reveal that HCR have 
enhanced fat oxidation throughout exercise and delayed glycogen depletion vs. LCR. 
We found that metabolic intermediates, malate, acetylcarnitine, and C5-carnitine, 
were associated with exhaustion and correlated with fuel selection.  
Given these data and evidence from the literature, we propose that fat oxidation 
and delayed glycogen depletion support higher exercise capacity. Our data are 
consistent with other reports showing fat oxidation is higher in individuals with higher 
exercise capacity (Hall et al., 2010; Morris et al., 2013; Nordby et al., 2006; Venables 
et al., 2005), and that disruption of fatty acid oxidizing genes results in poor running 
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capacity (Fernandez et al., 2008; Huijsman et al., 2009). We can speculate what 
mechanisms might underlie the difference in fuel preference between HCR and LCR.  
There is little to no evidence that circulating fuel availability is driving fuel use 
differences between HCR and LCR. Increased lipid availability during exercise can 
lead to increased fat oxidation (Romijn et al., 1995). However, in our study HCR and 
LCR have comparable levels of NEFA and glucose at rest and 10 min of exercise 
despite differences in fuel use. Even when comparing circulating lipid species, we do 
not find a difference between HCR and LCR at rest, with the exception of C14:0, 
which is lower in HCR. Decreases in lipids with exercise in HCR might be indicative 
of greater lipolysis of serum triglycerides, but the total sum of lipids was not different 
between HCR and LCR at 0 or 10 min of exercise. Although we did not measure 
intramuscular triglycerides, we measure specific fatty acids in muscle (stearic, oleic, 
and palmitic), only stearic acid was significantly different between HCR and LCR, 
and was lower in HCR at 10 min of exercise (Table A.1). 
Although fat availability is likely not driving differences in fuel use, it could be that 
HCR and LCR have differences in fuel uptake with exercise. Previous reports found 
that HCR have greater protein expression of fatty acid transporter CD36 (Lessard et 
al., 2009). The rise in muscle acyl-carnitine in HCR suggest greater fatty acid entry 
into the mitochondria with exercise, and this could be due to differences in fatty acid 
transport. Free carnitine availability is a proposed limiting factor for fatty acid entry 
into mitochondria (Jeppesen and Kiens, 2012; Jeukendrup, 2002). In this study, free 
L-carnitine decreases with exercise but does not correlate with fat oxidation, 
suggesting that L-carnitine is not limiting. It could be the case that CPTI activity is 
different between HCR and LCR, but total CPTI protein is not different between the 
strains (DeMarco et al., 2012; Rivas et al., 2011). LCR have notable increases in 
medium-chain plasma acyl-carnitines with exercise indicating production and export 
of acyl-carnitines from the tissue and likely greater incomplete fatty acid oxidation. 
Fatty acid transporters could be mediating increased fat oxidation, but we suspect 
that other mechanisms are also contributing to the difference in fuel use. 
Our data support the reciprocal relationship between fat and carbohydrate 
oxidation. Glycogen depletes as animals approach exhaustion and coincident with 
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lower fat oxidation. The metabolic products of immediately downstream of glycolysis 
— lactate and acetylcarnitine — were elevated with exhaustion and inversely 
correlated to fat oxidation. This reciprocal relationship between fat and carbohydrate 
oxidation has been well established (Randle, 1998). Glycogen breakdown and 
acetylcarnitine production increase with increasing-intensity exercise (Constantin-
Teodosiu et al., 1991; Gollnick et al., 1974; Hiatt et al., 1989; Sahlin, 1990; van Loon 
et al., 2001). Glycogen phosphorylase activity, which mediates glycogen breakdown, 
increases with exercise (Jensen et al., 2011). HCR maintain muscle glycogen for 
longer; this might suggest HCR and LCR have differences in allosteric 
inhibitors/activators or differences in muscle recruitment and contraction mediated 
activation of glycogen phosphorylase.  
Pyruvate dehydrogenase (PDH) activity increases with increasing intensity 
exercise (Howlett et al., 1998). Increased PDH activity might support increasing 
acetylcarnitine with increasing intensity. Acetylcarnitine accumulation with 
exhaustion signifies that acetyl-CoA is being made in excess of what can be used in 
the tissue. This excess can occur through the rapid production of acetyl-coA from 
glycolysis, but it also means that there is some limit on down-stream utilization - 
either in the citrate cycle or oxidative phosphorylation. Excess acetyl-CoA is 
converted to acetylcarnitine by the enzyme carnitine acetyl-transferase (CrAT). CrAT 
is highly expressed and active in skeletal muscle (Marquis and Fritz, 1965; Noland et 
al., 2009). Over-expression of CrAT in myotubes increased acetylcarnitine 
production, but also increased PDH activity and decreased fat oxidation. These data 
suggest a role of acetylcarnitine production in supporting changes in fuel preference.  
Beyond fat and carbohydrate use, our data give evidence for changes in BCAA 
metabolism with exercise and exhaustion. At 10 min of exercise, BCAA decrease in 
plasma of HCR and muscle BCAA is lower in HCR than LCR. Downstream BCAA 
metabolites (KIV, C3-carnitine, and C5-carnitine) are increased at exhaustion. 
Decreased muscle and plasma BCAA in HCR suggest greater BCAA degradation in 
HCR vs. LCR, and increased KIV and downstream metabolites in LCR with 10 min of 
exercise might indicate incomplete BCAA degradation in LCR. BCAA degradation is 
likely a important component of exercise capacity. Plasma BCAA levels inversely 
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correlate with exercise capacity (Morris et al., 2013), and knocking out a key enzyme 
in BCAA metabolism leads to decreased exercise capacity (She et al., 2010).  
As with all studies, there are some limitations. The indirect calorimetry was 
performed using an increasing-intensity exercise protocol - this is necessary to 
accurately measure VO2max, but determining fuel use on this type of protocol is less 
accurate due to non-steady state conditions. Therefore, we present the data as a 
best estimate of fuel use during this protocol. Our second assessment of fuel use 
employed targeted metabolomics. A targeted metabolomics approach inherently 
biases our results towards previously detected metabolites and known metabolic 
pathways, but at the same time allows for greater confidence in the metabolites we 
report. And finally, in exploring which metabolites associate with exhaustion, we 
assume that there are common factors related to exhaustion in both HCR and LCR. 
It is possible that HCR and LCR exhaust for different reasons. Our data might 
suggest that HCR have more extreme case of metabolic stress near exhaustion - 
severely depleted glycogen, lower blood glucose, extreme elevations in muscle and 
plasma acyl-carnitines and robust phosphorylation of AMPK at 45 min. Although, 
HCR and LCR might experience different metabolic extremes near exhaustion, the 
metabolites that are altered with exhaustion in both animals (muscle glycogen, blood 
lactate, muscle acetylcarnitine, and muscle IMP) are well described in the literature 
as associating with exhaustion (Constantin-Teodosiu et al., 1991; Hiatt et al., 1989; 
Rush et al., 1995; Sahlin, 1990; van Loon et al., 2001). 
Ultimately these data lead us to conclude that HCR's maintained fat oxidation and 
delayed glycogen utilization support increased running capacity. Mechanisms driving 
fuel preference are still unknown, although we find that accumulation of metabolic 
intermediates malate, acetylcarnitine, C5 carnitine, and lactate are correlate with use 
and coincident with exhaustion, suggesting that fuel use is dependent on 
mitochondrial oxidative capacity.  
 
3.5  Summary 
• HCR have greater fat oxidation during an increasing intensity exercise 
protocol. 
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• Fuel availability does not differ between HCR and LCR before exercise. 
• HCR have evidence for increased BCAA metabolism with exercise 
• 5 metabolites: plasma C5 carnitine, muscle malate, muscle IMP, muscle 
acetylcarnitine, and muscle glycogen are correlated with fuel selection and 
coincident with exhaustion. 
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Chapter 4 
Post-translational modifications that occur with exercise  
 
In the previous chapter, we assessed metabolite changes that occur with 
exercise. We found HCR have higher fat oxidation throughout exercise compared to 
LCR. Because fuel preference is driven by both fuel availability and enzyme activity. 
In this chapter we will look at proteomic differences between HCR and LCR at rest 
and examine changes in enzyme modification (phosphorylation and acetylation) that 
occur with 10 min of exercise.  
 
4.1  Introduction 
Fuel availability and enzyme activity modulate fuel preference. With a 
metabolomics approach we identified difference in fuel use between HCR and LCR. 
We used metabolite values to infer mechanisms that might lead to these differences 
and the overall phenotype. We expand on our understanding of molecular 
mechanisms of fuel selection by looking directly at the proteome. In vivo, enzyme 
activity is affected by amount of enzyme available and modifications to the enzyme. 
Amount of available enzyme is controlled by transcriptional activity and protein 
ubiquintination, which act in opposition to control enzyme synthesis and breakdown. 
These processes regulate enzyme availability on the time scale of minutes to hours, 
while acute regulation of enzyme activity is achieved through enzyme modifications 
and allosteric regulation. Thus to understand difference in fuel use with exercise, we 
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must look for both enzyme availability and protein modifications that occur with 
exercise.  
There is some evidence that increased availability of enzymes within the fat 
oxidation pathway can support increased fat-use during exercise and increased 
exercise capacity. Particularly, adaptation in response to exercise training is 
associated with increased transcription of HADH, FABP, FAT/CD36, and CPTI 
(Holloszy and Coyle, 1984). Active vs. inactive twins have greater expression of 
genes within the fat oxidization pathway, as do rats bred for high vs. low running 
capacity (Kivela et al., 2010; Pietilainen et al., 2008). However, there is contradictory 
evidence that increased availability of fat oxidizing enzymes — occurring with high-
fat food intake — is not sufficient to increase fat-use during exercise or running 
capacity (Hall et al., 2010). While enzyme availability is important, other factors, like 
enzyme modification, might be equally important in directing fuel use.  
Certain modifications to enzymes, like phosphorylation and acetylation, can 
support changes in fuel use. Phosphorylation of enzymes has been increasing 
studied since glycogen phosphorylase was demonstrated to have altered activity 
when phosphorylated (Fischer and Krebs, 1955). A number of other metabolic 
enzymes are modified by phosphorylation: pyruvate dehydrogenase (PDH), 
branched-chain keto acid dehydrogenase (BCKDH), acetyl-CoA carboxylase, and 
changes in phosphorylation of these enzymes occur with exercise and modify 
enzyme activity (Howlett et al., 1998; Jeppesen and Kiens, 2012; Lynch et al., 2002). 
In contrast to phosphorylation, enzyme modification by acetylation is a more recent 
discovery, with publications in 2010 demonstrating that most metabolic enzymes are 
acetylated on one or more lysine residues (Wang et al., 2010; Zhao et al., 2010). 
Relatively few acetylation sites have been assessed for functional consequence 
(Xiong and Guan, 2012), however enzyme acetylation changes with fasting and re-
feeding and with calorie restriction are associate with changes in fuel preference 
suggesting that acetylation can modify fuel use.  
We used proteomic analysis to better understand fuel use in HCR and LCR with 
exercise. Indirect calorimetry and metabolomic analysis presented in Chapter 3 - 
Metabolomics to define fuel use during exercise show that HCR have delayed 
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glycogen utilization and greater fat-use during exercise than LCR, despite LCR 
having similar fat-availability. We hypothesize that HCR and LCR have differences in 
enzyme availability, which is suggested from gene-expression data (Kivela et al., 
2010), and we expect HCR and LCR might have differential enzyme modification that 
could help explain differences in fuel preference.  
 
4.2  Methods 
 
4.2.1  Animal protocol and study design 
HCR and LCR male rats (generation 31) were housed at the University of 
Michigan, and the University Committee on Use and Care of Animals, Ann Arbor 
Michigan approved the study. All procedures were in compliance with University 
guidelines and state and federal regulations.  
At 11 weeks of age, exercise capacity was determined as described previously 
3.2.1 - Animal protocol and study design. The following week, the HCR and LCR rats 
were divided into rest and 10 min run groups (n=5), and were given ad libitum 
access to food prior to the experiments. Rats in the rest group were allowed to rest 
on stationary treadmills for 10 min, and animals in the Run group were run on the 
treadmill for 10 min (treadmill starting at 10 m/min and increasing 1/min every 2 min). 
After these time points, rats were immediately anesthetized by inhaled isoflurane 
(~30s) and then euthanized by decapitation. Trunk blood was used for preparing 
serum, and tissues were harvested and immediately frozen in liquid nitrogen. 
Tissues were stored at −80℃. Both right and left extensor digitorum longus muscles 
(EDL) were used for subsequent proteomic analysis.  
 
4.2.2  Mitochondrial isolations 
Crude mitochondria were enriched using previously described methods 
(Pagliarini et al., 2008), with some modifications for the current study. Rat EDL 
tissue was initially homogenized by crushing with a mortar and pestle (Coors) under 
liquid nitrogen, and all subsequent steps were carried out at 4ºC. The homogenate 
was then transferred into a Potter-Elvehjem glass/teflon homogenizer along with 8 
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mL of MSHE buffer (220mM mannitol, 70mM sucrose, 5mM HEPES pH 7.4, 1mM 
EGTA), supplemented with protease inhibitors, deacetylase inhibitors and 0.5% BSA, 
for further homogenization. After homogenization with 5 strokes at 1000 rpm, the 
resulting homogenate was decanted into a new 15 mL tube. The homogenizer was 
rinsed with an additional 2 mL of MSHE, which was then added to the homogenate. 
The sample was centrifuged at 800 x g for 10 min in bench-top conical centrifuge. 
Any lipid that formed at the top of the supernatant was carefully aspirated. The 
supernatant, containing the mitochondria, was gently drawn off with a pipet-aid and 
transferred to an ultra-clear 12 mL centrifuge tube. The samples were centrifuged at 
8000 x g for 10 min, and the resulting supernatant and any loose material was 
aspirated and discarded, leaving a dark brown pellet with a light brown halo around 
the center. An additional 10 mL of MSHE buffer was added to the pellet, which was 
resuspended by washing from the side of the tube until homogenous using as few 
pipetting strokes as possible. The sample was centrifuged an additional time at 8000 
x g for 10 min and the crude mitochondria were resuspended in 1 mL of MSHE using 
the same method as before. Crude mitochondria were transferred to a 1.5 mL 
microfuge tube and centrifuged at 8,000 x g for 10 min in bench-top microfuge. The 
supernatant was aspirated and discarded. The pellet was re-suspended in MSHE 
(without BSA) and centrifuged at 8,000 x g for 10 min in bench-top centrifuge. The 
supernatant was aspirated and discarded, and the crude mitochondrial pellet was 
flash frozen in liquid N2 and stored at -80°C until ready for use. 
 
4.2.3  Generation of peptides 
Mitochondrial cell pellets were re-suspended in approximately 500µL of lysis 
buffer (50mM Tris (pH 8), 8M urea, 40mM NaCl, 2mM MgCl2, 50mM NaF, 50mM β-
glycerophosphate, 1mM sodium orthovanadate, 10mM sodium pyrophosphate, mini 
EDTA-free protease inhibitor (Roche Diagnostics, Indianapolis, IN), phosSTOP 
phosphatase inhibitor (Roche Diagnostics, Indianapolis, IN), and deacetylase 
inhibitors) and lysed on ice with a probe sonicator. Protein content was evaluated 
using a BCA assay (Thermo Fisher Scientific, San Jose, CA).  
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Proteins were reduced with 5mM dithiothreitol (incubation at 58°C for 30 minutes) 
and alkylated with 15mM iodoacetamide (incubation in the dark, at ambient 
temperature, for 30 minutes). Alkylation was quenched by adding an additional 5mM 
dithiothreitol (incubation at ambient temperature for 15 minutes). Proteins were 
enzymatically digested in a two-step process. First, proteinase LysC (Wako 
Chemicals, Richmond, VA) was added to each sample at a ratio of 1:100 
(enzyme:protein) and the resulting mixtures were incubated at 37ºC for 3 hours. 
Next, samples were diluted to a final concentration of 1.5 M urea (pH 8) with a 
solution of 50mM Tris and 5mM CaCl2. Sequencing-grade trypsin (Promega, 
Madison, WI) was added to each sample at a ratio of 1:50 (enzyme:protein) and the 
resulting mixtures were incubated at ambient temperature overnight. Digests were 
quenched by bringing the pH to ~2 with trifluoroacetic acid and immediately desalted 
using C18 solid-phase extraction columns (SepPak, Waters, Milford, MA). 
Desalted material was labeled with TMT 10-plex isobaric labels (Thermo-Pierce, 
Rockford, IL). Only eight of the ten labels were used per experiment for the 
comparison of two biological replicates across each the four conditions. Prior to 
quenching the TMT reactions, ~5µg of material from each TMT channel was 
combined into a test mix and analyzed by LC-MS/MS to evaluate labeling efficiency 
and obtain optimal ratios for sample recombination. Following quenching, tagged 
peptides were combined in equal amounts by mass (~500µg per channel) and 
desalted. All experiments had ≥ 99% labeling efficiency, calculated by the number 
labeled peptides divided by the total number of peptide identifications.  
Labeled peptides were fractionated by strong cation exchange (SCX) using a 
polysulfoethylaspartamide column (9.4×200mm; PolyLC) on a Surveyor LC 
quaternary pump (Thermo Scientific). Each dried and mixed TMT sample was 
resuspended in buffer A, injected onto the column, and subjected to the following 
gradient for separation: 100% buffer A from 0-2 min, 0-15% buffer from 2-5 min, and 
15-100% buffer B from 5-35 min. Buffer B was held at 100% for 10 minutes and then 
the column was washed extensively with buffer C and water prior to recalibration. 
Flow rate was held at 3.0 mL/min throughout the separation. Buffer compositions 
were as follows: buffer A [5mM KH2PO4, 30% acetonitrile (pH 2.65)], buffer B [5mM 
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KH2PO4, 350mM KCl, 30% acetonitrile (pH 2.65)], buffer C [50mM KH2PO4, 500mM 
KCl (pH 7.5)]. Twelve fractions were collected over the first 50-minute elution period 
and were immediately frozen, lyophilized, and desalted. A small portion of each, 5%, 
was extracted and used for protein analysis. The remaining material was retained for 
phospho and acetyl lysine enrichment.  
 
4.2.4  Phospho and Acetyl-site enrichment 
Phosphopeptides were enriched using immobilized metal affinity chromatography 
(IMAC) with magnetic beads (Qiagen, Valencia, CA). Following equilibration with 
water, the magnetic beads were incubated with 40mM EDTA (pH 8.0) for 1 hour, with 
shaking. Next, the beads were washed four times with water and incubated with 
30mM FeCl3 for 1 hour, with shaking. Beads were then washed four times with 80% 
acetonitrile/0.15% TFA. Each of the 12 fractions were re-suspended in 80% 
acetonitrile/0.15% TFA and incubated with the magnetic beads for 45 minutes, with 
shaking. Following this incubation, all unbound peptides were collected for 
subsequent acetyl lysine enrichment. Bound peptides were washed three times with 
80% acetonitrile/0.15% TFA and eluted with 50% acetonitrile, 0.7% NH4OH. Eluted 
peptides were immediately acidified with 4% FA, frozen, and lyophilized. Each 
phospho peptide fraction was re-suspended in 20µL 0.2% FA for LC-MS/MS 
analysis.  
 Peptides unbound by IMAC enrichment were pooled into 6 fractions. Each 
fraction was dissolved in 50mM HEPES (pH 7.5)/100mM KCl buffer, combined with 
approximately 50µL pan-acetyl lysine antibody-agarose conjugate (Immunechem), 
and rotated overnight at 4°C. Samples were rinsed eight times with 50mM HEPES 
(pH 7.5)/100mM KCl buffer prior to elution with 0.1% TFA. Eluted peptides were then 
desalted, frozen, and lyophilized. Each acetyl lysine fraction was re-suspended in 
20µL 0.2% FA for LC-MS/MS analysis.  
 
4.2.5  Proteomic LC-MS/MS analysis 
Proteomic LC-MS/MS analysis. All experiments were performed using a 
NanoAcquity UPLC system (Waters, Milford, MA) coupled to an Orbitrap Fusion (Q-
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OT-qIT) mass spectrometer (Thermo Fisher Scientific, San Jose, CA). Reverse-
phase columns were made in-house by packing a fused silica capillary (75µm i.d., 
360 µm o.d, with a laser-pulled electrospray tip) with 1.7µm diameter, 130 Å pore 
size Bridged Ethylene Hybrid C18 particles (Waters) to a final length of 30cm. The 
column was heated to 60°C for all experiments. Samples were loaded onto the 
column for 12 minutes in 95:5 buffer A [water, 0.2% formic acid, and 5% 
DMSO]:buffer B [acetonitrile, 0.2% formic acid, and 5% DMSO] at a flow-rate of 
0.30µL/min. Peptides were eluted using the following gradient: an increase to 7% B 
over 1 min, followed by a 42 min linear gradient from 7% to 18% B, followed by a 28 
min linear gradient from 18% to 27% B, followed by a final 1 min ramp to 75% B 
which was held for 3 minutes. The column was equilibrated with 5% buffer B for an 
additional 25 min. Precursor peptide cations were generated from the eluent through 
the utilization of a nanoESI source. Phospho and acetyl enriched fractions were each 
analyzed in duplicate. 
Mass spectrometry instrument methods consisted of MS1 survey scans (8e5 
target value; 60,000 resolution; 350Th – 1400Th) that were used to guide ten 
subsequent data-dependent MS/MS scans (0.7Th isolation window, HCD 
fragmentation; normalized collision energy of 37; 5e4 target value, 60,000 
resolution). Dynamic exclusion duration was set to 60s, with a maximum exclusion 
list of 500 and an exclusion width of 0.55Th below and 2.55Th above the selected 
average mass. Maximum injection times were set to 100ms for all MS1 scans, 
120ms for MS/MS scans in whole protein analyses, and 200ms for MS/MS scans in 
phospho and acetyl enrichment analyses. 
 
4.2.6  Proteome data processing and normalization 
Data was processed using the in-house software suite COMPASS (Wenger et al., 
2011b). OMSSA (Geer et al., 2004) (version 2.1.8) searches were performed against 
a target-decoy database (Uniprot (rat), www.uniprot.org, August 19, 2013). Searches 
were conducted using a 3Da precursor mass tolerance and a 0.01Da product mass 
tolerance. A maximum of 3 missed tryptic cleavages were allowed. The fixed 
modifications specified were carbamidomethylation of cysteine residues, TMT 10-
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plex on peptide N-termini, and TMT 10-plex on lysine residues. The variable 
modifications specified were oxidation of methionine and TMT 10-plex on tyrosine 
residues. Additional variable modifications were specified for phospho-peptide 
analyses (phosphorylation of threonine, serine, and tyrosine residues) and acetyl-
peptide analyses (acetylation of lysine residues). Note that the acetylation 
modification mass shift was set to -187.1523 Da to account for the difference 
between an acetyl group and a TMT 10-plex tag, which enables the use of TMT 10-
plex as a fixed modification on lysine residues, even for acetylated peptides. TMT 
quantification of identified peptides was performed within COMPASS as described 
previously (Phanstiel et al., 2011). Peptides identified within each of 12 fractions 
were grouped into proteins according to previously reported rules (Nesvizhskii and 
Aebersold, 2005) using COMPASS. Protein quantification was performed by 
summing all of the reporter ion intensities within each channel for all peptides 
uniquely mapping back to a given protein. Protein, phospho-peptide, and acetyl-
peptide experiment sets were processed separately.  
 Phosphopeptide localization was performed using Phosphinator software within 
COMPASS, as described previously (Phanstiel et al., 2011). This program both 
localized phosphorylation sites and combined quantitative data for phospho-isoforms 
across all 12 fractions. All phosphosites had to be localized for a given phospho-
peptide to be included in subsequent quantitative analysis. 
Acetylpeptide localization was performed using LoToR software within 
COMPASS. Briefly, for each peptide spectral match (PSM) that contained an acetyl 
modification, theoretical fragmentation spectra were generated by performing in 
silico fragmentation of every possible peptide isoform. Each theoretical spectrum 
was then compared to the experimental spectrum using mass tolerances of 0.025Th. 
A peptide was declared localized if one isoform matched at least one peak more 
than any other isoform matched. Localized acetylated peptides were grouped 
together on acetylated positions and reporter ion intensities were summed. 
To generate a list of rat mitochondrial proteins, Entrez GeneIDs from the mouse 
MitoCarta compendium of mitochondrial proteins (Pagliarini et al., 2008) were 
mapped to NCBI HomoloGene group ID according to build 67. All rat genes 
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corresponding to these groups were then mapped to UniProt identifiers using the 
UniProtKB ID mapping table (July 2013). 
To account for variation in mitochondrial preparation, all quantitative data was 
normalized at the mitochondrial protein level. Only mitochondrial proteins were 
included in our analysis. All quantitative values were log2 transformed and mean 
normalized. To normalize phosphorylation and acetylation data for protein 
differences, the value for each phospho and acetyl isoform reporter ion channel had 
subtracted from it the quantitative value of that channel from the corresponding 
protein.  
 
4.2.7  Sirt3 Western Blot 
Western blot for SIRT3. Frozen gastrocnemius tissues collected from female 
HCR and LCR rats (generation 33, 6 month of age) at 0, 10, and 45 min of treadmill 
exercise were used for mitochondrial isolations. Isolated mitochondria were 
extracted in buffer containing 1% Triton X-100, 20mM HEPES, 20mM beta-
glycerophosphate, 150mM NaCl, 10mM NaF, 10mM Na-Pyrophosphate, 1mM EDTA, 
protease inhibitor cocktail (Roche) and phosphatase inhibitor cocktail (Thermo 
Scientific). After 20s sonication, samples were centrifuged at 8,000 x g for 10 min. 
Protein concentration was determined with Pierce BCA kit (Rockford, IL) and was 
used to normalize sample concentrations prior to loading. Sample extracts were 
separated by SDS-PAGE (Criterion, BioRad) and transferred to a nitrocellulose 
membrane. After blocking with 5% non-fat dry milk in TBS-T, the membrane was 
incubated overnight at 4°C with anti-SirtT3 primary antibody (1:1000, Cell Signaling 
#D22A3, generously provided by David Lombard). The membrane was washed and 
incubated for 1 hr at 20°C with appropriate secondary antibodies conjugated to 
horseradish peroxidase (1:2000). After final washes, target proteins were detected 
with Pierce ECL solution (Rockford, IL).  
 
4.2.8  Statistical analysis and graphing 
Statistical analysis and graphing was performed in the R environment (R Core 
Team, 2013). Protein and modification site fold-changes were calculated by 
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averaging protein-normalized values for each condition and calculating the difference 
of averages. Comparisons were made between HCR and LCR at rest and 10 min 
exercise and within strain between rest and 10 min exercise. Pathway enrichment 
analysis was performed through Enrichr (Chen et al., 2013). For statistics on 
pathway changes, each acetyl-site within a pathway for each individual samples 
were compared between groups. Thus, a pathway with 40 acetyl-sites and n=4 per 
group would be compared 4x40 with 4x40. This analysis gives equal weight to 
individual acetylation sites within a pathway, but maintains variance between 
individual, biological samples. For all comparisons, p-values were determined by 
permutation t-test using R perm package (Fay, 2010). 
Rank products (Hong et al., 2006) approach was used to rank differentially 
expressed and modified proteins. The combined rank score was used to generate a 
list of top 25 proteins differentiating between HCR and LCR at 10 min of exercise.  
 
4.3  Results 
 
4.3.1  HCR and LCR mitochondrial proteome 
We performed isobaric-tagged proteomic analysis on mitochondria isolated from 
EDL collected from HCR and LCR males before and after 10 min of exercise. In 
total, 428 proteins were identified, and of those 174 were significantly different 
between HCR and LCR when normalized for mitochondrial mass (Table 4.1). 
Although HCR tend to have greater mitochondrial content within skeletal muscle than 
LCR (Rivas et al., 2011; Seifert et al., 2012), our data show that mitochondrial 
composition differs by 40% between HCR and LCR. Many mitochondrial proteins 
identified had lower expression in HCR vs. LCR.  
Full tables with the relative expression of all identified proteins can be found in 
Appendix C. The most down-regulated proteins in HCR include mitochondrial 
encoded Mt-atp8, Mt-co2; and the most up-regulated is Acadsb, an enzyme involved 
in breakdown of isoleucine (Figure 4.1). KEGG Pathway enrichment analysis 
revealed differential protein expression in oxidative phosphorylation, fatty acid 
metabolism, BCAA degradation, aminoacyl tRNA biosynthesis, fatty acid elongation, 
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butanoate metabolism. Of the identified proteins within the enriched pathways, we 
see that 12 of the 18 proteins in oxidative phosphorylation are down in HCR vs. LCR, 
while 7 of the 9 fatty acid metabolism proteins are up in HCR vs. LCR. BCAA 
Degradation and fatty acid elongation proteins are up in HCR, while 7 of the 7 
proteins within the Aminoacyl tRNA biosynthesis pathway are down in HCR. Given 
the lower expression of mitochondrially encoded proteins Mt-atp8, Mt-co2 and tRNA 
biosynthetic proteins, it seems likely that mitochondrial biogenesis is different 
between HCR and LCR. Also, HCR have specific enrichment for fatty acid and BCAA 
metabolic enzymes.  
Comparing this data with a recent proteomic study with HCR and LCR heart 
tissue, we extend the HCR-LCR proteome by 15-fold. The previous proteomic study 
employed 2D-gel electrophoresis (Burniston et al., 2011) on whole tissue lysates, 
where as the current study focuses specifically on the mitochondrial proteome. 
Proteins Acca2, Cox4i1, and Cox5 were consistently overexpressed in HCR in both 
studies.  
 
Table 4.1 Number of proteins identified in mitochondria. This table includes 
number of phosphorylation sites and acetylation sites. 
 
 
 
Number of MitoCarta proteins identified
HCR vs LCR p<0.05 (Up in HCR)
Number of indentified modification sites
HCR Rest vs LCR Rest p<0.05 (Up in HCR Rest)
HCR Run vs LCR Run p<0.05 (Up in HCR Run)
HCR Run vs HCR Rest p<0.05 (Up in HCR Run)
LCR Run vs LCR Rest p<0.05 (Up in LCR Run)
Proteome
428
174 (22)
Phosphoproteome
73
131
8 (7)
3 (3)
0 (0)
3 (2)
Acetylome
85
241
13 (0)
10 (0)
4 (2)
2 (0)
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Figure 4.1 Differentially expressed proteins between HCR and LCR. Expression 
(log2 fold change) of each identified protein show that most proteins have lower 
expression in HCR relative to LCR. Asterisk * over the left side of the graph indicates 
protein expression is significantly different between HCR and LCR.  
 
4.3.2  Protein modification 
The phosphoproteome and acetylome were determined after enrichment for 
peptides containing phospho- and acetyl-sites. We identified 131 phosphorylation 
sites on 73 proteins and 241 acetylation sites on 85 proteins. We normalized the 
expression each phospho- and acetyl-site to the expression of the total protein. For 
example, expression of modified K171 on Sdha was normalized to overall expression 
of Sdha. Table 4.1 shows the number of protein phosphorylation and acetylation 
sites that were found to be significantly different between HCR and LCR at rest and 
after 10 min running.  
At rest, there are 7 phospho-sites on 6 proteins that are significantly more 
phosphorylated in HCR than LCR: Abcb8, Cox6b1, Cpox, Ldha (2 sites), Mitch2, 
Vdac2, and there were 13 acetyl-sites on 11 proteins that were significantly less 
acetylated in HCR at rest: Sdha, Etf1, Hspd1 (2 sites), Crat, Aco2, Dld, Ndufs1, Ivd 
(2 sites), Got2, and Hadha. When we look at pathway enrichment analysis for 
phosphorylation and acetylated sites we see that there is more acetylation 
enrichment in oxidative phosphorylation, BCAA degradation, propionate metabolism, 
and fatty acid metabolism pathways. There is relatively equal phosphorylation and 
HCR mitochondrial protein expression
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2
*
Mt−atp8
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Acadsb
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acetylation enrichment in the citrate cycle and more phosphorylation enrichment 
within the reductive carboxylate cycle.  
We compared fold-change Run/Rest for the proteome, phosphoproteome, and 
acetylome, to assess what proteome changes occur with 10 min of exercise (Figure 
4.2). There are only minor changes in the proteome and phosphoproteome with 
exercise, but the acetylome changes more dynamically exercise. Both HCR and LCR 
have decreases in acetylation state with 10 min of exercise; however, HCR have 
greater decreases in acetylation state. These data suggest that enzyme modification 
by acetylation might be more prevalent in pathways related to fuel preference.  
 
 
Figure 4.2 Mitochondrial protein acetylation is dynamic with exercise. Log2 fold-
change (Run/Rest) values for HCR and LCR were used to plot changes with exercise 
in the proteome (A), phosphoproteome (B), and acetylome (C). 
 
4.3.3  The acetylome is most dynamic with exercise 
Overall, mitochondrial acetylation was lower in HCR at rest (Figure 4.3A), and 
this difference was amplified following exercise (Figure 4.3B). KEGG pathway 
analysis revealed that these acetylation sites were enriched within the oxidative 
phosphorylation, citric acid cycle, BCAA degradation, propionate metabolism and FA 
metabolism pathways. By estimating the relative level of acetylation of all peptides 
within each of these pathways, we found that there was significantly lower 
mitochondrial acetylation in each pathway in HCR compared to LCR, both at rest and 
following exercise (Figure 4.3C). In addition, HCR had significant deacetylation in 4 
of the 5 acetyl-rich pathways after 10 min of exercise, while LCR had no significant 
pathway changes in acetylation, Consistent with differential fatty acid oxidation 
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between HCR and LCR at 10 min of exercise, relative acetyl-site occupancy on fatty 
acid metabolic enzymes is lower in HCR (Figure 4.3D).  
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Figure 4.3 HCR have less mitochondrial protein acetylation than LCR. Log2 fold-
change (HCR/LCR) values for the 141 acetyl-lysine sites were plotted against p-
values at rest (A) and at 10 min run (B) (n=5). For each enriched pathway (C), 
relative acetyl-site occupancy (small circles) and average pathway acetylation (large 
circles) are given for each group (n=5). The fat oxidation pathway (D) is less 
acetylated in HCR with exercise. Proteins (ellipses) are labeled by gene symbol with 
identified acetylation (circle) and phosphorylation (diamond) sites. The color scale 
designates log2 fold-change (HCR/LCR comparison for protein; or HCR Run/LCR 
Run comparison for acetylation and phosphorylation). 
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4.3.4  Sirt 3 
The enriched pathways are targets of the lysine deacetylase SIRT3 (Rardin et al., 
2013). Malate dehydrogenase, succinate dehydrogenase subunit A, and 
hydroxyacyl-CoA dehydrogenase subunit A, which are known targets of SIRT3 
(Finley et al., 2011; Hebert et al., 2013; Rardin et al., 2013), are among the proteins 
most differentially acetylated in mitochondria of HCR and LCR (see Appendix C, 
Table C.3), suggesting a role of SIRT3 in mediating the differences in acetylation. 
However, we found no difference in the SIRT3 levels between HCR and LCR in 
mitochondrial extracts by proteomic analysis (Appendix C, Table C.1) or by Western 
blotting (Figure 4.4). If SIRT3 is mediating these differences, then it is due to 
differential activation of SIRT3.  
 
  
 
Figure 4.4 SIRT3 expression in the mitochondria. Mitochondrial proteins isolated 
from gastrocnemius tissue of HCR and LCR were separated by SDS-PAGE. Anti-
SirT3 antibody (Cell Signaling) was used to detect SIRT3 expression. 
 
4.3.5  Integrating proteomics data 
We used a rank products approach to rank the most differentiating proteins in 
each of the data sets: proteome, phosphoproteome and acetylome. Rank products 
accounts for both fold-change and p-value to generate a rank score (Hong et al., 
2006). The combined rank score for an individual protein across the data sets 
incorporates both protein abundance and post-translation modification. The top 25 
proteins that differentiate HCR-run and LCR-run are presented in Table 4.2. Many of 
these top 25 proteins are involved in the electron transport chain and fatty acid 
metabolism, and a few are involved in citric acid cycle, BCAA metabolism, and 
transcriptional regulation. Differential expression/modification of these proteins are 
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consistent with metabolomic differences observed in HCR vs. LCR at 10 min of 
exercise.  
 
Table 4.2 The Top 25 differentially expressed or modified proteins. Rank 
products approach accounts for protein fold-change and p-value. The combined rank 
score of protein expression, protein phosphorylation, and protein acetylation for each 
protein was used to identifiy the top 25 proteins differentially expressed between 
HCR and LCR at 10 min of exercise. 
 
 
4.4  Discussion 
Proteomic analysis of HCR and LCR EDL mitochondria show that HCR have 
higher expression of proteins within fatty acid and BCAA metabolic pathways, but 
lower expression of proteins within tRNA synthesis. There were 7 phosphorylation 
sites and 13 acetylation sites that were different between HCR and LCR at rest. With 
Gene name Primary Pathway
Cox7c Electron transport chain
Fh Citric acid cycle
Cox7b Electron transport chain
Acadsb BCAA metabolism
Cox5a Electron transport chain
Ndufc1 Electron transport chain
Acot13 Fatty acid metabolism
Cox6b1 Electron transport chain
Ndufa4 Electron transport chain
Uqcrq Electron transport chain
Eci2 Fatty acid metabolism
LOC683884 Fatty acid metabolism
Dlst Glucose metabolism
Sod2 Oxoreductase
Etfdh Fatty acid metabolism/Electron transport chain
Hadha Fatty acid metabolism
Suclg1 Citric acid cycle
Mt-atp8 Electron transport chain
Mt-co2 Electron transport chain
Lrpprc Transcriptional regulation
Drg2 Cell proliferation
Mrps35 Transcriptional regulation
Ucp3 Mitochondrial Uncoupling 
Hk2 Glucose metabolism
Acadm Fatty acid metabolism
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exercise, we found that protein acetylation decreases in both strains but these 
decreases were greater in HCR. The pathways that were differentially acetylated at 
rest and 10 min of exercise were oxidative phosphorylation, citrate cycle, and fatty 
acid and BCAA metabolic pathways. 
We previously demonstrated that HCR have increased fatty acid oxidation during 
exercise compared to LCR (see Chapter 3 - Metabolomics to define fuel use during 
exercise). Akin to adaptations observed with exercise training (Holloszy et al., 1998; 
Kiens et al., 1993), we find that non-trained HCR have upregulation of enzymes 
within the FA oxidation pathway (Appendix A, Table C.1).  
In the previous chapter, elevation of metabolite intermediates near exhaustion - 
malate, acetylcarnitine, and C5-carnitine - were suggestive of a mitochondrial 
regulation of fuel selection. The excess production of acetyl-units and build up of 
citric acid cycle intermediates are evidence of imbalance between acetyl-unit 
production and downstream metabolism through the citric acid cycle and electron 
transport chain. In this study, we show that HCR and LCR have differential 
expression of proteins with the electron transport chain. Normalized to mitochondrial 
content, many of the electron transport proteins were lower in HCR than LCR. The 
combined rank product of protein expression, phosphorylation, and acetylation, 
demonstrates that expression and modification of proteins in the electron transport 
chain represent a predominate difference between HCR and LCR at 10 min of 
exercise. Further studies will be needed to understand the functional consequence of 
these modifications of electron transport chain proteins and their role in fuel 
selection differences with running. 
Accumulated evidence suggests that deacetylation of enzymes within fatty acid 
and BCAA pathways increases activity of these enzymes (Hallows et al., 2011; 
Hirschey et al., 2010; Rardin et al., 2013; Still et al., 2013). HCR's greater fatty acid 
oxidation during exercise is consistent with a functional consequence of lower 
protein acetylation in the fatty acid metabolism pathway. Our finding of rapid 
mitochondrial protein deacetylation with exercise provides an additional mechanism 
by which animals can increase substrate oxidation in response to increased energy 
demand. 
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Change in lysine acetylation of mitochondrial proteins is a balance between 
NAD+-dependent SIRT3 deacetylase activity (Lombard et al., 2007) and non-
enzymatic addition of acetyl groups to lysine (Wagner and Payne, 2013). In contrast 
to the lower acetylation observed with exercise training and calorie restriction 
(Palacios et al., 2009), the lower level of acetylation observed in HCR is not 
explained by SIRT3 content (Figure 4.4). Rather, the dynamic deacetylation is likely 
due to SIRT3 activation by expected increases in mitochondrial NAD+ that occurs 
with exercise (White and Schenk, 2012). In addition, the differences in acetyl-unit 
availability may also contribute to the observed differences in acetylation between 
HCR and LCR. Acetylcarnitine accumulation with increasing exercise intensity is a 
consistent phenomenon (Constantin-Teodosiu et al., 1991; Gollnick et al., 1974; 
Hiatt et al., 1989; Sahlin, 1990; van Loon et al., 2001), and like others (Kiens, 2006), 
we have shown that acetylcarnitine levels correlate positively with carbohydrate 
oxidation and negatively with FA oxidation. Increases in acetyl-unit availability in 
LCR from 0 to 10 min of exercise could potentially lead to increased or maintained 
acetylation of lysine residues.  
There are a few caveats to this study. The first is that mitochondria were isolated 
from the EDL muscle rather than gastrocnemius, which was used previously in the 
metabolomics study. Others have shown differences in fuel use and protein 
expression in EDL vs. soleus or red gastrocnemius muscle (Rivas et al., 2011). In 
general, greater differences in protein expression were observed between HCR and 
LCR in the EDL (Rivas et al., 2011). Secondly, the protein modifications described 
here are relative small fold-changes and thus might not have large functional 
consequences. However, dynamic-range suppression with an isobaric tag proteomic 
approach leads to lower apparent fold-change (Wenger et al., 2011a), thus the 
actual proteome changes in HCR and LCR are greater than they appear. Finally, 
there is high variability in the data, which is likely a combination of variation in 
individual animals and variability in the mitochondrial isolations. Future studies will 
need to be performed to understand the true biological variability and the 
consistency of change that occurs with exercise. Analysis of several data sets by 
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western blotting with pan-acetyl-lysine antibody show consistent trends of lower 
protein acetylation in HCR with 10 min of exercise (data not shown).  
In summary, HCR and LCR have differentially expression of many mitochondrial 
proteins, and HCR have higher expression of proteins involved in fatty acid and 
BCAA metabolic pathways. Mitochondrial protein acetylation, but not protein 
expression or phosphorylation, is robustly modified with exercise. HCR have lower 
protein acetylation with fatty acid and BCAA pathways, consistent with greater 
metabolic flux through these pathways. Thus, regulation of mitochondrial enzymes 
by changes in protein expression and acute post-translational modification offer 
additional explanations for fuel preference at rest and during exercise. 
 
4.5  Summary 
• 40% of the mitochondrial proteome of the EDL is differentially expressed 
between HCR and LCR.  
• Within the proteome, fatty acid and BCAA metabolic pathways are enriched in 
HCR, while tRNA synthesis pathway is more enriched in LCR. 
• Acetylation is dynamic with exercise; both HCR and LCR have deacetylation 
with 10 min of exercise. 
• HCR have less acetylation in oxidative phosphorylation, fatty acid metabolism, 
and BCAA degradation pathways.  
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Chapter 5 
Isotopic tracers to understand fuel use during exercise 
 
In the previous chapter we find that HCR compared to LCR have decreased 
mitochondrial protein acetylation at rest and with exercise. The most differentially 
acetylated pathways include oxidative phosphorylation, citrate cycle, BCAA 
degradation and fatty acid metabolism. We know from the data presented in Chapter 
3 that HCR have greater fat oxidation during exercise and that accumulation of 
metabolites in glycolysis and BCAA metabolism associate with exhaustion. Depletion 
of BCAA in HCR at 10 min of exercise indicates greater BCAA degradation and 
decreased acetylation state of BCAA enzymes is also linked to greater pathway flux. 
In this chapter we explore the kinetics of BCAA metabolism in HCR and LCR using 
an in vivo isotopic tracer approach and confirm increased BCAA metabolism in HCR 
with exercise. 
 
5.1  Introduction 
BCAA metabolism is associated with metabolic health and exercise capacity. 
Circulating BCAA levels are elevated in individuals with obesity, diabetes, and poor 
metabolic health (Batch et al., 2013; Connor et al., 2010; Newgard et al., 2009; 
Wang et al., 2011). Plasma levels of BCAA correlate with insulin resistance and 
predict development of diabetes (Fiehn et al., 2010; Menni et al., 2013; Wang et al., 
2011; Wurtz et al., 2013; Xu et al., 2013). Additionally, Morris et al. (2013) found that 
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circulating BCAA at rest correlate with exercise capacity, suggesting that pathway 
kinetics might differ between healthy and non-healthy individuals.  
In most tissues BCAA metabolism is localized within the mitochondria, the 
exception being in the brain. The BCAA (leucine, isoleucine and valine) share 
enzymes for the first two reactions of BCAA degradation. The first reaction is 
catalyzed by branched-chain amino-acid transferase (BCAT) and results in the 
transfer of nitrogen to an alpha-keto acid. This first reaction is a reversible and 
allows for nitrogen transfer between the BCAA and glutamate. The second reaction 
is catalyzed by the branched-chain keto acid dehydrogenase (BCKDH) complex. 
This complex is similar in structure to pyruvate dehydrogenase and alpha 
ketoglutarate dehydrogenase; it is comprised of 4 subunits and the E1alpha subunit 
has a phosphorylation site that regulates activity of this enzyme. Although muscle 
BCKDH complex activity is low at rest, the BCKDH is dephosphorylated (Rush et al., 
1995) and activated during exercise (Wagenmakers et al., 1991; Wagenmakers et 
al., 1989). The other enzymes involved in BCAA metabolism are specific to each 
amino acid. What regulates activity of these downstream enzymes is unknown. The 
data presented in Chapter 4 suggest a role for protein acetylation in modifying BCAA 
enzyme activity.  
We probe BCAA metabolism by introducing U-13C15N valine in vivo with and 
without exercise and measure enrichment of isotope labeling in downstream 
metabolites by metabolomics. Because HCR have decreases in circulating BCAA 
with exercise (Chapter 3) and lower protein acetylation within the BCAA pathway, we 
hypothesized that HCR would have increased valine metabolism with exercise. 
Additionally by exploring the BCAA metabolic pathway during exercise we hope to 
access how downstream metabolites (KIV and C3-carnitine) increase with 
exhaustion.  
 
5.2  Methods 
 
5.2.1  Animal protocol and study design 
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Female HCR and LCR rats (generation 31, 3 mo of age) were housed at the 
University of Michigan and the University Committee on Use and Care of Animals, 
Ann Arbor Michigan approved the study, and procedures were in compliance with the 
University guidelines, and state and Federal regulations. Although the previous two 
studies were done using male HCR and LCR, we have data that female HCR and 
LCR also have clear differences in running capacity and fuel preference during 
exercise. We chose to use female rats to be more cost-effective; female rats weigh 
less than male rats and thus require less isotope tracer to be injected.  
Exercise capacity was determined using the increasing intensity exercise protocol 
described previously (3.2.1 - Animal protocol and study design), metrics are 
presented in Table 5.1. Indirect calorimetry (see 3.2.2 - Indirect calorimetry) was 
performed to determine the effect of intraperitoneally (IP) injected valine (100 mg/kg) 
vs. control injected saline on exercise capacity and fuel selection (n=6, HCR and 
LCR, paired comparison design). We found no significant effect of valine injection on 
fuel use or exercise capacity (Figure 5.1).  
For the isotopic tracer study, animals were divided into 4 groups: LCR-Rest, LCR-
Run, HCR-Rest, HCR-Run (n=4-6). All rats were IP injected with U-13C15N valine 
(100 mg/kg) and allowed to rest on a stationary treadmill for 10 min. Rest groups 
remained on the stationary treadmill for an additional 10 min, while Run groups 
underwent the increasing intensity treadmill running protocol (Figure 5.2A).  
Immediately after removal from treadmill animals were briefly anesthetized with 
inhaled isoflurane (~30 sec) and then euthanized by decapitation. Trunk blood was 
used to prepare serum and tissues were harvested and immediately frozen in liquid 
nitrogen. 
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Table 5.1 Valine injected animals body weight and running time. Data are mean 
± SEM. Asterisks indicate *p<0.05.
 
 
Figure 5.1 Valine injection does not effect running capacity. HCR and LCR were 
injected with valine (100 mg/kg) and run to exhaustion while sampling VO2 and 
VCO2. Estimated carbohydrate oxidation (A) and fat oxidation (B) were not different 
between valine injection and control saline injection (n=6). Values are mean ± SEM. 
 
5.2.2  Muscle and serum metabolites 
Frozen gastrocnemius muscle was pulverized in liquid nitrogen with a mortar and 
pestle. Weighed samples (~ 30 mg) were extracted with 1 mL of solvent mixture 
consisting of 8:1:1 HPLC grade methanol:chloroform:water. Samples were sonicated 
(Branson 450, 40% duty cycle, output power 4) for 20 sec and then centrifuged 
(16,000 x g) to pellet proteins. Serum samples were extracted in solvent mixture of 
9:1 of acetonitrile and water, at an serum to solvent ratio of 1:4. Extracted serum 
LCR−Rest (n=5)
LCR−Run (n=5)
HCR−Rest (n=4)
HCR−Run (n=6)
Body weight (g)
204.8 ± 6.8
204.5 ± 2.8
150.1 ± 6.7*
151.5 ± 5.8*
Running time (min)
12.72 ± 1.08
13.00 ± 0.77
64.99 ± 3.44*
64.18 ± 0.91*
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samples were centrifuged to pellet proteins. These extracts were used for 
subsequent analysis.  
Glycolytic, citrate cycle intermediates were measured as described in section 
3.2.7 - Muscle and plasma metabolites. For carnitine and branched-chain keto 
analysis, extracts were dried by vacuum centrifugation at 45°C. Dried samples were 
reconstituted with water and analyzed using LC-MS. For amino acid quantitation, 
extracts were dried by vacuum centrifugation at 45°C and resulting samples were 
derivatized using N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA) 
and analyzed by GC-MS.  
Targeted metabolite quantitation was performed using Agilent Masshunter 
Quantitative Analysis software. Peak areas were quantitated for mass of naturally 
occurring isotope (M+0) and mass plus isotope shift (M+1:M+n, n being the number 
of potential isotope labeled carbons/nitrogens). Correction for natural isotope 
abundance was performed using an in-house script running in MATLAB (2012a The 
MathWorks, Natick, MA).  
 
5.2.3  Statistical analysis and graphing 
R statistical and graphing environment was used for all subsequent processing of 
the data: calculating isotope enrichment, statistical analysis and graphing (R Core 
Team, 2013). Metabolite and enrichment data are presented as mean ± standard 
error of the mean (SEM). Isotope flux comparisons were made between HCR and 
LCR for Rest and Run conditions and within HCR and LCR between Rest and Run 
and permutation p-values were used to assess significance (p<0.05) (Fay, 2010). 
 
5.3  Results 
 
5.3.1  Injection of Valine leads to 70% serum enrichment 
Preliminary experiments confirm that IP injection of 100 mg/kg valine does not 
alter fuel selection or running capacity in HCR and LCR (Figure 5.1). Isotopic 
labeled U-13C15N valine was used to trace BCAA-derived carbon and nitrogen 
metabolism.  
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Animals were divided into 4 groups: LCR-Rest, HCR-Rest, LCR-Run, HCR-Run 
(n=4-6), and all tissue were harvested 20 min after IP-injection of U-13C15N valine 
(100 mg/kg) (Figure 5.2A). Valine isotope enrichment in serum averaged 68.6 ± 
1.4% with no difference between groups (Figure 5.2B).  
 
5.3.2  HCR have greater valine nitrogen transfer 
Valine enrichment in gastrocnemius muscle was comparable to that in serum 
(Figure 5.2C). Valine isotope enrichment, as detected by mass spectrometry, was 
split between two main isotopes. The injected compound, U-13C15N valine, is 
detected 6 Daltons above the mass of unlabeled valine; thus the fully labeled valine 
is M+6 valine. Reversible transamination into KIV and reamination with unlabeled 
14N yields M+5 valine. HCR had greater M+5 and less M+6 isotope enrichment than 
LCR (Figure 5.2D). The greater M+5 enrichment suggests greater transamination 
and reamination in HCR. The labeled nitrogen group can be donated to any 
branched-chain keto-acid or to alpha-ketoglutarate to form BCAA or glutamate. 
Glutamate is considered main nitrogen acceptor. Muscle glutamate M+1 enrichment 
is greater in HCR-Run vs. LCR-Run (Figure 5.2E).  
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Figure 5.2 Valine enrichment in serum and muscle. Animals are injected with U-
13C15N valine and have 20 min exposure to isotope tracer in both Rest and Run 
groups (A). Valine isotope enrichment in in serum (B)and muscle (C) was similar 
between HCR and LCR, but valine reamination, as measured by M+5/M+6 ratio, was 
greater in HCR (D). Glutamate (Glu), the initial nitrogen acceptor, had greater labeled 
nitrogen (M+1) enrichment in HCR-Run (E). Ornithine (Orn) contained the greatest 
nitrogen enrichment and Urea and Alanine (Ala) were found to have little nitrogen 
enrichment. Values are mean ± SEM for each group (n = 4-6). Asterisks indicate * 
p<0.05 between HCR and LCR within Rest or Run groups. 
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5.3.3  Nitrogen transfer to other Amino Acids 
Glutamate is universal nitrogen donor and will participate in other transamination 
reactions leading to the formation of aspartate (from oxaloacetate) and alanine (from 
pyruvate). Although formation of glutamate removes an alpha-ketoglutarate from 
citrate cycle, transferring this nitrogen to other amino acids can lead to the 
reformation of alpha-ketoglutarate, resupplying the citrate cycle with carbons. 
Although previous studies show elevations of BCAA to lead to increases in alanine 
(Houten et al., 2013), we do not observe labeled nitrogen in the gastrocnemius or 
serum alanine pools (Figure 5.2E). Instead, we observe labeled (M+1) leucine, 
valine, isoleucine, aspartate, glutamate, glutamine, and ornithine. Glutamine and 
ornithine have 2 nitrogen groups and we observe some M+2 labeling in these amino 
acids. With the exception of skeletal muscle glutamate (at run) and M+2 glutamine 
(at rest), we do not observe significant differences between HCR and LCR. 
 
5.3.4  Valine degradation 
The next reactions in valine degradation yield NADH and FADH2 in a manner 
similar to beta-oxidation. The irreversible BCKDH complex generates the first NADH 
by converting the keto acid of valine (KIV) to isobutyryl-CoA. Percent isotope 
enrichment of muscle KIV was similar between HCR and LCR at rest and with 
running (Figure 5.3A). However, total and labeled (M+5) KIV are higher in LCR-Run 
than HCR-Run. The increase in muscle KIV with exercise in LCR is consistent with 
the observations of increased KIV with exhaustion (Chapter 3). The increase in KIV 
values suggests either greater deamination of valine or decreased degradation of 
KIV by BCKDH.  
BCKDH activity will lead to the formation of isobutyryl-CoA, which was not directly 
measured in this study. Excess isobutyryl-CoA is converted to isobutyryl-carnitine. 
Isobutyryl-carnitine is a component of the C4-carnitine, measured by LC-MS; the 
other component measured as C4-carnitine is butyryl-carnitine derived from fatty 
acid oxidation. We observe ~35% isotope enrichment of the C4-carnitine pool, 
presuming enrichment of isobutyryl-carnitine is similar to enrichment of KIV, we can 
calculate that valine-derived carbons account 50-60% of the total C4-carnitine pool. 
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Both LCR and HCR have increases in total and labeled (M+4) C4-carnitine with 
exercise, suggesting increased flux through BCKDH with exercise (Figure 5.3B). 
However, HCR-Run had greater total and labeled C4-carnitine than LCR-Run, 
confirming that HCR have greater flux of valine carbons through BCKDH while LCR 
accumulate KIV upstream of the BCKDH complex.  
Downstream reactions convert isobutyryl-CoA into β-hydroxyisobutyric acid (β-
HIB) and produce another NADH and a FADH2. β-HIB is a primary end product of 
valine metabolism (Lee and Davis, 1986; Spydevold, 1979; Wagenmakers et al., 
1985). With running, HCR and LCR have increased total and labeled (M+4) β-HIB, 
but there was no significant difference between HCR and LCR Figure 5.3(C).  
Although β-HIB is considered the major product of valine metabolism, propionyl-
CoA and succinyl-CoA are also possible end products of valine metabolism. 
Generation of propionyl-CoA from β-HIB will yield another NADH, but consume 1 
ATP. We measured propionyl-carnitine (C3-carnitine) to estimate propionyl-CoA 
production (Figure 5.3D). With running, LCR have increased total C3-carnitine 
similar to what was observed in Chapter 3 (Figure 3.4B). However, LCR have no 
increase in labeled (M+3) C3-carnitine. As a result, HCR-Run have greater percent 
enrichment and M+3 C3-carnitine than LCR-Run. Based on the low isotopic 
enrichment, we estimate that only 20% of the C3-carnitine pool is derived from valine 
metabolism. These data suggest that LCR's increase in C3-carnitine is derived from 
a non-valine precursor. The other intermediates in valine metabolism 
(methylmalonate, methylmalonylsemialdehyde, beta aminoisobutyric acid) were not 
detected. The remaining down-stream metabolite, succinate, increases in LCR with 
exercise, but there is minimal labeling (M+3) within the succinate pool (Figure 5.3E). 
These data suggest that valine-derived carbons do not contribute to citric acid cycle 
flux. 
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Figure 5.3 HCR have greater isotope enrichment in downstream metabolites. 
HCR and LCR show differences in relative concentration of metabolites downstream 
of valine: KIV (A), isobutyryl-carnitine (C4) (B), β-hydroxyisobutyrate (β-HIB) (C), and 
propionyl-carnitine (C3) (D). LCR-Run have greater KIV and other BCKA, while HCR 
have greater C4-carnitine. Values are mean ± SEM for each group (n = 4-6). 
Asterisks indicate * p<0.05 between HCR and LCR at a specific time point. Hashes 
indicates # p<0.05 difference from Rest. 
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5.3.5  HCR have greater BCAA metabolism 
Metabolite flux through a pathway is the rate at which the precursor metabolite is 
broken down to product metabolite. We estimate flux through various parts of the 
BCAA pathway by looking at ratios of product to precursor isotope-labeled 
metabolites (Figure 5.4). We find subtle differences between HCR and LCR flux at 
rest, but greater differences between HCR and LCR flux with exercise. From the 
product:precursor ratio of KIV:valine, it appears that LCR have greater flux through 
BCAT enzyme (Figure 5.4A). However, if we consider that HCR also have greater 
reaminated valine (M+5) to the fully labeled valine (M+6), it is likely that flux through 
BCAT is similar between HCR and LCR. Flux through the BCKDH complex as 
estimated by C4-carnitine:KIV ratio is significantly greater in HCR-Run than LCR-
Run, although both HCR and LCR increased flux through BCKDH with exercise 
(Figure 5.4B). Flux through the enzymes from Isobutyryl-CoA to HIB is estimated 
from the HIB:C4-carnitine ratio (Figure 5.4C). Because the elevated C4-carnitine in 
HCR-Run, there is a lower estimated flux out of isobutyryl-CoA. However flux from 
KIV to HIB remains overall higher in HCR-Run than LCR-Run (data not shown). The 
product:precursor ratio for C3-carnitine:HIB is lower in LCR with exercise and lower 
in LCR-Run vs. HCR-Run (Figure 5.4D). This trend holds true for the limited flux 
from C3-carnitine to Succinate (Figure 5.4E).  
In Figure 5.4 we also highlight the relative expression of acetylation and 
phosphorylation sites within the valine degradation pathway, as identified in Post-
translational modifications that occur with exercise. Of the eight enzymes identified 
to have acetylation sites, 6 are less acetylated in HCR-Run than LCR-Run. Of the 6 
phosphorylation sites identified, 5 are associated with the BCKDH complex. 
Dephosphorylation of BCKDHA is the most well known site of BCAA regulation. It is 
likely both acetylation state and phosphorylation state play a role in regulating BCAA 
metabolism.  
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Figure 5.4 HCR have greater valine metabolism during exercise. Isotope 
enrichment of product vs. precursor metabolite estimates flux through the shaded 
portions of the pathway (A-E). Product:precursor relationships are relative to LCR-
Rest (n=4-6). Many of these enzymes were identified as having acetylation sites (see 
Chapter 3 - Metabolomics to define fuel use during exercise). For each acetylation 
site, we show relative acetylation state as log2 fold change (LCR Run/HCR Run).  
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5.4  Discussion 
The flux analysis of U-13C15N valine during exercise in HCR and LCR suggest 
that BCAA metabolism increases in both HCR and LCR increase BCAA metabolism 
with exercise, but HCR have greater nitrogen transamination and greater flux 
through the BCKDH complex than LCR. Our data suggest that the increase in KIV in 
LCR at exhaustion is indicative of less flux through the BCKDH complex, and the 
increase in C3-carnitine with exhaustion is derived from a non-valine precursor. 
Although valine contributes far less to energy production than glycogen or fatty 
acids, certain aspects of valine metabolism might support increased running 
capacity.  
Nitrogen flux is important for maintaining the malate-aspartate shuttle, which 
allows cytosolic NADH to be taken into the mitochondria. Knocking out the BCAA 
transaminase enzyme (BCAT) in skeletal muscle of mice leads to significant 
reduction in running capacity and disruption of the malate-aspartate shuttle (She et 
al., 2010). The conclusion from this knockout study was that BCAA derived 
transamination was critical for the formation of glutamate, aspartate, glutamine and 
alanine. Although we do not find labeled nitrogen in the alanine pool, we observe 
labeled nitrogen in glutamate, aspartate and glutamine. Our data confirm that BCAA 
participate in nitrogen transamination at rest and during exercise, and in this capacity 
could support the malate-aspartate shuttle. 
The second step in BCAA degradation is irreversible and catalyzed by BCKDH 
complex. Although muscle BCKDH complex activity is low at rest, BCKDH is 
dephosphorylated (Rush et al., 1995) and activated during exercise (Wagenmakers 
et al., 1991). Activation of skeletal muscle BCKDH complex with exercise indicates a 
role for BCAA metabolism in supporting exercise capacity, and increased activation 
of BCKDH under low glycogen conditions (van Hall et al., 1996; Wagenmakers et al., 
1991) suggests BCKDH is modulated acutely to respond nutrient deficient and is 
associated with fuel changes in fuel selection.  
Beyond changes in phosphorylation state of BCKDH E1alpha subunit, we also 
found evidence that enzyme acetylation could modulate activity. The Dld subunit of 
  
80 
BCKDH complex is heavily modified by acetylation, and we identified 10 acetyl-sites 
in DLD that on average had less acetyl-occupancy in HCR-Run vs. LCR-Run (Figure 
5.4). As DLD is a subunit of the pyruvate dehydrogenase and α-ketoglutarate 
dehydrogenase complex, future studies are warranted to dissect the potential 
modulation of these complexes secondary to changes in DLD acetylation. 
One major caveat of this study is that by introducing a bolus of valine for the 
isotope tracer study, we likely create greater flux through the valine pathway than 
would be observed under non-elevated valine conditions. Acute ingestion of BCAA 
has been shown to increase activation of BCKDH at rest and during exercise (van 
Hall et al., 1996). However, despite this elevated valine condition, we observed 
increases in valine metabolism with exercise and differences in valine flux between 
HCR and LCR. Secondly, valine metabolism might not reflect the flux of the other 
BCAA. In our metabolomics analysis, we found plasma C5-carnitine was lower in 
HCR at rest, and elevation of C5-carnitine was associated with exhaustion. C5-
carnitine is not a valine-derived metabolite, but is instead derived from leucine and 
isoleucine degradation. One of the most differentially expressed proteins between 
HCR and LCR was isoleucine-specific enzyme ACADSB (Appendix C, Table C.1). 
The upregulation of ACADSB might lead to the lower levels of C5-carnitine in HCR 
vs. LCR. Thus, we suspect using the isotopic tracer isoleucine would demonstrate 
even more dramatic differences in BCAA flux between HCR and LCR.  
In conclusion, HCR have greater valine metabolism than LCR with exercise. This 
has implications to exercise capacity. Resting plasma BCAA levels were inversely 
correlated with exercise capacity (Morris et al., 2013), and disruption of proteins 
involved in BCAA metabolism lead to a significant decrease in running capacity (She 
et al., 2010). Both acetylation and phosphorylation of the BCKDH complex were 
modulated with exercise in HCR more than LCR, suggesting both phosphorylation 
and acetylation have a role in modulating BCAA metabolism.  
 
5.5  Summary 
• We observed similar uptake of U-13C15N valine in HCR and LCR 
• Metabolism of U-13C15N valine increased with exercise in both HCR and LCR 
  
81 
• HCR have greater nitrogen transamination and reamination 
• HCR also have greater flux through the BCKDH complex, resulting in less 
accumulation of KIV and increased production of C4-carnitine.  
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Chapter 6 
Study implications 
 
The previous chapters have focused on understanding the metabolic regulation of 
high and low exercise capacity. We found that HCR have higher fat oxidation during 
exercise than LCR, and that HCR have greater protein abundance and post-
translation modifications of enzymes within fatty acid and BCAA metabolic pathways. 
 
6.1  Model for enhanced exercise capacity 
Based on our results, we propose that animals with enhanced oxidative capacity 
have increased fatty acid and BCAA utilization. The higher capacity to oxidize these 
substrates is supported by the upregulation and deacetylation of proteins within 
these oxidative pathways (Figure 6.1). In conditions of increasing energy demand 
such as exercise, HCR are able to continue production of ATP through oxidative 
phosphorylation, at a time when LCR have reached their maximal oxidative capacity. 
When the ability to oxidize substrate becomes limiting, glycogen is mobilized and 
lactate is generated through anaerobic glycolysis. The buildup of acetylcarnitine, 
malate, and other substrates in muscle at exhaustion in both HCR and LCR points to 
the imbalance between the influx of substrates and ability to oxidize these 
substrates.  
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Figure 6.1 HCR have enhanced capacity to oxidize fatty acids and BCAA. This 
enhanced capacity is supported by greater protein expression and lower protein acetylation 
within FA and BCAA metabolic pathways, as well as the citric acid cycle and the electron 
transport chain. Enhanced oxidative efficiency leads to slower accumulation of metabolic 
intermediates such as short- and medium- chain acylcarnitines, which indicate imbalances 
between substrate supply and downstream oxidation. 
 
6.2  Implications to health and longevity 
Importantly, metabolic differences between HCR and LCR during exercise inform us 
about altered metabolic pathways that underlie risk for metabolic disease. 
Decreased fat oxidation during exercise (Hall et al., 2010) and impaired switching 
between glucose and fatty acid oxidation are both linked to insulin resistance and 
diabetes (Kelley and Mandarino, 2000). Many studies also link altered BCAA 
metabolism to the development of insulin resistance and diabetes (Wang et al., 
2011; Wurtz et al., 2013). Circulating BCAA levels are elevated with obesity, 
diabetes, and poor metabolic health (Batch et al., 2013; Connor et al., 2010; 
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Newgard et al., 2009; Wang et al., 2011) and correlate with measures of insulin 
resistance (Fiehn et al., 2010; Menni et al., 2013; Xu et al., 2013). Notably, resting 
plasma BCAA levels are also inversely correlated with exercise capacity (Morris et 
al., 2013). Based on our data, changes in the capacity of fatty acid and BCAA 
oxidation could be due to differential expression and post-translational modification 
of enzymes in fatty acid and BCAA metabolism, as well as citric acid cycle and 
electron transport chain. Intrinsic genetic differences could be amplified by 
mitochondrial protein acetylation in the setting of inactivity and over nutrition 
(Hirschey et al., 2011). Thus, phenotypes associated with metabolic disease, such 
as increased circulating BCAA and metabolic inflexibility, may reflect differences in 
the capacity to utilize BCAA and fatty acids. 
 Beyond implications to metabolic health, these data suggest a possible 
mechanistic link between exercise capacity and longevity. Like HCR, a number of 
longevity models have elevated fatty acid and BCAA oxidation, including Ames dwarf 
and growth hormone receptor knock-out mice (Westbrook et al., 2009) and caloric 
restriction in drosophila (Katewa et al., 2012), mice (Bruss et al., 2010) and humans 
(Huffman et al., 2012). Coincidently, long-lived organisms with mitochondrial 
mutations have elevated fatty acid utilization and display upregulation of energy 
producing pathways (Martin et al., 2011; Munkacsy and Rea, 2014). Like these 
models of longevity, HCR and LCR show pathway specific differences in 
mitochondrial protein abundance, with 40.6% of mitochondrial proteins differentially 
expressed between the strains and specific upregulation of fatty acid and BCAA 
metabolic enzymes.  
 
6.3  Future Directions  
This study leads to several new ideas that should be explored further. First, lysine 
acetylation is an increasingly recognized post-translational modification, and yet the 
functional characterization of specific lysine residues is sparse (Xiong and Guan, 
2012). Consequently, our interpretation of global changes in lysine acetylation is 
based in changes in physiology that occur with Sirt3 disruption or calorie restriction 
(Hallows et al., 2011; Hebert et al., 2013; Hirschey et al., 2010; Rardin et al., 2013; 
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Still et al., 2013). Also, global acetylation is tissue specific (Lundby et al., 2012), and 
thus physiological consequences of acetylation likely differ by tissue type. Though 
generalizations about global acetylation are useful, characterization of specific 
modifications would aid our understanding about the functional consequences to 
metabolism and other processes.  
Second, it is clear that metabolism helps regulate lysine acetylation (and other 
acyl-group modifications) both by regulating production of small-chain acyl groups 
(acetyl-CoA, propionyl-CoA, succinyl-CoA, malonyl-CoA) and by modulating NAD+ 
availability (Choudhary et al., 2014). Thus, changes in lysine modification can be 
indicative of nutrient status and be responsive to a wide-range of metabolic changes. 
Acute changes in non-histone lysine modification are just beginning to be explored 
(Masri et al., 2013; Zhang et al., 2012), and further characterization of lysine 
modification kinetics and metabolic regulation are important next steps for 
understanding dynamics of protein regulation. 
Third, metabolic differences between HCR and LCR likely underlie divergence in 
health and longevity. As discussed above, long-lived species also have changes in 
metabolism and mitochondrial restructuring (Munkacsy and Rea, 2014). The 
differences in mitochondrial content between HCR and LCR deserve further 
explanation. It is possible that mitochondrial dynamics (mitochondrial breakdown and 
mitochondrial biogenesis) is supporting metabolic and phenotypic differences in HCR 
and LCR. There is evidence that metabolite intermediates can act as signals to 
mediate changes in mitochondrial dynamics (Butler et al., 2013). By combining 
genetic (Ren et al., 2013) and metabolomic approaches to understand exercise 
capacity, we may provide important insights into the integration of signals in 
modulating the whole-animal response to exercise and aging.
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Appendices 
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A. Metabolomics data set 
 
Metabolomics data set (Table A.1) contains muscle and plasma metabolite values 
for HCR and LCR at 0, 10, and 45 min (HCR only) of exercise. Metabolite values are 
presented as mean ± SEM for each group, and permutation p-values are given for 
each comparison. 
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Table A.1 
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B. Confirmation metabolomics data set 
 
A confirmation metabolomics data set (Table B.1) contains muscle and plasma 
metabolite values for HCR and LCR at quarter (HCR only), half, and full exhaustion. 
For HCR this is approximately 15 min, 30 min, and 60 min of increasing intensity 
exercise. For LCR this is approximately 6 min and 12 min of increasing intensity 
exercise. Metabolite values are presented as mean ± SEM for each group.  
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E&%1'A&CF'CE&C.-
+
0122''3''4
5
01;6''3''2178
0197''3''217<
0199''3''21:9
;170''3''21<;
718<''3''21:7
!
"#$%&'S0=`0'SCE,JDJ,&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
010=''3''2106
01:9''3''217;
01:7''3''21:;
;122''3''012:
717=''3''21=;
!
"#$%&'S0=`7'SCE,JDJ,&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
010=''3''217=
710:''3''21;9
01=6''3''21:8
;1::''3''019<
7188''3''21=0
!
"#$%&'S08`2'SCE,JDJ,&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
0196''3''2108
71==''3''218<
7179''3''21:9
;182''3''2198
;127''3''21=9
!
"#$%&'S08`0'SCE,JDJ,&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
0172''3''2170
016<''3''21;9
01<:''3''218=
;17=''3''2169
7172''3''21=;
!
"#$%&'S06`2'SCE,JDJ,&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
21:<''3''212:6
0126''3''2178
017;''3''21:2
7172''3''21;;
0108''3''21;6
!
"#$%&'S06`0'SCE,JDJ,&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
21=;''3''2107
2182''3''2107
21=9''3''2109
01=2''3''210<
0107''3''21;<
!
"#$%&'S06`7'SCE,JDJ,&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
017<''3''217;
71;7''3''21:9
71<8''3''010:
:12=''3''01:6
71<7''3''2182
<
5&C%//.)%64&
!
"#$%&';@MB*#AB*@#&EJ,&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
21:7''3''21288
21=0''3''212:;
21:7''3''212::
2180''3''212:<
21:;''3''21289
!
"#$%&'5$&D)%AB*#ABCD&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
010=''3''2109
0129''3''210;
2166''3''21287
0122''3''210;
0129''3''2100
!
"#$%&'SE&CDJ,&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
2196''3''21269
219=''3''2128;
2190''3''21280
2162''3''212=9
2168''3''2100
!
"#$%&'SE&CDJ,&@AB*#ABCD&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
2192''3''2128<
2182''3''21289
2197''3''21267
216=''3''2129=
219;''3''2129:
!
"#$%&'SE&CDJ,J,&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
2199''3''2129=
2192''3''21297
2187''3''21289
2197''3''212=:
219=''3''21290
!
"#$%&'K&*?)"EJLJ,&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
2188''3''2127=
21:0''3''2129<
21<0''3''2170
0176''3''2178
21<0''3''2106
!
"#$%&'(%"$*,CD&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
21:<''3''2102
2182''3''212=9
21=7''3''212:<
21:<''3''2129;
21:8''3''212<;
!
"#$%&'(%"$*#CJ,&@0@M'C,L'@8@M
E&%1'A&CF'CE&C.-
+
0122''3''4
5
01;=''3''2177
01;7''3''2100
0120''3''2100
0108''3''2106
01;9''3''210=
!
"#$%&'(%"DCDBJ*,&H'*?JLJ]&L
E&%1'A&CF'CE&C.-
+
0122''3''4
5
2186''3''2128=
2187''3''212:6
21:6''3''2129
218=''3''212:;
218=''3''21298
!
"#$%&'(%"DCDBJ*,&H'E&L"$&L
E&%1'A&CF'CE&C.-
+
0122''3''4
5
2186''3''21280
21:<''3''21287
21:<''3''2129
2180''3''212=0
21:<''3''212:<
!
"#$%&'!
C%*,)%@S*5
E&%1'A&CF'CE&C.-
+
0122''3''4
5
01<7''3''210<
01;=''3''210:
71==''3''21=0
7167''3''21=2
;172''3''21=2
!
"#$%&'4
@5$&D)%*E,JDJ,&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
2189''3''2128<
2187''3''212=6
2199''3''21260
21<=''3''21267
2167''3''21269
!
"#$%&'MC,D*DB&,CD&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
216:''3''21280
2198''3''212<=
219:''3''2126
21<7''3''212:7
216;''3''2107
!
"#$%&'a
",*%J,CD&
E&%1'A&CF'CE&C.-
+
0122''3''4
5
21:;''3''212<<
21:=''3''212<8
21:7''3''2102
21=0''3''2102
2182''3''2129;
F/.&O
.$<
%'.=6/5'%&D$
IC>/C.;)5'5)%&
M%C#-
C'/@SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
0177''3''21280
0129''3''2107
010:''3''21267
21<6''3''212:;
21<7''3''2129
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Table B.1 Cont. 
 
M%C#-
C'S7'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
0179''3''212<=
01;=''3''2126:
0176''3''2100
0186''3''2106
010=''3''2107
M%C#-
C'S;'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
0177''3''21267
01;7''3''21287
21<:''3''210:
2166''3''212<6
01<;''3''210<
M%C#-
C'S='SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
019=''3''217:
0182''3''2100
0100''3''210=
01;=''3''2109
01:7''3''210<
M%C#-
C'S:`2'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
01=:''3''210:
0199''3''2102
2167''3''212:<
21<;''3''2109
0170''3''2126;
M%C#-
C'S8`2'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
0169''3''217;
716<''3''21:0
;10=''3''21;8
;1=<''3''21:6
;10:''3''21=9
M%C#-
C'S6`2'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
0188''3''2108
0169''3''2107
710=''3''2102
71:9''3''2107
71;0''3''210;
M%C#-
C'S6`0'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
0179''3''2107
01;7''3''212<0
012<''3''212:<
0178''3''2100
01;7''3''210;
M%C#-
C'S02`2'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
7176''3''21;;
7188''3''210<
;128''3''2176
=170''3''2176
=1;0''3''21;;
M%C#-
C'S02`0'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
01<0''3''2109
710;''3''217;
71;6''3''210:
;179''3''2108
;176''3''21;7
M%C#-
C'S07`2'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
019;''3''217;
717=''3''210<
7188''3''21;7
;16:''3''21;8
:18=''3''21:;
M%C#-
C'S07`0'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
012;''3''212<
017<''3''2107
012<''3''210:
7122''3''2170
71:<''3''2179
M%C#-
C'S0=`2'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
019=''3''210<
71=2''3''217;
71;2''3''217:
;18;''3''217=
9106''3''21:6
M%C#-
C'S0=`0'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
01<8''3''217:
7168''3''21;;
71:6''3''2178
=128''3''21:;
918=''3''219<
M%C#-
C'S0=`7'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
0169''3''217=
7187''3''217=
7170''3''2106
;16;''3''21;9
:188''3''21;6
M%C#-
C'S08`2'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
0199''3''2129=
7127''3''217=
01<2''3''210:
71:9''3''2172
:1;;''3''21=8
M%C#-
C'S08`0'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
712=''3''2177
;1;;''3''21=<
7198''3''21;0
:178''3''21=:
<17;''3''21=8
M%C#-
C'S06`2'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
7102''3''21==
7197''3''21=9
01<6''3''21;2
=1;<''3''21:0
91;7''3''0100
M%C#-
C'S06`0'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
001:8''3''=127
0712<''3'';1;8
61:0''3'';17=
001;2''3''=162
=21=<''3''0910<
M%C#-
C'S06`7'SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
71=0''3''21:=
;1;6''3''21::
71:9''3''21;2
:192''3''0126
<1;9''3''0106
M%C#-
C'S72`='SCE,JDJ,&
E&%1'A&CF'CE&C
0122''3''4
5
01:;''3''21;;
7176''3''21;;
01:2''3''210=
;199''3''21=7
:12<''3''2189
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C. Proteomic data sets 
 
Appendix C contains tables with log2 fold change values for quantified 
mitochondria proteins (Table C.1), phopho-sites (Table C.2), and acetyl-sites (Table 
C.3). Quantitative proteomics was performed on mitochondria isolated from skeletal 
muscle of HCR and LCR collected at rest and after 10 min of increasing intensity 
exercise. 
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Table C.1 
 
!"#$%&'()&&*+,-./-012+"$&32-,%-4%&5-$1&./"06%(
70+32-,&89 :%0%&;<4#-$ =0,2%>
$-6?&5-$1&
./"06%
@%24A,",+-0&
@BC"$A%
$-6?&5-$1&
./"06%
@%24A,",+-0&
@BC"$A%
$-6?&5-$1&
./"06%
@%24A,",+-0&
@BC"$A%
$-6?&5-$1&
./"06%
@%24A,",+-0&
@BC"$A%
$-6?&5-$1&
./"06%
@%24A,",+-0&
@BC"$A%
!"#$%& '()(*+, -.*/-0 1+23.. +2+*3 1+2-+* +2*/- 1+23-+ +2*4* 1+2+-" +2&30 +2+-. +2&30
!"567& '()(&, -.3-+3 1+2*4" +2+"& 1+233- +2*/- 1+2*34 +23"4 +2++" +204* +2*+* +2+"4
8-9:6/ '(;<**, =' +2+.3 +2"/0 +2+"& +24*/ +2+.. +24*/ +2+-" +2&&. +2+/- +2&++
>*-/-4 ')??3, *4+/." +2-+& +2+*+ +2-** +2**/ +2-+" +2+&. +233+ +2+30 +23*- +23++
@*AB.* ')?<0, 30/04- 1+2++0 +20*4 1+2+-3 +24*/ +2+*/ +20*/ +2+"0 +24*/ +2*+" +2/++
>*"."+ ')?<C, 3"3&4 +2*"/ +2+0& +23"3 +2**/ +2+". +24*/ +2*4- +2*/- 1+2+33 +2&"4
>+&"+- ')?<D, 3/*"& 1+2/.0 +2.+" 1*2-33 +2/++ +2-&" +2"4* +2-*+ +2"/- 32+*4 +2330
E-$40. ')?<D, =' 1+23". +2./4 +2+/& +20/- 1+2".+ +2/&. 1+233+ +24/- 1+2&3& +2-*/
!.7F:- ')?<G, ./-+/ +23-* +2+*0 +2*0+ +23++ +2343 +2+&. 1+2+3+ +2&30 +2+.3 +2.&.
>4+"&/ ')?<G(, 3".*& *2++3 H,+2++* *2**" +2+30 +2&&0 +2+30 1+2*-& +2.&. 1+2-./ +23&.
>*44./ ')?I*, 3"+*/ +2+/+ +2.-& +2+// +2&"4 +2+-. +24*/ 1+2+"- +2.++ 1+2+.+ +24*/
!0J5-/ ')K3, 403"+ +2+&" +2*4& +2*"- +2*/- +2+*& +2&"4 +2+3. +2&"4 1+2**+ +2+"4
8-9'0- ')KI*-, =' +2-+- +2+-0 +23*. +2-4* +2-&0 +2+"4 1+2+*/ +204* +2*"0 +2"4*
!.7F:& ')KI3, *03343 +23"+ +2+*- +2-/* +2+&. +2*"& +2330 +2+30 +2&30 1+2*"- +23"4
!/00=" ')GL3, =' 1+2/.* +2+3/ 1+2"4/ +2+&. 1+2-/4 +2330 1+2++0 +204* +23*& +2/"4
8-9M:4 ')GL-, =' 1+2*.- +2*3* 1+23+. +2330 1+2**0 +2/++ +2*+" +2/&. +2*0* +2+30
>*&*.- ')GC*, 3"3&& +23"& +2+*0 +2*0. +2-4* +2-3+ +2+30 1+2+0. +2"/- +2+30 +2&&.
8-99=- ')GG*, =' 1+2*03 +2343 1+2*// +2.&. 1+23/* +23++ +2+&* +20*/ 1+2+*. *2+++
8/'*E* ')NO3, =' 1+2*3. +2-30 1+23*0 +2/++ 1+2+-/ +2&++ +2*/3 +2-/- +2-34 +2*/-
!"@P!+ '<)Q-, =' +2+/4 +2./+ +2+./ +2.&. +2+-* +2&"4 +2*"& +2+"4 +2*3" +2"4*
E-$074 '<)Q", =' 1+23." +2+4. 1+2-.- +2*/- 1+2*.4 +2"4* 1+2+44 +2.&. +2**0 +244*
!/!!A- '<;LR*, -.3/4/ 1+23/- +2*+* 1+23"+ +2*4* 1+23-. +2/"4 +2+.+ +2&++ +2+4/ +2.&.
8-9A+& '<GC, =' 1+23&& +2+// 1+2/-- +2**/ 1+2*// +23&. 1+2+/+ *2+++ +23/0 +2*/-
#*%=03 'LS-C3, =' 1+2+"& +2/*0 1+2+4" +2/&. 1+2+/* +2&&. +2+-- +2."4 +2+.4 +2/30
8-90%+ 'SQ, =' 1+23./ +23.- 1+2-+- +2-4* 1+233. +2"4* 1+23/" +2/&. 1+2*.0 +2.++
E-$0." 'SO?I", =' 1+2-/3 +2+*- 1+2-33 +23++ 1+2-.- +2+&. 1+2++. +20/- 1+2+/. +2&30
!0PF"- 'TLD*, &-"-- +2+** +2&"- +2+/- +2/&. 1+2+33 +2&"4 +2+.3 +2"4* 1+2++- +204*
>30/*+ 'Q3, "+++-0 1+2+&/ +2.4+ 1+2*3- +2"/- 1+2+// +244* 1+2+"& +2&30 +2+3* +20*/
!&BE/" 'QU4?3, *4*//" 1+23+* +2+33 1+23+4 +2+"4 1+2*0. +2*4* +2+00 +2-/- +2*+0 +2/&.
E-$0A. 'C<;-?3, =' 1+2"0" +2+*+ 1+2.&3 +2*/- 1+2"+& +2*4* 1+2*3/ +2"*/ +2+"+ +2&&.
E-$0/" 'C<;"?*, =' 1+2+/+ +2."4 1+2+.& +24*/ 1+2+*- +2&&. 1+2+"" +24*/ +2+++ *2+++
E-$4P+ 'C<;.?*, =' +2*4* +2**. +23*. +23&. +2*3" +2-*/ +2+/. +244* 1+2+/. +244*
!./+"4 'C<;4?*, 30*/"+ 1+2**- +23+& 1+2*3" +2/30 1+2*+* +2"/- +2+** +2&"4 +2+-" +244*
!0P%P- 'C<;0?*, ./+/+ 1+2/3" +2++. 1+2/-" +2*4* 1+2/*" +2+&. 1+2+*4 +20*/ +2++- *2+++
!"M*A. 'OKKC, -*4*0* 1+2+30 +2&3- 1+2+.0 +2&30 +2+** +20/- +2+++ *2+++ +2+&+ +24*/
@*A@A/ 'UD)*+, =' 1+23"- +2++/ 1+2-/4 +2+30 1+2*.+ +2330 +2+/4 +2."4 +23-/ +2+"4
!"+"P0 'I?<*, -+0"-3 1+2**. +2+/4 1+2*-* +2*4* 1+2*+3 +23&. +2+-* +24*/ +2+"0 +23++
!-65J+ 'I?<-, =' 1+2+0/ +233" 1+2*-3 +23&. 1+2+". +2.30 1+2++0 +20/- +2+.& +2/&.
V-"".4 'IT), 30"/+. 1+2/33 +2+** 1+2"+" +2**/ 1+2--& +2*4* 1+2*&4 +24*/ 1+2+3+ +2&&.
>*"000 'IO"?*, ."3.3 1+2++0 +20/4 1+2+"& +24*/ +2+-0 +2&"4 +2+"4 +24/- +2*"/ +2"*/
>*0"** 'IO"L*, =' +2+-4 +2-.0 +2+3- +2.30 +2+"* +2/&. 1+2+"" +2/"4 1+2+34 +2.++
>-*-00 'IO";, ./*/-/ +2*". +2+-" +2*+0 +2-4* +23+- +2+30 1+2+3+ *2+++ +2+4- +2"/-
>30/*0 'IO"T, */+.+& 1+2+** +20-* +2*+& +244* 1+2*30 +2/"4 +2*+. +2-/- 1+2*-* +2.++
>3*"4* 'IO"W, "++".+ +2+&& +2.*. +23-/ +2/"4 1+2+"& +2&&. +2++& +20/- 1+23&/ +2-4*
8-9'#. 'IO"W3, =' +2*+- +2+43 +2+&4 +2*4* +2*3+ +2-/- 1+2+.3 +24/- 1+2+-+ +24*/
!.>8M4 'IO"C, =' 1+2+30 +2&." 1+2+.4 +2&++ +2++0 +204* +2*30 +2."4 +23+/ +2/"4
!+../4 'IO"K, *033/* +2++* +200- +2+-& +2&"4 1+2+-" +2&&. 1+2*.. +2"4* 1+23-& +2-4*
8-9X"+ 'IO?L*, =' 1+2*+4 +2-+/ 1+2**3 +2/"4 1+2*+* +2.++ +2*33 +2/"4 +2*-3 +2/++
8-9YA4 'IO?L3, =' +2+.- +2"/0 +2*+" +2"*/ +2+3* +20/- +2*43 +2+"4 +2+&0 +2.30
!+--// 'IOTL*, =' 1+23"" +2+/- 1+2*". +2/"4 1+2-"" +2+30 +23-+ +2+&. +2+-+ +2&"4
E-$&Y0 @?Z, =' 1+2/+- +2++. 1+2/3+ +2+&. 1+2-&. +2+"4 1+2+3+ +204* +2+*/ +204*
@*A@=- @)Q<;?, 3"3// 1+2*-& +2*3& 1+2*"/ +2330 1+2*33 +2"*/ +2+33 +2&&. +2+"- +2"/-
>-"4-& @)Q<;(, 304** 1+2*+* +2--. 1+2+.4 +2."4 1+2*-. +2/30 +2**. +2/&. +2+/4 +24*/
!++043 @)Q<Q, 30.+- 1+2*-4 +2*&. 1+2*/* +2"*/ 1+2*-- +23&. +2+"0 +2"/- +2+.4 +2/&.
8-9Y4* @)C3C*-, =' 1+2-/+ +2*0. 1+2-4. +2/"4 1+2-+/ +2-/- 1+2+/" +20/- +2+3. +204*
!":7F+ @)G*C, -+*"*/ 1+23/3 +2+30 1+2-+* +2+30 1+2*&- +2/++ 1+2*"" +2"*/ 1+2+-4 +24/-
>30*/4 @<;*, **4+00 +233" +2/4* +2*." +24/- +23&" +2/++ 1+2340 +24/- 1+2*"0 +2"/-
!-@&=0 @O;C, -.*3-0 1+2.0" H,+2++* 1+2&/. +2+30 1+2"// +2+"4 1+2+.* +24/- +23/* +23++
V-"40. B*[(O, 30.&* 1+2*4" +2-.* 1+2"3* +2*/- +2*4* +2-4* 1+23&* +2**/ +2/*3 +23"4
!.'X+/ B3KUL/4 =' 1+2+.& +2.-+ 1+2+/4 +20/- 1+2+0+ +24*/ 1+2+.3 +24/- 1+2*+" +2/30
!./3'/ B&KUL&3 =' 1+2-+0 +2+*4 1+2-3" +2330 1+230/ +2+&. +2+"" +244* +2+&. +2/&.
@3E$"4 B?UG3, =' 1+2-"/ +2+3" 1+2/.0 +23"4 1+23-0 +2+"4 +2+-" +20*/ +23." +2-4*
!">>=4 B)<)"*, -*.++& 1+23"+ +2+3. 1+233/ +2*4* 1+2344 +2*/- +2++3 *2+++ 1+2+"* +24*/
!/$&04 B)<)0+(, -+&&3+ 1+2"+- +2++/ 1+2"/3 +2*/- 1+2/./ +2+30 1+2+/- +2&"4 +2+-" +20*/
8/'B3- B)I4, =' 1+2"-+ +2++* 1+2.-& +2+30 1+2/3* +2+&. 1+2+.+ +20*/ +2*". +2-/-
8-9!@. BR)U", =' 1+2-&0 +2++- 1+2/0+ +2+"4 1+23&& +2+30 1+2++3 *2+++ +2*00 +23++
@"8J5" B;);<*, -.*++" 1+2/-3 +2++. 1+2/.& +2+"4 1+2-04 +2**/ +2+4/ +24*/ +2*/" +2.++
!.-9X& B;);<*+, =' +230/ +2+*& +2/+3 +2**/ +2*&. +2**/ 1+2+/& +2&++ 1+23.- +2*/-
8-9M:" B;);<-, =' +2+-/ +2./4 +2*++ +2/++ 1+2+-* +2.&. +2++. +20/- 1+2*3. +2-*/
!"@P=" B;);</, -*3""0 1+2*/0 +2-+- 1+2*+4 +2"4* 1+2*03 +2/30 +23.+ +2330 +2*4" +2-*/
@+6+3+ BTG<*, =' +2+*0 +2404 +2+// +244* 1+2++. +20/- 1+2+** +20*/ 1+2+.+ +24/-
F+5'8" BCOO, =' 1+2*3. +2*.. 1+2*4. +2+"4 1+2+4" +2&++ 1+2+-& +20*/ +2+.- +2"*/
!"M3M+ BCOZ, -++4&. 1+2*0. +2+&4 1+2*03 +2-*/ 1+2*00 +23"4 +2++- +204* 1+2++/ +2&&.
!"7+6- BCN(C, -+.*0& +2+"/ +2.3" +2*+0 +2.30 +2+++ *2+++ +2+-/ +24/- 1+2+4" +2.&.
>334-/ BKDI, 3/3.4 1+2.*3 +2++* 1+2.+* +2+"4 1+2.33 +2+30 +2+-* +2&"4 +2+*+ +2&"4
8-9F3* BKDI<*, =' 1+2+// +24." 1+2+*& +20/- 1+2+.0 +20*/ +2*+* +24*/ +2+"+ +2&30
D'EFG'E D'E&E%H,&F&G'E&E%H, D'E&EA0&F&G'E&EA0 G'E&EA0&F&G'E&E%H, D'E&EA0&&F&D'E&E%H,
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8-9:4/ BK[*+?, =' +2*4+ +2*** +2+43 +24/- +23.0 +2+&. 1+2*+* +2/30 +2+0. +2"4*
!.-*"0 BK[-, 30-+0 1+2*/" +23** 1+2*.* +2*4* 1+2*3& +2"4* +2*/- +2/++ +2*4" +2-/-
!/E+./ BK[", =' 1+2**0 +2-.0 1+2*-& +2/"4 1+2*++ +244* +2*+" +2.&. +2*/- +23"4
!.&#M4 BK[., 300*0" 1+2*.+ +2+00 1+2*"* +2330 1+2*.0 +2/++ +2+"- +24/- +2+-" +24/-
!.&#Y* BK[0, =' +2+-& +2... +2**0 +2/++ 1+2+/3 +24/- +2+3* +2&"4 1+2*/+ +2-*/
>*+&&& BKZ/T*, 30//" +2*"* +2++0 +2*/& +2+&. +2*"" +2+&. 1+2+4. +23&. 1+2+4+ +2/++
>**3/+ BKZ"?, 3"30-/ +2-"3 +2++& +2--- +2+&. +2-4+ +2+"4 1+23/& +2+&. 1+23** +23&.
>*3+4" BKZ"(, 0/*0/ +2*./ +2++- +2*"- +2**/ +2*4" +2+"4 1+2+&. +2+"4 1+2+." +2/"4
>*+&*& BKZ.?*, 3"3&3 1+2*0- +2-3/ 1+2303 +2/"4 1+2+0- +2"4* +2*+/ +24/- +2-+- +23&.
E-$&F/ BKZ.?3, =' +2+// +240- +2+"- +20*/ +2+-" +204* +2+*+ *2+++ 1+2++0 +20/-
8-98+0 BKZ.(*, =' +2*/- +2-"" 1+2*-4 +2"*/ +2/3- +2+"4 1+23++ +2-*/ +2-.+ +23++
>**0"* BKZ.)3, =' +23"+ +2+/+ +2-*" +2*4* +2*&" +23++ 1+2+-3 +2&++ 1+2*.3 +2-*/
>-"*4* BKZ4?3, =' 1+2++3 +204. 1+2+"/ +2."4 +2+/0 +244* +2++0 +204* +2**3 +2/++
8-9X:& BKZ4?3C, =' +2+/- +233" 1+2+*3 +20*/ +2+0& +2+&. 1+2+*- +20*/ +2+04 +2**/
>&+/-* BKZ4(, -+--0- +2"&- +2*3- +23/& +2.++ +20*0 +2*4* 1+2&++ +2*/- 1+2*30 +2&++
>&+/-3 BKZ4), =' +2-&* +2++/ +234- +2330 +2/&& +2+30 1+2*.. +2/30 +2+/& +24/-
!-@48+ BOKZ, -+/+3/ 1+2--4 +2+*0 1+2/0- +2+"4 1+2*&+ +2-4* 1+2*3" +2"*/ +2*&4 +2-/-
>*&&&. BOI3, 3"/*- 1+2++. +20/3 +2+/& +24/- 1+2+"0 +2"4* +2+/4 +2"*/ 1+2+.+ +2&++
!4+/\& BU?I, -**&/0 +2*3" +2+&" +2*+- +2/30 +2*/4 +2+30 +2+./ +23"4 +2*+& +2/30
!"M3$" BUCG*, -..*0. 1+23/& +2/+" 1+2*4+ +2."4 1+2-3. +2/&. 1+2-/. +2/"4 1+2"+3 +23&.
>+/*.. BN("(, =' 1+2*4* +2*4" 1+23/& +23++ 1+2+0/ +2.30 1+2+*3 +2&&. +2*/- +2"*/
>*4*4& BNO34?*, -+*"*4 +2+"4 +2"&" +2**+ +2/"4 +2++/ *2+++ +2*-- +2/30 +2+34 +2&"4
#4J99+ 8?O-, =' 1+2-43 H,+2++* 1+2-00 +2+30 1+2-/" +2+&. +2+*+ +204* +2+./ +2"/-
@3E$*" 8(I, 30.** +2+"/ +2"&. +2*+& +2/30 +2++* *2+++ +2+-- +2&++ 1+2+4" +2."4
!.'X"" 8)?Q<, -.+.-0 1+2/&* H,+2++* 1+2"33 +2+30 1+2//+ +2+30 +2++* +204* +2+&- +2"*/
E-$4-/ 8R)U*, =' +2**- +23&" 1+2++4 +204* +23-/ +2*4* 1+2*30 +2-4* +2**- +2"/-
8-98J/ 8S]KQ, =' 1+2+04 +2-++ 1+2+3* +20/- 1+2*43 +23"4 +2*&0 +23"4 +2+-0 +2&"4
!.-4+4 8;K<;, ."*". 1+2*4" +2*44 1+233+ +2/++ 1+2*30 +2"4* 1+2+-" +2&&. +2+". +2.30
!&$78* 8;UG/, 3...&. 1+2+4/ +2"-& 1+2+&/ +2."4 1+2+." +24/- 1+2+3" +2&30 1+2++. +204*
>+&/.* 8C?I, &*."/ +23-* +2++. +23." +2+&. +2*04 +2+&. 1+2+/+ +2."4 1+2*+4 +2-4*
!.>.53 8C<, 30&0/3 +2*** +2-+. +2*3" +2/++ +2+04 +2.30 1+2+-+ +2&30 1+2+"& +24*/
E-$.>3 8CGI, =' +2*34 +2"&" +23.3 +2"*/ 1+2++0 +204* 1+2+"- +2&"4 1+2-3/ +2/30
@*A@X" 8^?W)**, -.3... 1+2-.. H,+2++* 1+2/*+ +2+30 1+2-33 +2+"4 1+2+.- +2"4* +2+3/ +244*
@35X$+ 8^?W)-+, =' 1+234. +2**/ 1+2/+4 +23"4 1+2*// +2/++ 1+23*& +2"4* +2+/" +2&30
8-98B* 8US3, =' 1+24.. +2++* 1+2"// +2**/ 1+20&4 +2+30 +2/-3 +2*4* 1+2+** +20/-
>4+"&- 8]I, =' 1+2"*- H,+2++* 1+2"4* +2+30 1+2/"/ +2+30 1+2*30 +24*/ 1+2+*3 +2&"4
!.3."* J);*, ./"3. +23*& +2++" +2*/" +2*/- +230+ +2+30 1+2+"" +24*/ +2+0* +23&.
>*/.+/ J);G*, */+"/4 +2+/- +2""/ +2+-+ +24/- +2+"" +2."4 1+2+3/ +24/- +2++* *2+++
!.&E/* J)T*, =' 1+2*.4 +2+"" 1+2*4+ +2330 1+2*./ +2*/- 1+2**. +2/&. 1+2**+ +2*4*
!":7B+ J)T3, =' +233. +2+*& +2*3& +2/++ +2-3" +2+30 1+2+*& +2&30 +2*40 +2330
!":7B3 J)GTI, -++//4 1+2*-" +2*+. 1+2*"/ +23++ 1+2**" +2/30 +2+"+ +24/- +2+&0 +2-4*
!00-43 JC^, 3"+/- 1+2./+ +2++* 1+2&+0 +2+"4 1+2/43 +2+30 1+23*0 +2.++ +2**4 +2"4*
@+@=E+ JD)3, =' 1+2"** +2+3& 1+2".4 +2*4* 1+2/"" +2+"4 1+2-+/ +2/30 1+2*0- +2.30
!-$":& J^<KS, =' 1+2-"0 +2+*- 1+2/&4 +2+&. 1+23-+ +2330 1+2*3+ +2/&. +2*-4 +2"*/
>"."4* J\* =' 1+2+*" +2&.* +2+"+ +24/- 1+2+40 +2-*/ +2*-3 +2/++ +2++3 +204*
>*-&+- JIL?, -++43. +2*-/ +2*4+ +2*&/ +2-/- +2+&- +2/"4 +2+/3 +2."4 1+2+.+ +2&30
!.&#M- JIL(, 303&/" +2*4+ +23&4 +23/* +23&. +2+00 +2&30 1+2+&+ +244* 1+2333 +23&.
!.._#- JIL<;, 30"*/- +23/+ +2+/. +2*.* +2/++ +2-*0 +2+"4 1+2*.& +2-/- 1+2+** *2+++
@+@=P/ JI;R*, 3034*+ 1+2*4. +2+0/ 1+2*"4 +2-4* 1+2*0" +23"4 +2+.3 +2.&. +2+3- +2&++
8-9YA0 JZKS, =' 1+2/.- +2++3 1+2""* +2+&. 1+2-4. +2+"4 1+2+&* +2&30 +2+0/ +24*/
!.'X!& #?;<*, -+30&+ +2+/3 +2"-3 +2+.* +2-/- +2+3/ +2&&. +2*+" +2**/ +2+.& +2"4*
@35XA0 #?;<3, =' 1+2*3* +23*" 1+2+"3 +24/- 1+2*0+ +2**/ +2*"& +23&. +2+3+ +20*/
!":7P/ #?D3*+?, =' +2+*3 +20*/ 1+2+** +204* +2+-/ +204* +2+"" +2&30 +2*++ +244*
!.'::. #?D3*-?, =' 1+2-4. +2+3" 1+2/+0 +2*4* 1+2-/- +2*/- +2+-& +2&++ +2*+/ +2.++
!"F4$4 #?GIQ<3, -+*/.- 1+2*34 +2/.+ 1+2+4* +244* 1+2*&3 +2-*/ +2+-4 +20*/ 1+2+4/ +2&&.
>"."33 #<ZU, 40*33 1+2--& +2+*3 1+2-.0 +23++ 1+2-+. +2+&. 1+2+-+ +20/- +2+-- +2&"4
8-9@F- #R);, =' 1+2+/- +24-* 1+2+34 +2&"4 1+2+"& +20/- +2+0" +2.30 +2+./ +2."4
!"F0./ #;, =' +2/4" +2*3/ +2"++ +2/30 +2/"* +23"4 +2+*+ *2+++ 1+2+-0 +24/-
!-@4M0 #Q(O&, 30+."3 1+2//+ +2++3 1+2"*0 +2+&. 1+2-.+ +2+"4 1+2**- +2"*/ +2+/" +2&++
!":PA3 E?<</"STO*, 3&&0*. 1+2*-/ +234* +2+33 +20/- 1+230+ +2*4* +2*0. +2/++ 1+2**. +2/++
E-$4E& E?UG, =' 1+2/+/ +2+*0 1+2"/. +2+30 1+23.* +2-*/ +2+34 +20/- +2-*3 +2*4*
8-9X.& E?I), =' 1+2*0+ +2.&" 1+2+** +20/- 1+2-.0 +2/"4 1+2-*+ +2"*/ 1+2..& +2"*/
!"56+& E(?G, /0&*4/ 1+2+/3 +2.&- 1+2++. *2+++ 1+2+40 +2"4* +2*0+ +2*/- +2**. +2"4*
8-9Y0+ E)<;, =' 1+2*&& +2+0/ 1+234- +2+&. 1+2*+- +2/&. +2+3/ +2&&. +2*0/ +23++
!+4&+- ELD*, **/+*4 1+2*0- +2+"* 1+23+. +2**/ 1+2*&+ +23++ +2+-3 +24*/ +2+"0 +2/"4
!":7'& E;TID, 30+"0. 1+2*3* +2+0- 1+2+/& +2&++ 1+2*0" +2+&. +2+4& +2/30 1+2+.0 +2"*/
8-9B7+ EQ, =' 1+2*.- +2*+" 1+233& +2*4* 1+2+04 +2"/- 1+2*34 +2/"4 +2++/ +20*/
!.':A* ECUZ3, **/+33 1+23.- +2*+* 1+2-&+ +2*/- 1+2*/" +2/&. 1+2+"3 +2&"4 +2*&/ +23"4
8/'884 ECUZ", =' 1+2+*& +2&0/ +2+*3 +204* 1+2+/0 +2&"4 +23.& +2+"4 +23+4 +2/"4
>*-3./ ECG, 3/-0& 1+2*.. +2-*/ +2*** +2."4 1+2//3 +2**/ +2*/& +2/++ 1+2/+" +2*/-
>*+&.+ EC]<*, 3/-00 1+2*/. +2+3/ 1+2*&3 +2**/ 1+2*+0 +2330 +2+3+ +2&"4 +2+03 +23++
>++"+4 EKI3, -*/*3- +2*/" +2+"* +2*&/ +2*/- +2*+. +2-*/ +2+-/ +2.30 1+2+/- +24*/
V-"+44 EO<*, .+... 1+2/+3 +2++/ 1+2/0. +2+"4 1+2-+& +2**/ 1+2+"- +24/- +2*-" +2/"4
>-""4* EO<3, 3"+.3 1+2--. +2+"3 1+2--- +2330 1+2-/+ +23"4 +2+.4 +2&&. +2+.+ +20*/
E-$&43 EOI3, =' 1+2"4+ +2+*4 1+24./ +2+&. 1+2-4" +2*4* 1+2+4- +2&"4 +2-*. +2-4*
>+/+/* EOZ*, 3//+/ 1+2-04 +2+3" 1+2/*4 +23++ 1+2-44 +2*/- 1+2+/* +2&++ 1+2++* *2+++
>04"4. EUORC*, 40".- 1+2+3+ +20/* 1+2+3- +20/- 1+2+*4 +204* +2*+" +244* +2*** +2&++
>3//4- EGIQ*, 304+30 1+234+ +2+*+ 1+2-3. +2+"4 1+23*/ +2330 +2+-0 +24/- +2*"+ +2-*/
8-9_#& E]L*, =' 1+2/&0 H,+2++* 1+2/0. +2+"4 1+2/&3 +2+30 1+2**3 +2&"4 1+2+04 +2-/-
!0A$64 _?<;, **-0." 1+2++/ +204& 1+2*&. +2/"4 +2*40 +2/&. 1+2*"* +2"4* +23*" +2/++
!.//3& _?<;?, *4+.4+ +23-/ +2++. +23./ +2*/- +23+/ +2+30 1+2+/& +2.30 1+2*+0 +2/30
!.+"&4 _?<;(, *4**"" +234* +2++* +2--0 +2+30 +23+- +2*/- 1+2+3/ +2&"4 1+2*.+ +2+&.
#*%!7* _?S;, =' 1+233& +2+00 1+2-4& +2+30 1+2+40 +2&++ 1+2*"& +2/"4 +2*/3 +2330
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8-9%&" _))G, =' +2*30 +23.0 +2+"* +2.30 +23+& +2-4* 1+233& +2330 1+2+4* +2."4
>303.. _T(?<;, =' 1+2+"& +2.0. +2+3* *2+++ 1+2*-4 +2.30 +2*+& +2.30 1+2+"+ +2&"4
!":7J. _T();, -+*-&/ 1+2*+- +2**/ 1+2+// +2.30 1+2*.3 +2**/ +2*/- +2*4* +2+3" +2&++
8/'@+* _T^I3, =' 1+2+30 +240& +2+-0 +244* 1+2+0& +2"/- +2+-. +2&"4 1+2*+* +2"/-
>34&&* _Q3, 3"+"0 1+2"/* +2++/ 1+2-4* +2*4* 1+24** +2+"4 +2*+3 +2.&. 1+23-& +23++
>04"*0 _DS)C, 403-& 1+2*&* +23*" 1+2*-/ +2/&. 1+2330 +2-4* +23*0 +2*4* +2*3- +2.30
@+@FA3 _G<*4(*+, .-&./ +2+/" +2/-& +2+&. +23"4 +2++/ +20/- +2**4 +23++ +2+-" +24*/
>04&"3 _G<*4(/, 403// 1+2"/- +2++/ 1+2..3 +2**/ 1+2/3" +2+"4 1+2*3+ +2&30 +2**4 +2&++
!.FE@" _G<*4(&, -.*&+3 1+2"*" +2++* 1+2.*- +2+30 1+2/*4 +2+"4 1+2+/3 +2&&. +2*"- +2/++
!/$&#0 _G<C3, =' +2*." +2+.& +2*&+ +2330 +2*"+ +2330 +2+"/ +2."4 +2+3/ +2&&.
#*F0"- _GO?0, =' +2+"+ +2/&- +2+3/ +2&&. +2+4. +2/++ +2+/" +2-4* +2+04 +2"*/
@"8#E/ _GO(4, "+"." 1+2/*4 +2+-. 1+2"3" +2*/- 1+2-+0 +2*4* +2+4* +2&++ +23&4 +2-/-
>.-+-0 _GO<*, 3&0.*/ 1+2++3 +20&. +2+&" +2.++ 1+2+&0 +2/&. +2+&/ +2/"4 1+2+0+ +2"/-
8-98>3 7)I*, =' 1+2*.. +233* 1+2+0- +2.30 1+23-0 +23"4 +2*0/ +2*/- +2+/& +2&30
>/*".3 7<;*, 3//40 1+2340 +2+&- 1+2-/+ +2*/- 1+23*& +2/++ 1+2*3* +2"4* +2+++ *2+++
>"."4/ 7<;3, -.*"0. +2++3 +200+ +2*&4 +2/30 1+2*&/ +23"4 +2*+* +2"/- 1+234+ +2*4*
!.&#:+ 7<;-@, 0/*4- +2+0" +2+0. +2*-0 +23++ +2+"+ +2-4* +2+"/ +2/30 1+2+-" +2.&.
!":7P- 7<;-S, 3"*40 +2*+* +2"-4 +2*/" +2.&. +2+"4 +24*/ 1+2+-" +20*/ 1+2*33 +244*
!-65&. 7DDI, -*3/// +2+44 +2**& +2++4 +20/- +2*/& +2+"4 1+2+0* +2**/ +2+"+ +2"/-
8/'/%" 7G)?3, =' 1+23"3 +2*+" 1+2-.3 +23++ 1+2*/3 +2/30 1+2*.+ +2"*/ +2+.+ +244*
@35940 7G)], =' 1+233" +2++. 1+233+ +2+30 1+23-+ +2*4* 1+2+-" +2&++ 1+2+/" +2.30
>*3++4 7`<, 3/"*- 1+2*4- +2+44 1+2+4/ +2"/- 1+234- +2*4* +2*-& +2-/- 1+2+.* +24/-
!":7F4 6?UG, 303+3& 1+2/*+ +2++3 1+2/4/ +2+"4 1+2-/. +2+&. 1+2+/3 +2&30 +2+&4 +2/++
8-9$\3 %3;S<;, =' 1+2*+. +2-+. 1+2+-0 +24/- 1+2*4- +2-4* 1+2++/ *2+++ 1+2*-4 +2330
!-3>:0 %?)R*, =' +2+-+ +2&/+ +2*.. +2-4* 1+2*+4 +2."4 +2*4& +2/"4 1+2+0" +2/"4
8-9#P. %?)I(, =' 1+2*+* +2*+0 1+2*/* +2*4* 1+2+.3 +2-4* 1+2*". +2+&. 1+2+44 +2/30
!.&#\/ %?O-, 3&0..& 1+2-&- H,+2++* 1+2//& +2+30 1+2-*0 +2+30 1+2+4- +24*/ +2+"4 +2/"4
>+/./3 %<;?, -..-"" 1+2"*- +2++/ 1+2.&& +2+"4 1+2--& +2**/ 1+2+/* +2&&. +2-+0 +2*4*
>/3*3- %<;(, 3/"-/ 1+2*./ +2*-3 1+2-". +2+&. +2+3& +2&"4 1+2330 +2+"4 +2*"" +2-*/
!4Y>P/ %<;<, -+4&"& 1+2303 +2*+- 1+2-/* +2-4* 1+23/3 +2*4* 1+2+0. +2&++ +2++- *2+++
!":7=. %RID*, -+"/"4 1+2*&" +2*"& 1+2*"& +2/++ 1+23*3 +2-4* +2+". +2."4 +2++3 *2+++
!":7_/ %T?G, -+"-/& 1+2-./ +2++4 1+2-.- +2**/ 1+2-." +2+&. +23++ +23++ +2*00 +2"/-
#*%:'+ %VB*++0*+4*+, =' 1+2*+" +23&+ 1+23+4 +23"4 1+2++3 +204* 1+2+*0 +20*/ +2*&. +2+&.
!-F_Y3 %VB*++0**+-/, =' 1+2**/ +2-"* +2+33 +20/- 1+23"+ +23"4 +2+.0 +244* 1+23+- +23++
!.75%3 %VB*++0**/&", =' 1+23&. +2+*. 1+2-+& +2*4* 1+23.- +2*/- 1+2+3. +2&30 +2+*0 +20*/
8-9B90 %VB*++0*3"00, =' 1+2+.0 +2"&. 1+2+&4 +2.++ 1+2+"3 +20*/ 1+2+"" +2&30 1+2+3+ +20*/
8-9#*- %VB.&-&&/, =' +233" +2*+& +23+" +2"*/ +23/" +2+30 1+2+"" +2&&. 1+2+*. +2&"4
'0MF$4 %VB.&.//3, =' 1+2-0& +2-/- 1+2..& +2/"4 1+2*3& +2.&. 1+2*3" +244* +2/*. +2.&.
!03/\" %K^O*, *4+0*. 1+2*/" +2**& 1+2*-- +2/&. 1+2*"4 +2*4* +2+&+ +2/&. +2+". +244*
!"\EJ+ %UOOU), -*-&.4 +20+4 +2+4. +2/"4 +2"/- *2-"4 +2**/ 1+2-&4 +2-*/ +2"*3 +2.++
E-$09- F?K?, =' 1+2*44 +2*33 1+23*/ +23&. 1+2*/+ +2/30 1+2+4. +24/- 1+2++3 *2+++
!.._E0 F?`G, =' 1+2-// +2+3- 1+2-*/ +2*/- 1+2-4/ +2**/ 1+2*+/ +2."4 1+2*./ +2/&.
8-9>#3 F)?I, =' 1+2-0+ +2+"- 1+2-.+ +2/++ 1+2/*0 +2+30 +2+.- +2&30 +2++/ +204*
!":7Y0 F)))3, -.*&&/ 1+2+.* +2-&& 1+2+.+ +2.30 1+2+.- +24*/ +2+/" +2&++ +2+/3 +2"4*
8/'*04 F)RR, =' +23+4 +2*43 +23". +2-*/ +2*"& +2/30 +2*0. +2/++ +2+0& +2.30
F+587" F)], =' 1+23.3 +2++0 1+23-0 +2+"4 1+23&" +2+&. +2+-0 +20/- 1+2++4 +20*/
V&&0&0 F<;*, 3/""* 1+2+/+ +24"0 1+23/& +23&. +2*.& +23"4 1+2*.+ +23&. +23". +2330
>+/.-. F<;3, &*&30 +2+/* +2//. +2+.3 +2"*/ +2+3+ +24*/ +2+&/ +2-*/ +2+/- +2.30
8-9P_0 FR3, =' 1+24*- +2++3 1+20-/ +2+&. 1+2/0* +2+"4 1+2-.4 +2-/- +2+4" +24/-
!&5/90 FL^*, *03./4 1+2+.& +2/4/ 1+2*+- +2/"4 1+2+-- +2&30 1+2++/ +204* +2+.. +2."4
!03+#" FCN)<, &"3-0 1+23.4 +2+.* 1+2/++ +2**/ 1+2*-- +2"*/ 1+2*"+ +2/"4 +2**4 +2"/-
@"8#=- F^L*, =' 1+2*"* +2+0/ 1+2*"" +23++ 1+2*/& +2/30 +2+.4 +2."4 +2+4/ +2/&.
>.-+-* FO)*, =' 1+2+3* +20*3 +2*40 +2"4* 1+2333 +2-/- 1+2+/0 +24*/ 1+2/"* +2*/-
>04"-3 FOGI, *03*43 1+2*+* +2-4. +2++- *2+++ 1+23+/ +23&. +2*/3 +2/++ 1+2+./ +24/-
!":7J- FUOC**, 30-... 1+2300 +2+-3 1+2-.. +2**/ 1+23-3 +23"4 1+2+"4 +2&30 +2+44 +2."4
8-9:#0 FUOC*3, =' 1+2+&" +2/*3 1+2*** +2.++ 1+2+.+ +2.30 +2+*. +2&30 +2+.4 +244*
!4F+J4 FUOC*/, -+*3"+ 1+23&. +2++- 1+234& +2+&. 1+230- +2+30 +2*-. +23&. +2*3* +23&.
8/'/'0 FUOC*0, =' 1+2-/" +2+*3 1+2/+. +2+"4 1+23&- +2**/ +2*.& +2/"4 +230* +2+"4
!/0&Y/ FUOC3, =' 1+2"-3 +2++- 1+2..3 +2+&. 1+2/+- +2+&. 1+2*-* +2.30 +2*3& +2.++
@3E$.3 FUOC3+, =' 1+2--" +2+*+ 1+2340 +2*4* 1+2-0* +2+"4 +2*04 +2/"4 +2+&. +2/"4
8-9F50 FUOC3*, =' 1+2*3+ +23&* 1+2*+- +2"4* 1+2*-. +2/30 +2**3 +2"*/ +2+40 +2"4*
>+B3B+ FUOC33, 3&4-+3 1+23*0 +2+.+ 1+2*&/ +2-/- 1+23"/ +2*4* +2+*& +2&&. 1+2+"- +24*/
!.._/4 FUOC3/, 30"33/ 1+23". +2++3 1+23.. +2+"4 1+23/. +2+"4 +2+"* +2&++ +2+4+ +2/30
8-9PX* FUOC3&, =' 1+23&4 +2++" 1+23"+ +2**/ 1+2-3/ +2+&. +2*/" +2330 +2+4* +2.++
>+B3B* FUOC-+, "+333- 1+23.& +2+/0 1+2-+- +23&. 1+23-3 +2*4* +2+3" +2&&. +2+0. +2-4*
8/'@%4 FUOC--, =' 1+2/"* +23*- 1+2"*& +2-4* 1+2-&/ +2/"4 +2*"3 +2&30 +23&. +2.++
!.':Y+ FUOC-4, ".3&* 1+2-*. +2++* 1+2-/+ +2+30 1+230* +2+&. 1+2+". +2.30 1+2++. *2+++
!">!=0 FUOC-&, =' 1+2--" +2+*/ 1+2-/- +2*/- 1+2-3& +2+"4 +2+-. +2&++ +2+"3 +244*
8/'*-* FUOC/, =' 1+23+" +2+-" 1+2*&& +2*/- 1+233- +23"4 +2++- +204* 1+2+-3 +2&"4
!/E+.4 FUOC//, -+*""3 1+230& +2+&* 1+23&- +2/30 1+2-*- +2**/ 1+2+0/ +244* 1+2*3/ +2"4*
8/'*+/ FUOC/", =' 1+2340 +2++3 1+2--0 +2+30 1+23*0 +2*/- 1+2++0 +204* +2**3 +2-4*
!"56++ FUOC/., 30-+"/ 1+2-.. +2++* 1+2/+* +2+30 1+2--3 +2+&. +2+3* +2&"4 +2+0+ +2/"4
8-98:4 FUOC/&, =' 1+2*.4 +2*+& 1+2**/ +2/30 1+233* +23++ +2++& +204* 1+2+00 +2"/-
!4Y>44 FUOC/0, -+0*4. 1+2-/- +2++0 1+2/"+ +2+&. 1+23-" +2*/- 1+2+.3 +244* +2*"- +2330
8-9X%/ FUOC"+, =' 1+2-*. +2++4 1+2-"* +2+&. 1+23&* +2+&. 1+2+40 +24*/ 1+2++0 +204*
@35XA/ FUOC"-, -.3-&& 1+23+. +2"+* 1+23&0 +2.++ 1+2*3- +2&"4 1+2+.0 +20*/ +2+04 +2.++
8-9063 FUOC"/, =' +2+00 +2"&3 +23&/ +2-4* 1+2+&" +24/- +2+/3 +2&&. 1+2-3& +2-*/
!./*:0 FUOC0, -*+."- 1+2-4* +2++/ 1+2/3& +2+"4 1+2-*/ +2+"4 +2+3" +204* +2*-0 +2-*/
8/'+/+ FUOG**, =' 1+2-/4 +2++" 1+2-&4 +2+"4 1+2-+& +2**/ 1+2+/4 +2&30 +2+-* +2&++
!":7-4 FUOG*", 30&"*4 1+2/-" +2++. 1+2/"* +2+&. 1+2/3+ +2+"4 +2*// +2/&. +2*4" +2/++
8-9Y5* FUOG*4, =' 1+23// +2+.. 1+2*0* +23"4 1+2304 +23++ 1+2+-- +20*/ 1+2*-0 +2-4*
#.!"64 FUOG*&(, =' 1+2-+4 +2+*+ 1+234- +2*/- 1+2-/+ +2+"4 +2+.& +2."4 +2++* +204*
8-97=4 FUOG3-, =' 1+2-00 +2++. 1+2-./ +2**/ 1+2/-" +2+"4 +2+0/ +244* +2+3- +2&"4
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'0MF$3 FUOG3/, =' 1+2-4* +2++3 1+2-33 +2+30 1+2/3+ +2+&. +2*&4 +2/30 +2+&0 +2/&.
!/!5&+ FUOG3", 304/"0 1+2//. H,+2++* 1+2-0+ +2+30 1+2"+3 +2+30 +2+&& +2.30 1+2+3/ +20*/
8/'&-- FUOG-+, =' 1+2340 +2+-/ 1+2-+. +2*4* 1+23"3 +2330 +2+*3 +204* +2+.4 +24/-
@+@=". FUOG-*, 30+&"+ 1+2-// H,+2++* 1+2--& +2+30 1+2-"+ +2+30 +2+43 +24*/ +2+.+ +2"4*
!+9#\/ FUOG--, 30.00" 1+2-/& +2+*4 1+2-"/ +2*4* 1+2-/3 +2+&. +2*"/ +2-*/ +2*." +2"*/
8/'@F" FUOG-/, =' 1+2-/& +2++" 1+2-*3 +2+&. 1+2-&- +2+"4 +2**& +2/"4 +2+/4 +24/-
8/'09. FUOG-", =' 1+2"&* +2++" 1+2*.0 +23"4 1+200- +2+30 +2.4& +2+30 1+2*/4 +2-4*
F+544. FUOG-., =' 1+2+&- +2./- 1+2*+- +2&30 1+2+.- +2&++ 1+2+.0 +2&&. 1+2+30 +2&&.
8-9XY3 FUOG", =' 1+24*3 H,+2++* 1+24.+ +2+30 1+2.." +2+"4 +2+". +2&++ +2*"3 +2/++
!"7+6& FUOG4, **-0"& 1+2/&- +2++3 1+2"4& +2+30 1+2-&& +2*4* 1+2++4 *2+++ +2*&- +2-*/
@+@=.& FUOG0, -+*-4* 1+2/*- +2++* 1+2/30 +2+30 1+2-04 +2+"4 +2+43 +2.&. +2*+/ +2-4*
!&_7B& FI1?IO&, =' 132.3" H,+2++* 132./+ +2+30 132.*+ +2+30 1+2++/ *2+++ +2+3. +2&&.
!&_7B0 FI1)K*, =' 1+2*+- +2..4 +2+*& +204* 1+233- +2-*/ 1+2**0 +24*/ 1+2-.+ +2"*/
!&\J9" FI1)K3, =' 132-.- H,+2++* 132-/* +2+30 132-&" +2+30 1+2+"0 +20*/ 1+2*+3 +20*/
!&_7B. FI1^</, =' 1+2-3* +2+-/ 1+23.3 +2-4* 1+2-&* +2+30 +2++/ *2+++ 1+2**" +2&"4
!4_**- FI1^</C, =' 1+2/*& +2+"& 1+2""4 +2*/- 1+2340 +2-4* 1+23-4 +2.++ +2+/3 +2&&.
!&\J9+ FI1^<", =' 1+23+0 +2+*0 1+23+/ +2+&. 1+23*/ +2330 +2+44 +2"4* +2+.4 +2/"4
@+@="3 FI);3, 30"033 1+2*+" +23-& 1+23"* +2*/- +2+/3 +2.++ 1+2+&0 +2*/- +23+/ +23++
!":7E0 FILO*, =' 1+2*4+ +2*"+ 1+23+. +23"4 1+2*-/ +2."4 1+2+-+ +2&"4 +2+/* +2.&.
@+@=+3 FIZ*, =' 1+2-*- +2+** 1+2-"0 +2+"4 1+23.. +2*4* 1+2+.. +244* +2+34 +2&30
!"M*90 FIZ3, 3&&*"+ 1+2*+0 +2-/* 1+2++- *2+++ 1+23*" +23"4 +2+&- +2/"4 1+2*30 +2"4*
8/'*_4 F]C*, =' +2+40 +2&.& +2-/+ +24/- 1+2*&3 +2/&. +2+3" +20/- 1+2/0. +2"4*
#*%>$+ =?UG, =' 1+24++ +2++* 1*2+/4 +2+30 1+2-"- +2*/- 1+2/&. +2-*/ +23+& +2-*/
E-$0\. =<]L?*, =' 1+2-/- +2-04 1+2"&* +2-/- 1+2*+" +2&"4 +2+&* +2&&. +2""& +2-4*
!&+A&0 =<]L?**, -+**3- 1+2*-. +23&4 1+2*+" +2.30 1+2*.4 +2/&. +2+0+ +244* +2+34 +20/-
8-9\"& =<]L?3, =' 1+2++3 +200+ 1+2+.3 +24/- +2+"0 +2&"4 1+2*.3 +2"*/ 1+2+/+ +2&"4
#*F&%. =<]L?-, =' 1+2*-" +2300 1+2+"3 +244* 1+23*4 +2-*/ +2+0. +24*/ 1+2+.0 +24/-
@3598. =<]L?/, =' +23." +2+/0 +23"* +2-/- +2340 +2330 1+2*+3 +2.++ 1+2+4" +2.30
!.--.3 =<]L?", 3"/&& 1+2+-- +2&-. 1+2*4" +2/30 +2*+& +2.30 1+2+4- +2."4 +23*+ +2/30
8/'-$3 =<]L?., =' 1+2+&& +2/.- 1+2-*& +2**/ +2*/3 +2-/- 1+2*.+ +2-/- +2-++ +2**/
!4Y>4& =<]L?&, 30.."& +2+-3 +2&4" 1+2*&/ +2-*/ +23/& +2"*/ 1+2-+" +2/"4 +2*3. +2/++
!"@6.- =<]L?0, =' 1+2*-" +2*04 1+2*"4 +2/++ 1+2**/ +2/"4 +2++& +204* +2+"* +2&++
#*%AE/ =<]L?L*, =' 1+2*-- +233* 1+23+. +2*4* 1+2+.+ +2&30 1+2+*- +20/- +2*-- +2330
V+&44. =<]L?L-, =' 1+234. +2++- 1+2-43 +2+30 1+2*&+ +2*4* 1+2+"/ +24/- +2*-& +2**/
!0=!5& =<]L?L/, =' 1+2**" +2**0 1+2*++ +2*4* 1+2*-+ +2-/- +2+"/ +24*/ +2+3/ +24/-
@3E$4* =<]L?L", =' 1+23+- +23*. 1+23./ +2"*/ 1+2*/- +2"*/ 1+2+./ +2&30 +2+"4 +2.++
8-9=/- =<]L?L., =' +2+-+ +2&34 +2*+" +2.&. 1+2+// +2&"4 +2*.& +2/&. +2+*0 +20/-
!":740 =<]L?L4, =' 1+2.// +2++- 1+24"3 +2**/ 1+2"-. +2+30 1+2*.- +2&30 +2+"- +2&++
8/'+Y+ =<]L(*+, =' 1+23+0 +2+.+ 1+2*34 +2"/- 1+230+ +2+"4 +2+.+ +2"4* 1+2*+3 +2.&.
8/'4%/ =<]L(**, =' 1+2*+. +2/+- 1+2+3" +2&&. 1+2*&& +2/30 +2+&. +244* 1+2+4& +2"4*
@35XM+ =<]L(3, -.3-// 1+2"." +2++* 1+2.+. +2+&. 1+2"3/ +2+30 1+2*** +2.&. 1+2+-+ +2&"4
8/'"." =<]L(", =' +2+3& +240/ +2+++ +204* +2+"4 +2&"4 1+2+/* *2+++ +2+*. +2&"4
8-993* =<]L(., =' 1+2330 +2++- 1+23.. +2+"4 1+2*0- +2+"4 +2+&3 +2-/- +2*"" +2*/-
8-9%Y* =<]L(4, =' 1+2-.* +2+/- 1+2-&* +2*4* 1+2-/* +2330 1+2++. *2+++ +2+-" +2&++
@35X\& =<]L(&, 30-00* 1+23+. +2+*- 1+2*4/ +2**/ 1+23-& +2*/- +2+/" +2&"4 1+2+3+ +2&30
@35XA- =<]L(0, 3000"/ 1+2*-0 +2+&/ 1+2*&- +23++ 1+2+0" +2/++ 1+2++3 *2+++ +2+&" +2/&.
8-9\4" =<]L)*, =' +2300 +230. +23&- +2/&. +2-*. +2/&. 1+2"3. +23&. 1+2/0- +2330
!">!90 =<]L)3, 30-*-+ 1+2-+0 +2++- 1+2-&& +2+"4 1+23-* +2**/ +2+"* +2"4* +23+& +23++
!.._#* =<]LG*, -+*/"& 1+2**. +2+0. 1+2*** +23"4 1+2*3+ +2*4* +2+-/ +2."4 +2+3" +2."4
!./*X3 =<]LG3, =' 1+2*0" +2++3 1+2333 +2+30 1+2*.& +2+&. 1+2++& +20*/ +2+/" +2.30
8-9E/- =<]LG-, =' 1+2+&+ +2-+" +2+** +20*/ 1+2*43 +2*/- +2+&* +2.&. 1+2*+3 +2-*/
!":7#- =<]LG/, =' 1+2+44 +2.&3 1+233+ +2/&. +2+.. +2&"4 1+2*.. +2"*/ +2*3+ +2."4
@"8J%& =<]LG", -.3"&& 1+233+ +2-*/ 1+2-"0 +2-/- 1+2+&+ +24/- 1+2+30 +20*/ +23"* +2/&.
!"5P=+ =<]LG4, -.3&-4 1+2*+. +2+-+ 1+2+". +2/++ 1+2*"4 +2+30 +2+*3 +2&++ 1+2+&0 +2-*/
@+@=J. =<]LG&, 30-."3 1+2+4" +2-/+ 1+2+/- +24*/ 1+2*+. +2/30 +2+/& +24/- 1+2+*" +20*/
!":7_- =<]L`*, 30-."" 1+2+&" +2/-& 1+2*0/ +2-4* +2+3- +2&&. 1+2+03 +2/"4 +2*3/ +2"4*
>*03-/ =<]L`3, &*43& 1+2*** +2+-+ 1+2*-/ +2+&. 1+2+&& +23"4 +2+/" +2"4* +2+0* +2**/
E-$.// =<]L`-, =' 1+2-0/ H,+2++* 1+2/"+ +2+30 1+2--& +2+"4 1+2+-+ +2&"4 +2+&3 +2"4*
!.>BM& =<]L`-, =' 1+2*43 +2*3" 1+2*&3 +2-/- 1+2*.- +2/30 1+2+0/ +244* 1+2+4" +2-4*
8-9'&" =L]*, =' 1+2*0+ +2+&" 1+2+.0 +2."4 1+2-** +2+"4 +2*3& +2"/- 1+2**/ +23"4
>/3.4. =C^, **4+/* 1+2-*4 +2+33 1+2-/- +2*4* 1+230+ +2*/- +2+-- +2&++ +2+&4 +2"4*
!"#$!& =CUZ*, =' 1+23&/ +2++* 1+2-*+ +2+30 1+23"4 +2+"4 +2+-" +2.30 +2+&& +23"4
>*0&+/ =DR3, &-4&3 1+2*.- +2+3& 1+23+" +2**/ 1+2*3* +2330 +2+/& +2"*/ +2*-- +23++
@3EM:" =I")-?, =' 1+23&0 +2++. 1+230& +2+"4 1+23&+ +2+&. +2**& +2/&. +2*-. +2**/
!.'X80 =]<I*0, -+&"*& 1+234& +2+-& 1+230" +2+"4 1+23.3 +23"4 +2+*0 +204* +2+"3 +2"*/
8-9J_. =]<I&, =' 1+2*+. +2-// 1+2*4/ +2-/- 1+2+-0 +2&"4 1+2+*+ +204* +2*3" +2/++
>+/*&3 V?I, ./-*- 1+23"3 +2+-" 1+2*.& +2-4* 1+2--. +2+&. +2*/. +2-4* 1+2+33 +2&"4
!":7E/ V)T?<*, 3&0"0+ 1+2*.4 +2+43 1+2*"/ +23"4 1+2*40 +2-*/ 1+2++3 *2+++ 1+2+34 +2&30
!":74& VS<;, =' 1+2+** +240+ +2+3+ +244* 1+2+/3 +2/30 +2++/ +20/- 1+2+"& +23&.
8-9\4/ VD?*, =' 1+230- +2+*" 1+2--4 +2*4* 1+23/0 +2**/ +2+43 +2"4* +2*.+ +2-4*
8-95_* VZ?*C, =' 1+2-++ +2++/ 1+2-.- +2+30 1+23-4 +2*/- +2+/4 +2&30 +2*4- +2*4*
@3E$+. VZ)I*, =' +2*+3 +2*"4 +2+.+ +2"4* +2*/- +2330 +2+3/ +2.++ +2*+. +2/"4
8/'+X/ VZ^?<*, =' 1+2+&+ +2/*& 1+2+/* +2"4* 1+2*3+ +2.30 +2*&/ +2*/- +2*+. +2"/-
E-$.54 VZGD, =' 1+23.. +2+3. 1+23+* +23++ 1+2--+ +2+"4 +2*0- +2330 +2+./ +2.&.
8-99$* >?D*., =' 1+2+"4 +2"+. 1+2++. *2+++ 1+2*+& +2"*/ +2+3- +2&"4 1+2+4& +2"/-
V&&4.4 >?UQ4, -./"&- 1+23"" +2+-. 1+2-./ +2+"4 1+2*/. +2/++ 1+2+-0 +2&30 +2*4& +23&.
>"3&4- >), =' 1+2*3- +23/4 1+2*4* +2/30 1+2+4" +2"*/ +2+-3 +2&"4 +2*3& +2330
>*/&&3 >))?, .&4++& 1+2**" +2"3- 1+23*. +2"*/ 1+2+*" +20/- +2+&" +2.++ +23&. +2/"4
!.&#9& >))(, 3/.3/ 1+2*"" +23.0 1+2+0/ +24/- 1+23*. +23"4 +2*-+ +2/"4 +2++& *2+++
>/0/-3 ><;(, 3&00"+ +2+"& +2"** +2*"4 +23++ 1+2+/* +2&&. +2*/- +2-4* 1+2+"" +2.&.
!./"-. ><Q3, &*"-+ 1+2+-. +243* +2++- +20/- 1+2+4. +2.30 +2*&& +2-*/ +2*+0 +2-4*
'*%*P/ ><O*, =' 1+2+0" +2-+. 1+2+"4 +2."4 1+2*-3 +2/"4 +2+-0 +244* 1+2+-. +244*
8-9:'. ><OU, =' +2+*+ +20*+ +2+"0 +2.&. 1+2+-0 +2&30 +2*+. +2/&. +2++& +204*
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!4"!/* YKDD33, -+++4" 1+23*3 +2+03 1+2*&- +2-*/ 1+23/+ +2-*/ +2+3* *2+++ 1+2+-" +20/-
!-658" YKDD-/, -**.3* 1+2"+4 +2++* 1+2.3& +2+30 1+2-&4 +2+"4 +2+3. +2&&. +23.4 +23"4
8-9P\- YKDD., =' 1+23"* +2+.- 1+2-** +2330 1+2*0+ +23++ +2+/. +244* +2*.& +2-4*
!4"!-0 YKDD4+?, .&+*/3 1+2--/ +2++* 1+2-./ +2+"4 1+2-+- +2+"4 1+2+"+ +2&30 +2+** +2&&.
!":_9+ YU?O*, 3&4+.0 1+2/0/ H,+2++* 1+2/34 +2+30 1+2".* +2+30 +2*"+ +23&. +2+*. +204*
>3/-30 YGI, 3"34/ 1+2+"0 +2.// +2+.* +24*/ 1+2*4& +2/"4 +2+.+ +2&30 1+2*40 +2*/-
8/'.84 YI)*0, =' 1+234. +2++0 1+2-.& +2+"4 1+2*&/ +23"4 1+2+&" +2"/- +2+00 +2/"4
>&"&-/ Y]LD, 30-/&* +2+4" +23+3 +2+&* +2-/- +2+.& +2/"4 +2+&. +2-4* +2+4/ +2/++
>04.*" YZ^3, 40/.3 1+23&& +2**- 1+2-4/ +2*4* 1+23+* +2/&. +2+"" +2&30 +233& +2-*/
V&0+/0 YZ^U<*, =' 1+2-0. +2++- 1+2/03 +2+30 1+2-+* +2**/ 1+2+*& +20/- +2*4- +23&.
!09+P" YZ^U<3, "+""* 1+2+&0 +230" 1+2**. +23&. 1+2+.3 +2.&. +2+"/ +24/- +2*+& +23&.
>"./00 M)O-, 3"4+& +23.. +2+-" +2*". +23&. +2-4. +2**/ 1+2+03 +244* +2*3& +2/"4
!.&#X+ M[)U)*, -+*+** +2+*+ +2&43 +2++* *2+++ +2+*0 +2&30 1+2++. +20*/ +2+*3 +204*
>-3""* M[)U)3, =' +2+-* +24-+ +2+4. +2/&. 1+2+*/ +20*/ 1+2+0& +23&. 1+2*&& +23"4
>3+4&& M[)ULG*, 30**+- +2+-/ +2./0 +2*-- +23++ 1+2+.. +24*/ +2*+/ +2+&. 1+2+0" +2"/-
!4Y!*. M[)U[, =' +2+/& +2&+- 1+2+&4 +2&++ +2*&- +2/"4 1+2*+& +24*/ +2*.3 +2.++
>&**"" $<?)3, &-"-* 1+2+3& +24+/ 1+2+"* +2.++ 1+2++" +204* +2+*. +20*/ +2+.3 +2.30
!05*9+ $<?)-, &-"-3 1+233. +2-30 1+2+4+ +204* 1+2-&* +2*/- 1+2+4/ +24/- 1+2-&" +2-4*
#*F&_3 A?UG3, =' 1+2-/& +2+// 1+2-+3 +23&. 1+2-0" +2+&. +2*&- +2-4* +2+0+ +2.&.
8-9Y5" 9(R<", =' 1+2+-0 +24*4 +2+-0 +2&30 1+2**. +2"*/ 1+2+"3 +24*/ 1+23+. +2*4*
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Table C.2 
 
 
!"#$%&'()&&*+,-.+,/-01%&2,$3&4+"56%(
750.8,1&9: ;%5%&<=>#,$ ?518%@ <01%
$,6)&2,$3&
4+"56%
*%8>A1"10,5&
*/B"$A%
$,6)&2,$3&
4+"56%
*%8>A1"10,5&
*/B"$A%
$,6)&2,$3&
4+"56%
*%8>A1"10,5&
*/B"$A%
$,6)&2,$3&
4+"56%
*%8>A1"10,5&
*/B"$A%
$,6)&2,$3&
4+"56%
*%8>A1"10,5&
*/B"$A%
!"#$%& '()(&* +,-+.- /,01 .2+&& .2.." .2""- .2.-0 .2--3 .2-.. .24,0 .2+14 5.24"0 .23..
!"#$%& '()(&* +,-+.- 6,-4 5.2-.& .2.01 5.2443 .2,-0 5.2+.- .2414 .2."+ .2143 5.24+" .2,"1
!"#$%& '()(&* +,-+.- /1.. .2-1+ .2.3, .24"& .2-&, .2+&1 .243+ 5.2--- .2"3+ .2..1 .2043
74",". ')89:* -"-&1 /40+ .240& .2-"" .2-.0 .23&, .24&1 .23-0 5.24.- .2,-0 5.24-3 .2,"1
!0;#+3 ')<-* 10-". /""0 5.2"-- .2..3 5.2+0+ .2."1 5.2,"4 .2."1 .243, .2,-0 5.244- .2,..
74&4,+ ')=:4* -"-&& /3-3 .241& .244+ .2-.+ .243+ .24"+ .23-0 .24+3 .23&, .2.&3 .2"43
74&4,+ ')=:4* -"-&& /-+. 5.2-"1 .2+&" 5.2+"" .2,"1 5.24"0 .2+43 5.24,- .2&-0 .2.+" .2,..
>3'4?4 ')@A-* B' /,0 .2.+0 .20.- 5.24.& .2&"1 .24&, .2,"1 .24.& .2143 .23.- .23"1
!0CD"+ 'EFG4* &+"++ /+13 .2431 .2.,- .2-,- .2.&, .2.++ .2,&, .24-- .23"1 5.24.1 .2443
!0CD"+ 'EFG4* &+"++ /-,1 5.2.+, .2033 5.2+,3 .2"14 .2-0- .2,&, .2+-4 .2143 .2011 .2+43
!0CD"+ 'EFG4* &+"++ /+1. .2-4" .2..& .24&1 .243+ .2-3- .2.&, 5.2.,4 .2,&, 5.2.., .2&&,
!"H4I, 'A<<:* +41404 6+3 .23"4 .2.-1 .2,34 .243+ .2-,4 .2."1 .2.,+ .2114 5.2+4, .23..
!"H4I, 'A<<:* +41404 J30 .2--& .234& 5.2.-0 .2014 .23&3 .2."1 5.2,40 .2--0 5.24., .2,-0
K4IKI3 'LG)4.* B' /3+ .2.-+ .20-4 .2.1" .2&-0 5.2.+. .2&.. 5.2-1" .243+ 5.2+&. .2+14
740"44 'MA"F4* B' /--& .2441 .2++- 5.2.4+ 42... .2-31 .2--0 5.2.-" .2043 .2-+3 .2--0
740"44 'MA"F4* B' J4," .2430 .2+"1 .24., .2,-0 .240+ .2+3+ .2440 .2"14 .2-., .23-0
7-0340 'MA"E* 43.,.& /,& 5.243. .23"0 5.23+. .2.-0 .24"4 .2143 5.2+-4 .2+43 .2-,. .2-"1
7-0340 'MA"E* 43.,.& J+- .2+," .23-+ .23+3 .23"1 .2-01 .2114 .2--3 .2,-0 .2.&1 .203+
>+N'O, 'MA"P-* B' /+- .2-1& .24,1 .2410 .23"1 .2+11 .2+43 5.2+33 .243+ 5.243, .2,&,
>+NJ". 'MA8F4* B' /1, 5.2,0, .2.33 5.21+, .2414 5.2,"1 .2-.. 5.2"31 .2-"1 5.23,& .2+14
K4IKB+ K)Q9R8* -"-33 /+3& .2.-1 .2&1, .2-.0 .23"1 5.24"" .2+43 5.243. .23.. 5.2".3 .2443
K4IKB+ K)Q9R8* -"-33 /++& 5.2-0- .2"., .24"1 .2&.. 5.2134 .2.&, 5.2.3& .2014 5.203, .2443
!..01- K)Q9Q* -0,.+ /+4 .24+" .2+.- .2-"1 .2+3+ .2.4+ .2043 5.2.4& .203+ 5.2-,- .2414
>+NHS" TR)R9+* B' J30 5.2..+ .20&1 5.2--4 .23-0 .2-4" .2"3+ 5.2.43 42... .23-- .243+
>+NHS" TR)R9+* B' J410 5.2--. .2+4- 5.2303 .2-.. .2."+ .2&-0 5.2-+4 .2"14 .2+4, .243+
>+NHS" TR)R9+* B' /"4 5.234, .2+1. 5.2"1. .2,-0 5.2-,+ .2,"1 .24,& .2,.. .231" .23&,
>+NHS" TR)R9+* B' 64&& .24+4 .2",. .2.-+ .203+ .2-3. .2"14 5.24-& .213+ .2.&& .2114
>+NHS" TR)R9+* B' /-0 5.2.4, .20.& 5.2.31 .2&.. .2.4" .2043 5.2.-& .2&"1 .2.+" .2&"1
>+NHS" TR)R9+* B' /44- .243+ .2+"4 .24"4 .2+3+ .24+" .2,"1 5.2.." 42... 5.2.-. .2014
!,&O64 T<U0* B' /&. 5.24-- .2-+, 5.2400 .2--0 5.2.3, .2&.. 5.2.&. .2143 .2.13 .2+3+
74.&&& T<V3E4* -033" J33 5.2"&" .2.0. 5.2-1. .23"1 5.20.4 .243+ 5.24+4 .2114 5.21,- .2414
74.&&& T<V3E4* -033" /-, .2+,1 .2+43 .2++3 .2"14 .23.. .23-0 5.2414 .2143 5.24." .2114
74.&&& T<V3E4* -033" /"& .24.. .2+,. .2-.& .243+ 5.2..1 .2014 .2-.& .2-"1 5.2..1 .2043
>+N>.0 T<V,(4* B' /"- .2-&+ .2-.+ .2,+1 .2.-0 5.2.14 .2043 .24&+ .2,&, 5.2"-" .2443
7&.3+- T<V1)* B' /41 5.2.-3 .2&0- .2-+& .2-&, 5.2-&, .23.. .2-10 .2+14 5.2-3" .2-"1
!+K1>. TA<V* +.3.-3 /4.4 .2410 .2.03 .2+&4 .2.-0 5.2.-+ .2&&, .244- .2--0 5.2-0- .243+
K-?W4" >(M* -0,44 /--. 5.2.4, .2&03 5.2-4. .23-0 .2410 .2-.. 5.243" .23&, .2-33 .2443
?+W,7- >:=M* B' 64,- 5.2.,4 .2&&0 .2-+0 .2114 5.2+,4 .2"3+ .2-.- .213+ 5.2+0& .2,..
74+&.+ ;MF8* +..1-, /41- 5.23-1 .2-13 5.2,03 .2+14 5.24,. .2,-0 5.2""" .2414 5.2.-4 .2014
!"D0,3 OR* B' /+,- 5.2-10 .2+-0 5.2-"0 .2"14 5.2-00 .2"14 5.2433 .2114 5.24&3 .2"43
74.&,. ?:X94* -3+00 J3"4 .241, .241. .2-4, .23.. .24+1 .2+43 .2440 .23.. .2.3. .2043
7..".1 ?<M-* +434-+ /+., 5.2."4 .21." 5.2.33 .2114 5.2."& .2&.. 5.2.31 .2&"1 5.2.,4 .2&..
7..".1 ?<M-* +434-+ /4++ 5.2-,0 .244+ 5.2+.4 .23"1 5.2-+1 .2--0 5.2.1, .2&-0 5.2.4- .2043
Y+".11 ?A94* ,.,,, /+.& .2,.4 .2..+ .2,"- .243+ .2""4 .2.-0 .24.3 .2143 .2..+ .2014
!0IW$1 Z89R* 44+0," /4+ 5.2+"1 .2+0& 5.2414 .2114 5.2"33 .2"43 5.2.,1 .2014 5.233. .2-&,
!,33-& Z89R8* 41.,1. /,34 .2.,4 .2,+. .24-- .2143 .2... 42... .240" .2+3+ .2.1+ .2143
!,33-& Z89R8* 41.,1. /,3+ .2.4" .20.& .2.1. .2&"1 5.2.34 .2&-0 .24-0 .23&, .2.41 .2014
!,33-& Z89R8* 41.,1. 6+0" .24", .23"& .240& .2+14 .244+ .2114 .2.&3 .2&"1 5.2..4 42...
!,D?K" Z=941(&* +,4&.- /"& .2."" .2"", .2.1" .213+ .2.+, .2&.. .2."+ .213+ .2.4+ .2043
7","13 %9R-* +,4"0, /3-+ .24,1 .23.+ .243- .2,-0 .240- .2"43 5.2.-. 42... .2.+4 .2014
!"S%C+ %9R+[* -"410 64-. .24+. .2,&+ .23-+ .2+3+ 5.24,- .2114 .2"4" .2414 5.2.1. .2&&,
!+$#&, %GGM* +4-333 J"1& .2.". .2,-+ .24-+ .2"43 5.2.-+ .2&&, .2..& 42... 5.24+& .2-..
!+$#&, %GGM* +4-333 64&" 5.2-.- .2431 5.2-44 .23-0 5.2403 .2+43 5.24+" .2,-0 5.2440 .2+14
!+$#&, %GGM* +4-333 /,0 .2.1+ .2,,, .24&" .23&, 5.2.+0 .2043 .2.04 .2114 5.24++ .2,-0
!+$#&, %GGM* +4-333 /+.- .24&, .244. .2-,3 .2."1 .24.& .2,"1 .24+, .2"3+ 5.2.-. .2&-0
!+$#&, %GGM* +4-333 /".1 5.24&& .24,. 5.2-," .243+ 5.2444 .2,"1 5.24-" .2,.. .2.-0 .2&-0
!+$#&, %GGM* +4-333 /+00 5.2.14 .21"0 .2.+, .203+ 5.241& .2,.. .2-1. .23-0 .2.", .203+
!+$#&, %GGM* +4-333 640- 5.2-.- .2-," 5.240. .2&"1 5.2-4+ .2-.. .2.4- .203+ 5.2.44 42...
7.3,3- \9R8* +,,+"" J-+0 .2.", .2,3- .24,3 .2--0 5.2."- .2&"1 5.244& .23.. 5.2++3 .2443
7.3,3- \9R8* +,,+"" 6+.1 .2-,, .2.-. .2++& .2.-0 .2403 .2443 5.2.,, .2,"1 5.2-44 .2443
7.3,3- \9R8* +,,+"" 6&, .23-" .2..& .2""3 .2.-0 .2-01 .2--0 .2..& 42... 5.2-". .243+
7.3,3- \9R8* +,,+"" /&3 .2.-0 .20.1 5.24-" .2&"1 .24&+ .2"14 .2."+ .2043 .2+,- .23-0
7.3,3- \9R8* +,,+"" 6+-- .2+"" .2..- .2+"" .2.&, .2+", .2.-0 5.2.,+ .2143 5.2.,- .2"43
!"S%60 D)))-* +,4&&3 /300 .2++3 .2.+4 .2-1+ .2+3+ .2+0, .2.&, 5.2.3, .2&&, .2.1, .2&"1
Y&&0&0 D9R4* -3""4 /-34 5.2.,- .2,," .24". .2+43 5.2-1+ .2--0 .2++3 .2.-0 5.2.&0 .2"3+
7.3,+, D9R-* &4&-0 6-+" .2-"- .2.&. .2-04 .2-.. .2-4+ .2-&, .2.44 .2014 5.2.,1 .213+
7.3,+, D9R-* &4&-0 /-3, 5.2.+3 .2&43 5.2.&+ .2114 .2.43 .203+ 5.2.-, .203+ .2.1. .213+
K.KB"- DM)R-* -0"0-- /44, .23"1 .2.14 .21,4 .2.-0 .24"+ .2114 .24,. .2114 5.233& .2414
K.KB"- DM)R-* -0"0-- /-&+ 5.2.+, .2&3" .2+44 .2414 5.2+&- .2-.. .2-1, .2.&, 5.234, .2-&,
O4D&\, B9XF8+* B' /,& .2.3" .21-1 .2..3 42... .2.&, .2&.. 5.2-.4 .2+43 5.244& .2"3+
K-#N>, B9XF83* B' /,1 5.2.0" .2&.4 5.2"44 .23-0 .2+-4 .23"1 5.2,-- .2-.. .2-4. .213+
>3'.6. B9XF(4.* B' /3 .2-34 .2-,3 5.2..3 42... .23&" .2414 .2.., .203+ .230" .2--0
>3'.6. B9XF(4.* B' 6+4 5.2+4, .24&, 5.2"1+ .243+ 5.2."0 .2&.. 5.2+41 .2"43 .2401 .23..
>3'.6. B9XF(4.* B' /-" .2430 .2-&4 .2.1& .2143 .2--4 .2414 .2.++ .2&-0 .241, .23&,
>3'.6. B9XF(4.* B' /-4 5.2-4. .2,,& 5.2-1" .2&-0 5.2433 .2&-0 .24"4 .2114 .2-&4 .213+
>3'.6. B9XF(4.* B' 641 5.234. .2+,1 5.24,. .2&"1 5.2,"0 .2+3+ .2-&1 .213+ 5.2-44 .2114
C'DEF'D C'D&D%-1&E&F'D&D%-1 C'D&DA5&E&F'D&DA5 F'D&DA5&E&F'D&D%-1 C'D&DA5&&E&C'D&D%-1
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Table C.2 Cont. 
 
  
>3'.6. B9XF(4.* B' 64++ .2+.1 .2.31 .2+-3 .2--0 .2-0. .2443 .2.&. .2,&, .2.3, .2&-0
>3'.6. B9XF(4.* B' J+- 5.2+4. .2-"- 5.2.&- .2&-0 5.2"+& .2-.. .23+, .2+14 5.2.40 42...
>3'1\3 B9XF(44* B' /+0 5.2443 .2-"4 5.24-" .2"43 5.24.- .243+ 5.2.0. .2,-0 5.2.,1 .2"3+
>3'"," B9XF("* B' J4&4 5.2.03 .21-- 5.2.., .2014 5.24&- .2114 .2.-3 .2014 5.24"4 .2143
>3'"," B9XF("* B' /4&- .24-. .2,3& .2-40 .2,.. .2.-- 42... .243- .2&"1 5.2."" .2043
>+N\64 B9XF(1* B' J,- .2+3- .2.43 .234, .2.&, .2-,& .2414 .2.0& .2"14 5.2.". .213+
K-#J/& B9XF(&* -0+004 J4&3 .2.", .214. .2.&0 .2&.. .2.-- .2&&, 5.2.&, .213+ 5.24"3 .23&,
K-#J/& B9XF(&* -0+004 /41" .2.,3 .2+3- .24+- .2+43 5.2..3 .203+ .2.,, .23&, 5.2.1. .2"14
!"S%O+ B9XF=3* B' /433 .23-& .2.11 .2"33 .2414 .2+4+ .23"1 .2-." .23&, 5.2.-, .2014
!"#CB. B9XF=1* +,-&+1 /"& 5.2.-4 .2&+0 5.2.,1 .23&, .2.-, .203+ .2."3 .2,-0 .2431 .23&,
!"#CB. B9XF=1* +,-&+1 /+0 5.2.&, .2"&0 .2.-+ .203+ 5.240, .23-0 .2.0. .2114 5.24-& .2,-0
?+W,33 B9XF]+* B' /4"3 5.2+4- .2-4, 5.23-& .2-"1 5.240" .2,.. .24,1 .2,"1 .23.. .2+3+
!,7TH& B9XF]+* B' /"3 5.24"1 .2-"" 5.24"" .23"1 5.24"& .23"1 .2..& .2014 .2.." .2014
740&.3 BG^-* &+1&- 603 5.2.4- .203- 5.2431 .2,-0 .24-+ .2."1 5.24&0 .2"3+ .2.&4 .2-&,
!"S%?3 Y)E894* -&0"0. /43+ 5.2-," .2-&0 5.24&+ .213+ 5.2+3& .2+3+ .2+0" .2+43 .2-+. .23&,
!"S%?3 Y)E894* -&0"0. /40& .2."1 .211" .2.&- .213+ .2.+- .2043 5.2..& 42... 5.2."1 .2014
!"S%Z1 7R(-* 4431,, /43 5.2."4 .21,1 .2.34 .2&"1 5.243+ .2"14 .2-"" .23-0 .2.14 .2,"1
!"S%Z1 7R(-* 4431,, 64"" .2-14 .2-+" .2".4 .2.&, .2.3- .2043 .23., .2+14 5.2."+ .2&"1
!"S%Z1 7R(-* 4431,, /4"4 .2.+- .2&00 .240+ .2"3+ 5.24-0 .2&.. .2+33 .23"1 .2.-- 42...
D.#K$0 7_Q9* B' /4-4 .2+3- .2.30 .2""4 .2443 .24+- .2"14 .2+"- .2-"1 5.2.,& .2,&,
>3'1S" 7AG4Q* B' /-3& .23+4 .2.". .2"-" .2-&, .2++& .2414 .24+& .23&, 5.2.30 .203+
!,,Z4" #G9_+* B' /3, .2.0- .2",. .2-&+ .2+3+ 5.2.00 .2+14 .2-&& .2.-0 5.2.03 .2&-0
!0-.\- /9R8* 4"1.13 /++4 5.24-4 .2+,1 5.2.0" .2143 5.2431 .23"1 5.2.&3 .2,.. 5.24+1 .2"3+
!0-.\- /9R8* 4"1.13 /"-- .2."0 .230" .244- .2-&, .2.., 42... .2."" .213+ 5.2.". .213+
!0-.\- /9R8* 4"1.13 /301 .2.4" .2&0+ .2.", .213+ 5.2.-, .2014 .2.3- .213+ 5.2.3. .2&..
7-404+ /9R(* -0&"0, 64-4 5.2.-+ .2&&" .2.&& .2,"1 5.24++ .2,.. 5.2.4+ .203+ 5.2-+3 .2-"1
7-404+ /9R(* -0&"0, /--3 5.241& .2+4& 5.2.4& .2043 5.2++& .2-.. .24,- .2,-0 5.24"& .23..
7"+0&1 /:)4,84* -".-1 /-4+ 5.2+"" .2-.4 5.2+&" .23&, 5.2+-" .2-.. .2.., .2014 .2.," .2014
7"+0&1 /:)4,84* -".-1 /30- 5.24&+ .2-"& 5.2-.4 .2"3+ 5.24," .2414 5.2.3& .2&&, 5.2.44 .2014
7"+0&1 /:)4,84* -".-1 /-4.`/-4+ 5.24.4 .2+.- 5.2."" .2114 5.2431 .2.&, .2.00 .2,-0 .2..1 .2014
>3'3I, /:ELA* B' 64.3 5.2.+- .2&31 5.2.4" .2&&, 5.2.30 .2&.. 5.2.1+ .213+ 5.24.1 .2,-0
>3'3I, /:ELA* B' 64.3`/4." .2-+3 .24-3 5.2.-- .2&-0 .23&0 .2.-0 5.230- .2.-0 .2.40 .2&"1
>3'3I, /:ELA* B' /4." .2-11 .23+1 .2-4- .2143 .2+3- .2"3+ 5.24.4 .2&"1 .2.-0 .2014
O4\D31 /X):8-* B' /-&4 .2.-, .2&00 5.2.13 .2&.. .24-, .2143 5.2.-& .2&&, .2414 .2+3+
K.KB&, 6G^G44* +.+40, /4"`/4, 5.2,1. .2.,3 5.2000 .2443 5.2+3. .2"3+ 5.2.04 .2&"1 .2",& .2-"1
K.KB&, 6G^G44* +.+40, /4" 5.2-33 .2-&. 5.244" .213+ 5.2+1- .2-"1 .2414 .2,&, 5.2.&, .213+
!+$#>" 6<GG+3* +44,-4 /4&, .2440 .2+-. .24+, .2"3+ .24.- .2-&, .24+. .2"14 .2.0, .2143
!1"!+0 6<GG1.8* ,&.43- /03 5.24-, .2-.0 5.24.4 .23"1 5.24"4 .2+3+ 5.24-3 .23-0 5.2413 .2--0
!1"!+0 6<GG1.8* ,&.43- /&3 5.23-4 .2-"+ 5.2+4" .2,"1 5.2"-1 .2+3+ .23+3 .23"1 .2--- .2,&,
!1"!+0 6<GG1.8* ,&.43- /1& 5.2333 .2-.0 5.2".0 .23-0 5.2+&. .23"1 5.2.0& .2&.. .2.+4 .2014
7&"&+3 6XFG* -0+3&4 /+4- 5.24&+ .2"+3 5.2+," .2"3+ 5.2..4 42... .2.,. .2&"1 .23-+ .2-&,
!,&OJ. HU)L)4* +.4.44 /--4 5.2..- .20&& 5.2.0& .2,&, .2.03 .2,-0 5.2-"" .23.. 5.2.,+ .213+
7+-""4 HU)L)-* B' /+,1 .2-,& .2."1 .2+4- .2."1 .2--3 .2+14 .2--. .2-&, .24+- .2"3+
7-.1&& HU)LF=4* -044.+ /00 5.2.34 .2&11 5.2+"0 .23"1 .2-1& .23.. 5.2+,3 .23"1 .2-13 .2+14
7-.1&& HU)LF=4* -044.+ /4"1 .24+4 .2.0- .2.3. .2-&, .2--4 .243+ 5.244- .2+3+ .2.,0 .2"3+
!16!4, HU)LU* B' J+. .2.&1 .21,0 5.2..3 42... .2410 .2143 .243. .2114 .2+-3 .23-0
7&44"" W98)-* &+"+4 /44, .2.+, .21-. .2--+ .2.&, 5.24"4 .23&, .24-" .2,.. 5.2-30 .2."1
7&44"" W98)-* &+"+4 /-"+ .2+.- .2..+ .23-& .2.-0 .241, .2-.. .2--+ .2."1 5.2.-0 .2&..
7&44"" W98)-* &+"+4 /-"- .2434 .230" .2.-& .203+ .2-"3 .2443 5.2-." .2114 .2.-. 42...
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Table C.3 
 
 
!"#$%&'()&&*+%,-$./0,%&12$3&+4"56%(
750892,&:; <%5%&=->#2$ ?5,9%@&:; =0,%
$26A&12$3&
+4"56%
B%9>C,",025&
B.D"$C%
$26A&12$3&
+4"56%
B%9>C,",025&
B.D"$C%
$26A&12$3&
+4"56%
B%9>C,",025&
B.D"$C%
$26A&12$3&
+4"56%
B%9>C,",025&
B.D"$C%
$26A&12$3&
+4"56%
B%9>C,",025&
B.D"$C%
!"#$#% &'()*+ ,#,-. /0"1 2%3."- %3%0, 2%3.-. %3,-$ 2%3$01 %3"04 2%34## %3404 2%3,". %3.."
!"#$#% &'()*+ ,#,-. /1, 2%3""- %3"4" 2%3,%- %3%-$ 2%3%,1 %3-%% 2%3""0 %3,%% %3%$# %3$,1
5$6784 &'()9+ $04%0 /4%- 2%34.- %3%11 2%3$4, %3"04 2%3",0 %3$#. 2%344% %34"0 %3".1 %3$%%
!.%#-0 &'()9:+ ,#$"- /,-0 2%3.1" %3%"% 2%3--, %3%-$ 2%3.%% %3,%% 2%34"- %30#. 2%3"4$ %3$-$
!"..$0 &'(;"+ ,#%"0 /,#0 2%3"40 %3.,$ %3"%. %3-%% 2%34.$ %3404 2%34#$ %30%% 2%3-41 %3,%%
!"..$0 &'(;"+ ,#%"0 /-% 2%3%#. %3-.0 %3"11 %3$,1 2%34"4 %3#." 2%3"-1 %3-%% 2%3.%, %3,%%
!"..$0 &'(;"+ ,#%"0 /"-. %3,4$ %30$% %3$#- %3,,1 2%3"-# %3.04 %3,-, %3#." 2%3#$, %3,#.
!"..$0 &'(;"+ ,#%"0 /"." 2%3",# %3$#, 2%3%%$ "3%%% 2%3,00 %3$,1 2%3%-. %3-,1 2%34,# %30%%
!"..$0 &'(;"+ ,#%"0 /,0, %3"4$ %3041 %3,%4 %30,1 %3%$1 %3-,1 2%3""0 %3$-$ 2%3,01 %30,1
!"..$0 &'(;"+ ,#%"0 /,,% 2%3,-, %3%-. 2%3,$0 %3,#. 2%34%% %3,-$ 2%3"04 %3#"0 2%3".1 %30,1
!"..$0 &'(;"+ ,#%"0 /,"% 2%3,%% %3%-0 2%3"%$ %3#"0 2%3,14 %3"04 %3%#4 %3.." 2%3"40 %3404
!"..$0 &'(;"+ ,#%"0 /44# 2%3%-% %3.#1 %3%4# "3%%% 2%3"1# %3#." %3"." %3$#. 2%3%#1 %3--$
!"..$0 &'(;"+ ,#%"0 /,0- 2%3,%1 %30#4 2%3"$0 %3.04 2%3,## %3#04 %3"4, %3-#. %3%0" %3--$
51<=40 &'>,+ .1,#% /#,4 2%3$$4 %3%%% 2%3#,# %3%#. 2%3-%" %3%,1 2%3%$- %3-,1 2%3404 %3%-$
51<=40 &'>,+ .1,#% /.,4 2%3"1# %3,., 2%3".4 %30,1 2%3,". %3$,1 2%3%." %3--$ 2%3""# %30-$
51<=40 &'>,+ .1,#% /#". 2%3$," %3%%% 2%3#1- %3%,1 2%3$00 %3%,1 %3%10 %3$,1 %3%0- %3-%%
51<=40 &'>,+ .1,#% /#% 2%34,- %3%.. 2%34#4 %3"." 2%34%0 %3404 %3,01 %34"0 %3,11 %3%-$
51<=40 &'>,+ .1,#% /$-1 2%3$0- %3%%% 2%3.,- %3%#. 2%3#$1 %3%,1 %3"0# %3#04 %34%0 %34."
?4@&14 &'>;"4+ A& /04 2%304" %3%00 2%34-% %30%% 2%30-" %3%#. 2%3,41 %3$%% 2%340" %3"."
?4@&14 &'>;"4+ A& /",. 2%34.# %3"4, 2%3"", %3."0 2%3$41 %3%#. %3,%$ %3$%% 2%34," %34."
5$678- &'>;,+ "1,,., /-4 2%34#$ %3%"% 2%30"# %3%#. 2%3,1- %3,%% 2%3%"1 %3104 %3%1- %3$#.
51B7#4 &CDE"+ -4#44 /#1, %3,$, %34-# %3$#% %3""0 2%3",$ %3-,1 %3,4% %3#." 2%3#0. %3,,1
F4G.B% &*)H$("+ A& /## 2%3,-" %3,0, 2%3$,0 %3%#. %3%$4 %3-,1 %3%4. %3104 %3.,# %3%-$
!"1#"" &;I#D"+ A& /,44 2%3"%" %30.% 2%3%0" %3--$ 2%3"$" %3$#. 2%3""- %3$%% 2%3,4- %3%-$
!"1#"" &;I#D"+ A& /"$, 2%3%"# %3--1 %3%%# %31." 2%3%40 %3-#. 2%3%01 %3--$ 2%3%-- %3,-$
!"1#"" &;I#D"+ A& /"-- %3""4 %3$,, %3"10 %3$,1 %3%4" "3%%% %3"%% %3-,1 2%3%$4 %31"0
!"1#"" &;I#D"+ A& /,4- 2%3%.1 %3."0 %3%", %31." 2%3".% %3$,1 %3",, %3."0 2%3%#1 %3-%%
!"1#"" &;I#D"+ A& /"10 2%3,,. %30-1 2%3,%% %3."0 2%3,#0 %3$,1 %3%"# %31." 2%3%41 %3104
!"1#"" &;I#D"+ A& /,00 %3%,% %3-#. %3%0% %3-#. %3%%% "3%%% %3"0- %34"0 %3"%- %3$%%
!4"411 &;I#H+ $0"040 /-# %3,,1 %3$-" %304, %3$%% %3%,$ %31." 2%3%4# %31." 2%300, %3$%%
!4"411 &;I#H+ $0"040 /1# %3%,4 %31#- %344" %3#04 2%3,-# %3.." %3,%- %3.04 2%30%1 %3$%%
!4"411 &;I#H+ $0"040 /$4J/." 2%3,04 %300" 2%3"%$ %3--$ 2%34-" %3404 2%3"%4 %3-%% 2%34.. %3%-$
!4"411 &;I#H+ $0"040 /." %3%%4 %311" %3,1# %34"0 2%3,1% %30,1 %3,%- %30-$ 2%34.$ %3,-$
!4"411 &;I#H+ $0"040 /.4 %30$- %3,40 %300$ %3#04 %30-1 %3404 2%3,-0 %3$,1 2%3,0, %3$-$
!4"411 &;I#H+ $0"040 /$4 2%3,,. %3"". 2%3%1# %3$-$ 2%34$% %3%#. %3%$. %3-,1 2%3"1. %3,%%
!4"411 &;I#H+ $0"040 /"". %3%#% %3$%$ %3"1" %3"." 2%3%1, %3#"0 %3%1% %3$%% 2%3"14 %3%,1
!4"411 &;I#H+ $0"040 /0- 2%34%, %3%#$ 2%3,"1 %30%% 2%34-0 %3""0 %3%#" %3-,1 2%3""4 %3$#.
!4"411 &;I#H+ $0"040 /.- 2%3,4- %3".- 2%3%-0 %3-%% 2%341, %3"04 %3"1$ %3#"0 2%3"", %3#"0
!4"411 &;I#H+ $0"040 /"," %3"#, %3#14 %3%4" %3--$ %3,.0 %3.." 2%3,.$ %3-#. 2%3%44 %31"0
!,10"1 &;I#C+ "0%$%- /0- 2%3%#- %31,$ %3%,- %31." 2%3"0# %3-#. 2%3-." %3#." 2"3%0# %3,-$
!,10"1 &;I#C+ "0%$%- /40 2%3%$4 %3-01 %3%"4 "3%%% 2%3"41 %3$%% 2%3"0, %3--$ 2%3,10 %3404
!,"#." &;I#K+ #%%#$% /.1 2%30". %3",. 2%30.4 %34"0 2%34$, %30%% 2%3".0 %3$,1 2%3%$4 %3-,1
!,"#." &;I#K+ #%%#$% /0" %3%%, %311$ %3%$0 %3--$ 2%3%#1 %31"0 %3,%4 %3$#. %3%-% %3--$
!,"#." &;I#K+ #%%#$% /0$ %3,$. %34$$ 2%3".0 %3$,1 %3.%- %3"04 2%3#0# %3"04 %344$ %30,1
?4@&L$ &;I#K,+ A& /"$ 2%3%14 %301- 2%3%"4 %31"0 2%3".4 %3$%% %3"-" %3#." %3%," %3.."
5%$$0. &;I#>+ "1,,0" /.% 2%3""0 %3$0$ 2%3"%, %3$%% 2%3",# %3-#. %3,40 %3$,1 %3,"% %30#.
5%$$0. &;I#>+ "1,,0" /14 2%341$ %3",1 2%30-$ %3"04 2%34%$ %30-$ %3%41 %31"0 %3,"1 %3$,1
5%$$0. &;I#>+ "1,,0" /$% 2%3%,# %31"- 2%3%4. %3--$ 2%3%", "3%%% %3,4" %30-$ %3,#. %3$,1
5%$$0. &;I#>+ "1,,0" /"1, %3%"1 %314, %3%#$ %3-,1 2%3%"- %31." %34-. %3404 %34"4 %3,-$
5%$$0. &;I#>+ "1,,0" /,%0 2%3%-1 %3.4- 2%3,,1 %30#. %3%#, %31"0 %34". %30%% %3#1- %3""0
5%%1., M'N)N+ ,1$%4 /,0# 2%3%.1 %3.04 2%34", %30-$ %3"#4 %3#04 2%3001 %34." %3%"$ %31"0
?4@O8# PH'H)4+ A& /"4% 2%3,0# %3#$, 2%30%. %3$#. 2%3%-0 %3.." 2%30"4 %3.." 2%3%1" %3.."
M%/%,% PC9)"+ A& /## %3,44 %304# %3"%- %3.." %34#1 %34." 2%3#-" %3,#. 2%34,1 %34."
M%/%,% PC9)"+ A& /$- 2%3"#$ %301. 2%3,1, %30-$ 2%3%," %31"0 2%3%-4 %3-#. %3"-- %30%%
!"%--- P>Q0C"+ ,100# /"$- 2%3,4# %3$.# 2%3%0% "3%%% 2%30,1 %30%% 2%340. %3--$ 2%3.4# %30%%
!"%--- P>Q0C"+ ,100# /$. 2%34"$ %3%%- 2%3,1" %3"04 2%340" %3%#. 2%3%"$ %3104 2%3%$. %3$#.
!"%--- P>Q0C"+ ,100# /.- 2%3,%0 %3"$, 2%3"-4 %34." 2%3,,$ %34." %3%4% %3--$ 2%3%"0 %31."
!"",0% P>Q#(+ ,#,140 /-4 2%3-4" %3%0% 2%3-%. %34"0 2%3-#$ %3""0 2%3"%0 %3.." 2%3"#4 %3$#.
!"",0% P>Q#(+ ,#,140 /"%1 2%30$0 %3%-# 2%30," %30#. 2%3#%. %3"04 2%3%," %31." 2%3"%. %3.."
!",%.# P>Q#:+ 10"10 /.0 2%30%0 %30"# 2%30,0 %3$,1 2%34-4 %3404 2%3$#" %3#04 2%3$"% %34"0
!",%.# P>Q#:+ 10"10 /"," 2%34"- %3,0" 2%34," %3$,1 2%34"# %3,-$ %3,%0 %3#." %3,"% %3."0
?4@?%1 P>Q$:"+ A& /-# 2%304# %3,-$ 2%3,4- %3.." 2%3$44 %3"04 2%3,41 %3$-$ 2%3$40 %30,1
!4#"." P>Q.(,+ A& /44 2%34.4 %3%"- 2%34,# %3""0 2%30," %3%-$ 2%3%04 %31"0 2%3"0% %3$%%
!-%04" P>Q.:+ 4%4414 /4$ 2%3#,, %3#4" %3"-1 %31." 2"3,44 %3%-$ %3""0 %3-#. 2"34%- %3,#.
!-%04" P>Q.:+ 4%4414 /.# 2%3$%0 %3"-# 2%344. %3#"0 2%3-., %3,%% %3.%4 %34." %3"$- %3$-$
!-%04, P>Q.'+ A& /,# 2%30.4 %3%0. 2%3"#" %30#. 2%3.1# %3%-$ %3"-# %3#04 2%30#1 %3""0
!-%04, P>Q.'+ A& /$, 2%344- %3"%1 2%3,#4 %3$#. 2%30,, %3%-$ %3%$0 %3--$ 2%3"%# %3$#.
5.%0R- PS(;+ 4""-01 /0-$ 2%3"$0 %3#". %3%#. %31." 2%34-# %3%#. %3%$0 %3.04 2%34.- %3#"0
5.%0R- PS(;+ 4""-01 /,$- 2%3,1. %3%%% 2%3,-, %3%,1 2%34"4 %3%#. %3%.% %3$-$ %3%0% %3$#.
5.%0R- PS(;+ 4""-01 /$%1 2%3#44 %3"4- 2%3.#% %3,%% 2%34". %3#"0 2%3%"0 %31." %30"1 %34."
!%0"$$ PT:#:+ A& /"%" 2%3,,0 %34,4 2%3,%4 %3$#. 2%3,00 %34"0 %3"-% %34." %3"41 %3.."
?4@?<0 ?UV>N+ A& /,", 2%3%14 %340. 2%3"$" %34." 2%3%,0 %3--$ 2%3%"0 %3104 %3",4 %3%-$
5$!$=, ?*)+ ,1-10, /0"% %3%", %31$0 %3,-% %3,,1 2%3,#$ %3$%% %3%4# %3104 2%3#%" %3%#.
5$!$=, ?*)+ ,1-10, /",, 2%30", %3%-% 2%34"1 %3,#. 2%3#%0 %3,-$ 2%3%44 %3104 2%3,"- %3$%%
5$!$=, ?*)+ ,1-10, /$$ 2%3"4" %30-# %3%"" %31." 2%3,.4 %30#. %3"4" %3.04 2%3"#4 %30,1
5$!$=, ?*)+ ,1-10, /,$. 2%3"", %3#". %3""$ %3$,1 2%340% %3"." %30,% %3,%% 2%3%4$ %3-#.
5$!$=, ?*)+ ,1-10, /,.4 %3%#, %3.0" %3,"1 %3,-$ 2%3""0 %3$-$ %34%1 %3,,1 2%3%,0 %3--$
5$!$=, ?*)+ ,1-10, /"04 2%344" %3%.# 2%34"# %3404 2%340$ %3,%% %3%$. %3-%% %3%4. %3-#.
E'FGH'F E'F&F%/,&G&H'F&F%/, E'F&FC5&G&H'F&FC5 H'F&FC5&G&H'F&F%/, E'F&FC5&&G&E'F&F%/,
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5$!$=, ?*)+ ,1-10, /"%0 2%34,$ %3"%4 2%34%# %30,1 2%340$ %3,,1 %3%1" %3.04 %3%#% %3--$
5$!$=, ?*)+ ,1-10, /"## 2%34## %3%4% 2%30,- %3%,1 2%3,-" %30%% 2%3%0$ %31." %3"%% %3#"0
5$!$=, ?*)+ ,1-10, /0,% 2%3,14 %3%4, 2%3,14 %3""0 2%3,10 %3,,1 %3"$4 %3#"0 %3"$" %34"0
5$!$=, ?*)+ ,1-10, /,." %3%4. %3.-. %3%"- %3104 %3%#$ %3$#. %3"4" %30,1 %3"$- %3#04
F4G$!, ?*9;+ A& /,.0 %3#-1 %3,1# %3"0, %31"0 "3%4. %3,,1 2%31-0 %3,,1 2%3%-1 %31"0
F4G$!, ?*9;+ A& /,$- 2%3%-1 %3.4" 2%3"%" %3-%% 2%3%.. %3-%% %3,". %3$,1 %3,0" %3$,1
F4G$!, ?*9;+ A& /"## 2%3,$- %30,# 2%3$,, %3,-$ %3%-. %31"0 2%3,"% %3."0 %3011 %34"0
F4G$!, ?*9;+ A& /,.4 2%304- %344$ 2%3.4$ %3,,1 2%3"41 %3-,1 %3",$ %3-#. %3.,4 %3404
!"0$%0 <'H9"+ "0%#0. /"%" %3%,4 %3-%, %3%11 %34." 2%3%#0 %3.04 %3%4" %3-,1 2%3",, %3404
5$-F0" <'C"+ A& /,## 2%3%,0 %31"# 2%3%,- %3104 2%3%"1 %31." 2%3%-" %3-,1 2%3%." %3-#.
5$-F0" <'C"+ A& /.$ %3,"$ %34.% %34,% %30%% %3""4 %3.04 %3"." %3$,1 2%3%4$ %31"0
5$-F0" <'C"+ A& /,,1 2%3,0" %3,-" 2%34"# %30%% 2%3"$. %3$,1 2%3%0$ %3-#. %3"%, %3-,1
5#86P% <'C,+ A& /.1 2%3#0, %3%". 2%30-0 %3%#. 2%3$%% %3,%% 2%3",# %30,1 2%3,0" %3$%%
5#86P% <'C,+ A& /"#- 2%3%,, %3-,$ 2%3%"1 %31." 2%3%,$ %3104 %3"$0 %3%#. %3"#. %30#.
!#$#." <R" A& /1- 2%3".0 %3#$, 2%3%$1 %3-%% 2%3,.1 %3$-$ 2%3"1$ %3$#. 2%30%$ %30,1
!#$#." <R" A& /,4" 2%3%1% %3##, 2%3%4" %3104 2%3"0- %3$%% 2%3%,$ %3104 2%3"0, %30-$
!#$#." <R" A& /"$, 2%3"#$ %3,04 2%3""4 %3#." 2%3"11 %34"0 %3%#1 %3.04 2%3%,$ %3--$
!#$#." <R" A& /"## 2%3""# %30%0 2%3"0. %34." 2%3%-, %3.." %3%," %3104 %3%-$ %3#."
!"4-%4 <;D(+ 4%%.,$ /$1 2%3"-4 %3"#. 2%3"1# %3%,1 2%3".% %3#"0 2%3%$- %3."0 2%3%04 %3$-$
!"4-%4 <;D(+ 4%%.,$ /"$, 2%3".4 %3,1. 2%3"." %3$#. 2%3".0 %3,#. %3"1% %3,-$ %3"-. %3$,1
5$-LO4 <;D:+ ,1,-0# /""% 2%30," %3%1% 2%341$ %3,-$ 2%300$ %3404 %3%,$ %31." 2%3%,0 %31."
5$$WL4 <;D)H+ ,1#"04 /1# 2%34%" %3,"4 2%3,"- %3#." 2%34-0 %3"04 %3%"0 %31." 2%3"#, %3.."
5$$WL4 <;D)H+ ,1#"04 /,-4 2%3,". %3",% 2%3%-. %3#04 2%340- %3,,1 %3"", %3.." 2%3"01 %3,#.
5$$WL4 <;D)H+ ,1#"04 /"4" 2%34.# %3%1$ 2%30.# %3,,1 2%3,.# %34." 2%3,$1 %3$,1 2%3%$- %3$-$
M%MAB0 <;HX"+ ,1,."% /"., 2%3"". %340" 2%3,%$ %3,-$ 2%3%,1 %31." %3"-. %3,#. %34$0 %3%,1
5#71$0 LH+ A& /$4 2%300# %344% 2%3".4 %3-,1 2%3."$ %3404 2%3%%4 "3%%% 2%3#0# %3,,1
5#71$0 LH+ A& /,-1 2%3"#. %3$$% 2%3%#, %31." 2%3,$, %3.." %3,0, %3-,1 %3%4, %3--$
5#71$0 LH+ A& /.. 2%3010 %3"#, 2%3.44 %3"04 2%3,## %3$%% 2%3%4# %31." %3004 %3,,1
5#=/%- F:(9+ 01-".0 /10 2%3"0" %3#1- %3%%0 "3%%% 2%3,-$ %30#. %3"#$ %3."0 2%3"40 %3-,1
!"%-$% F*V)"+ ,0411 /0"# 2%3,,- %3#%" 2%3400 %3$,1 2%3"", %3$-$ 2%3#0" %3404 2%34%1 %34"0
!"%-$% F*V)"+ ,0411 /-0 %3",% %34$0 %3"$$ %3404 %3%.4 %3-#. 2%3"1- %3,-$ 2%3,1, %3"."
!"%-$% F*V)"+ ,0411 /#%4 2%3%"- %3-#" 2%3%0, %3-#. %3%%# %3104 2%3",# %30,1 2%3%.- %3#."
!"%-$% F*V)"+ ,0411 /#,. 2%3%,4 %3-0- %3%"% %31." 2%3%#$ %3$,1 %3%00 %3-%% 2%3%,4 %3-#.
!%%#%. F>;,+ 4"0",4 /,1$ 2%3"4, %3440 2%3%,4 %3104 2%3,0, %3404 %3"#0 %3#." 2%3%$0 %3$#.
!%%#%. F>;,+ 4"0",4 /.4 2%3"%" %34,$ 2%3%0- %3#." 2%3"## %30#. %3%$. %3$-$ 2%3%0" %3."0
!%%#%. F>;,+ 4"0",4 /41$ 2%304, %3%"$ 2%3#0. %3%-$ 2%34". %3"." 2%3,#1 %3,-$ 2%3%,1 %31"0
!%%#%. F>;,+ 4"0",4 /1% %3%%0 %31-$ %3%". %3104 2%3%%1 "3%%% %3%#4 %31"0 %3%,. "3%%%
!%%#%. F>;,+ 4"0",4 /4$4 2%3",. %34,1 2%3"14 %30%% 2%3%$" %3."0 2%3%", %3104 %3""1 %3#."
!%%#%. F>;,+ 4"0",4 /4%, 2%3"0" %3".4 2%3".. %3%#. 2%3"%0 %3#." %3%$. %3$,1 %3"0" %34"0
!%%#%. F>;,+ 4"0",4 /0%0 2%34,1 %3%4% 2%340. %3%-$ 2%34"% %34"0 %3",, %3$-$ %3"#- %34."
!%%#%. F>;,+ 4"0",4 /",, 2%300. %3,%, 2%3-., %3%,1 2%3%,, "3%%% 2%3$00 %3,%% %3,%$ %3."0
!%%#%. F>;,+ 4"0",4 /"#1 2%3%0- %3-,. 2%3%$, %31"0 2%3%40 %3--$ %3,,0 %30#. %3,#, %30%%
51YG/. W()H+ ""41$# /,0" 2%3%4. %3-$" %3".- %3#04 2%3,#, %3#." %3%%4 %31." 2%30,$ %3%#.
51YG/. W()H+ ""41$# /"-# 2%3"0# %3#1- 2%3"%, %3-#. 2%3"-- %3#04 2%3%$% %31"0 2%3"0$ %3-%%
5$00,- W()H(+ ".%$.% /0"" 2%34%% %3%4# 2%3,%. %34"0 2%3410 %3%#. %3%$4 %3-,1 2%3",4 %3#."
5$00,- W()H(+ ".%$.% /#0% 2%3.4- %3%," 2%3-#% %3"." 2%3$,$ %3"." 2%3,-. %30-$ 2%3%$4 %3--$
5$00,- W()H(+ ".%$.% /",1 2%3401 %3,,1 2%341% %3$-$ 2%34%1 %3,%% 2%3",$ %31." 2%3%0$ %3-%%
5$00,- W()H(+ ".%$.% /0%$ 2%340, %3"0. 2%340- %34." 2%344$ %30%% 2%3%"1 "3%%% 2%3%%. "3%%%
5$00,- W()H(+ ".%$.% /,-1 2%3,,. %3,$- 2%3"01 %3#04 2%34%0 %30%% %3,%0 %3$,1 %3%01 %3-#.
5$00,- W()H(+ ".%$.% /"$4 2%3"## %3"$$ 2%3%14 %3#"0 2%3,". %3,#. %3"-% %3,-$ %3%## %3-%%
5$00,- W()H(+ ".%$.% /4#4 2%3".% %3,0- 2%3""- %3#04 2%3,," %34." %3,#4 %3,,1 %3"#% %3#04
5$00,- W()H(+ ".%$.% /$% 2%3"$$ %30,% 2%3%1" %3.04 2%3,0" %34." %34., %3"." %3,,, %30,1
5$00,- W()H(+ ".%$.% /.,- 2%3#4, %3%%, 2%3#,$ %3%,1 2%3#4- %3%#. %3,1% %34"0 %3,.- %3%,1
5$%#-. W()H:+ ".""## /,00 2%341$ %3%#" 2%34,# %34." 2%30$- %3%-$ %3%0% %3-%% 2%3"%4 %3$-$
!,1,$$ WC:()H+ A& /.- %34#1 %34$" %3#0, %3,,1 %3".. %3-%% 2%3%-- %3-%% 2%30#, %3404
!,1,$$ WC:()H+ A& /"00 2%3%-$ %3#." 2%3%$1 %3.04 2%3"%4 %3.04 2%3%.0 %3$,1 2%3"%- %3$-$
!,1,$$ WC:()H+ A& /,4. 2%3%#% %3$0. %3%%4 "3%%% 2%3"%, %30,1 %3"4" %34." %3%,$ %3--$
!1.#"1 WEU'*+ .1,4- /0- 2%3$". %3%%" 2%3$"% %3%,1 2%3$,0 %3%,1 2%34,% %3%,1 2%3440 %3%#.
L"71#4 W9I(1+ A& /$%% 2%3",1 %3.,. %3%$# %3-#. 2%34,4 %3."0 2%3441 %3#"0 2%3.,$ %3,%%
L"71#4 W9I(1+ A& /$", 2%3"0$ %3#10 %3%#% %31"0 2%3404 %3#." %3%0$ %31." 2%340- %3404
L"71#4 W9I(1+ A& /"4# 2%3,0- %3%1% 2%3"%, %3$%% 2%3410 %3%,1 2%3%00 %3-,1 2%344$ %3"04
L"71#4 W9I(1+ A& /4%% 2%3,.$ %30.# 2%3#.% %30#. %3%". %3104 2%3.00 %3,,1 2%3"#. %3#"0
L"71#4 W9I(1+ A& /,-- 2%344% %3%"# 2%3401 %3"04 2%34"" %3"04 %3%-. %3$-$ %3",0 %30-$
!$4%41 W9I)"+ ,-1$"0 /0## %3%#. %3."# %3"#" %30,1 2%3%4. %31"0 %3%4- %31"0 2%3"#" %30%%
!$4%41 W9I)"+ ,-1$"0 /"4% 2%3"1$ %3"%- 2%3%-# %3#"0 2%34%- %3,,1 %3%.- %3$-$ 2%3"00 %30%%
!$4%41 W9I)"+ ,-1$"0 /",# 2%3,.4 %3%%1 2%3,#" %3%,1 2%3,10 %3,%% %3%40 %3-#. 2%3%%1 %31"0
!$4%41 W9I)"+ ,-1$"0 /,%, 2%34$# %3%%, 2%30.0 %3%,1 2%3,#$ %3"04 2%3"-$ %3,%% %3%4, %3-%%
!#$#.0 6)H,+ 4$"#1$ /"11 2%3,"% %30## 2%34-# %30-$ 2%3%4# "3%%% 2%34-1 %30#. 2%3%41 %3104
!#$#.0 6)H,+ 4$"#1$ /,.# 2%3""0 %3$$, 2%3""% %3-#. 2%3""- %3-#. %3%40 "3%%% %3%,$ "3%%%
!#$#.0 6)H,+ 4$"#1$ /4-0 2%3",- %301% 2%3"10 %3#." 2%3%$4 %3.." 2%3%41 %3-%% %3%1, %3.."
!#$#.0 6)H,+ 4$"#1$ /"$$ 2%3",, %30$- 2%3,"0 %30#. 2%3%4% %3104 2%3%-# %3#04 %3%11 %3."0
!#$#.0 6)H,+ 4$"#1$ /"-% 2%3"11 %3"$4 2%3,0. %34." 2%3"#% %30,1 %3%4% %3-#. %3",. %3$#.
!#$#.0 6)H,+ 4$"#1$ /,-% %3%4$ %3-.# %3%40 %3104 %3%4- %3104 %3"-% %3#." %3"-4 %3#."
!#$#.0 6)H,+ 4$"#1$ /"44 2%3"04 %30.1 2%3"01 %3-%% 2%3"4- %3#"0 %3,", %3404 %3,,, %3$,1
!#$#.0 6)H,+ 4$"#1$ /"## %3%4% %3-#. 2%3%40 %3--$ %3%14 %3$-$ %3",. %3$,1 %3,## %34"0
!#$#.0 6)H,+ 4$"#1$ /0- 2%30"0 %3"44 2%3.-$ %3%#. 2%3%0" %3--$ 2%30#4 %34." %3,1" %3404
!#$#.0 6)H,+ 4$"#1$ /,-, 2%3"41 %30-# 2%3,0" %30-$ 2%3%4. %3-,1 %3"%" %3-%% %34%# %3404
5#86B4 6)H4U+ ,#".1 /"#1 2%3,1- %3%#1 2%300# %3"." 2%3"#" %3%-$ 2%3%$$ %3.04 %3,,- %34."
5#86B4 6)H4U+ ,#".1 /""# 2%3#4- %3%#. 2%3-0- %3%#. 2%3,,- %3$%% 2%3,"- %3$#. %30%, %3,-$
54/=-$ 6EE;+ 4",000 /,#" 2%3",% %3-"$ %3"#4 %3--$ 2%3414 %3#." 2%34"$ %3."0 2%3-$, %3404
!",%%. 6Z)+ ,0#"4 /#$ 2%3,$# %3%.- 2%3414 %3%,1 2%3"4$ %3$,1 2%3%." %3#"0 %3"-$ %3#04
!",%%. 6Z)+ ,0#"4 /.$ 2"3".4 %3%%" 2"3#.$ %3%,1 2%3..% %3""0 2%3#.0 %3404 %3,4, %3$%%
!%0$0, [)H(+ 4$$4## /,,0 2%3"0. %3..# %3"%# %3104 2%30%% %3,#. 2%3$%- %3#." 2"3""4 %3"."
!%0$0, [)H(+ 4$$4## /,,- 2%3"#% %3.,0 %3""1 %3104 2%30"- %3""0 2%34.$ %3."0 2%31"4 %3,%%
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Table C.3. Cont.  
!%0$0, [)H(+ 4$$4## /,4, 2%3%-0 %3-1" %3%-1 %3104 2%3,#. %30,1 2%30.% %3-%% 2%3-"$ %3404
!%0$0, [)H(+ 4$$4## /",$ 2%3%## %3#.- %3%.4 %3."0 2%3"-, %3,,1 %3%"0 %3104 2%3,0" %3%-$
!%0$0, [)H(+ 4$$4## /,04 2%34$, %34,, 2%30%. %3$%% 2%34"- %30,1 2%3,%" %3-%% 2%3"", %3-%%
L"[8&% [\P"%%1"%."%+ A& /04 2%3,04 %34-# 2%3%#% %31"0 2%304$ %34"0 2%3,$1 %3#"0 2%3$## %3%,1
L"[8&% [\P"%%1"%."%+ A& /"%" 2%3##1 %3%4. 2%34$0 %34." 2%3.#4 %3%,1 %3%10 %31"0 2%3,1# %30,1
?4@P@1 [\P"%%1",#11+ A& /"", 2%34#% %3"-, 2%34.# %3"04 2%34,# %3#04 2%3%11 %3-#. 2%3%01 %3--$
?4@P@1 [\P"%%1",#11+ A& /0" 2%3410 %3%%. 2%30-4 %3%-$ 2%34%0 %3%-$ 2%3%". %31." %3"$, %30%%
?4@L"4 [\P$-4--0+ A& /1, 2%3,-$ %3$%$ %3%$0 %3104 2%3$4$ %3,#. 2%3,1- %3-,1 2%311- %3%-$
7%=?6# 7'V+ A& /44" 2%3"%, %3$$# 2%3,#% %3#04 %3%0$ %31"0 2%34#, %3,#. 2%3%#. %3.."
!%0$4$ 7)H,+ -"-,1 /,41 2%30%1 %3,11 %3%"0 "3%%% 2%3-4, %3%,1 2%3%#- %31"0 2%31%# %3%#.
!%0$4$ 7)H,+ -"-,1 /1" 2%30,% %30"" 2%30"" %3$#. 2%30,- %34"0 2%3$04 %30#. 2%3$$" %3#"0
!%0$4$ 7)H,+ -"-,1 /"-# 2%3"11 %34", 2%3"$0 %3$-$ 2%3,40 %34." 2%3".1 %3$,1 2%3,01 %3,,1
!%0$4$ 7)H,+ -"-,1 /44# 2%3#"# %3%%0 2%30", %3%-$ 2%3$"1 %3%-$ %3%,% %3104 2%3"-. %34"0
!%0$4$ 7)H,+ -"-,1 /4%" 2%3%#- %3$"$ %3%-. %30-$ 2%3,%4 %3404 %3,"4 %3,-$ 2%3%.- %3$%%
!%0$4$ 7)H,+ -"-,1 /"$# 2%304. %3,,0 2%3#," %3#"0 2%34#0 %34." %3,11 %30#. %30$$ %30-$
!%0$4$ 7)H,+ -"-,1 /4,1 2%34-1 %34#% 2%3$4, %3,-$ 2%3"0$ %3-,1 %3".. %3$#. %3$$, %34."
54M-=. 7SI*0.+ A& /"0$ %3%%% "3%%% 2%3,%$ "3%%% %3,%$ %3$%% 2%3$-. %30#. 2%3,.# %3,-$
?4@R#- A)VD(,+ A& /$, 2%30%$ %3%#" 2%30." %3%#. 2%340% %30-$ %3%04 %3104 %3".0 %3,-$
M,=@?$ A)VD(0+ A& /#$ 2%3,$4 %3".# 2%3,.$ %34"0 2%3,#% %30,1 %3"-% %3$,1 %3,%$ %30-$
5$44$, A)VD(#+ ,#0-- /## 2%3,.- %3$0, 2%3%1$ %31"0 2%30$" %30#. 2%3-## %30,1 2"3,,% %3%#.
5$44$, A)VD(#+ ,#0-- /0$ 2%344% %3"4# 2%3%,$ %3104 2%3$40 %3%-$ %3",# %3.04 2%30-4 %3%#.
5$44$, A)VD(#+ ,#0-- /$% 2%34-4 %3"-$ 2%3,"1 %3."0 2%3#0. %3""0 %3%0# %3-#. 2%3,-4 %3,-$
5$44$, A)VD(#+ ,#0-- /4$ 2%30%0 %3%.# 2%3,"1 %30-$ 2%3#-1 %3""0 %3"-% %3$-$ 2%3"1" %3#04
5$44$, A)VD(#+ ,#0-- /0% 2%30-" %3%$# 2%344# %30#. 2%3$,. %3"." %3"$" %3.04 2%3"4% %3$-$
5#M/$4 A)VD(1+ A& /"-1 2%341, %3%,$ 2%3,04 %30%% 2%3#0" %3%,1 %3%-4 %3."0 2%3,"# %30%%
?4@@," A)VD:$+ A& /,0 2%3"0. %3"#0 2%3%$% %3#04 2%3,40 %3"." 2%3%," %31"0 2%3"1# %34"0
M,=]Y4 A)VD:1+ ,111#0 /#, 2%3",. %3.14 2%3""# %3-#. 2%3"4- %3.04 2%3..- %34." 2%3-%" %3%-$
M,=]Y4 A)VD:1+ ,111#0 /"," 2%3,%% %3404 2%3"4# %3-,1 2%3,$# %3,%% 2%3"$" %3$#. 2%3,1" %3"."
M,=]Y4 A)VD:1+ ,111#0 /#1 2%3,#" %3%-0 2%3,," %3404 2%3,-% %3"." 2%3%,. %3--$ 2%3%-# %3$-$
?4@R.# A)VD'"+ A& /4- 2%3.00 %3%0, 2%3."$ %3,-$ 2%3.., %3""0 %34-$ %3#"0 %34,1 %34."
5$$WL" A)VD9"+ 4%"0#- /-0 2%3,-. %3%"4 2%3,1# %3%-$ 2%3,.- %3,#. %3%"4 %31." %3%,1 %3$-$
5$$WL" A)VD9"+ 4%"0#- /.%1 2%3,-. %3%.0 2%34.4 %3"04 2%3,%" %30,1 2%3"%, %3."0 %3%.% %3$-$
5$$WL" A)VD9"+ 4%"0#- /,-1 2%34$. %3%,# 2%3#4" %3%,1 2%3,%4 %30%% 2%3"14 %3#04 %3"4# %3#04
?4@F04 A)VD94+ A& /,$0 2%34.0 %3,,. 2%3,"$ %3#"0 2%3#4, %3"." 2%34,% %30-$ 2%3$4$ %3%-$
?4@F04 A)VD94+ A& /,$% 2%3404 %3"0" 2%3,-. %30#. 2%3411 %3,%% 2%34%1 %30%% 2%30," %3""0
M#?<[- A)VD9#+ 4$,#-- /"%" 2%3"#% %3.4# 2%3,.$ %3$#. 2%3%,4 "3%%% 2%3,4" %3.." %3%," "3%%%
5#86W4 A)VDZ"+ ,14$## /4$ 2%34,1 %3,14 %3"%$ %3-#. 2%3.$0 %3%-$ %3%,$ %31"0 2%3-04 %3%-$
5#86W4 A)VDZ"+ ,14$## /",$ 2%3#"0 %3,". 2%30,0 %3#04 2%3$%4 %3,,1 2%3,., %3#." 2%30#" %3#."
5#86W4 A)VDZ"+ ,14$## /$0 2%34,, %3%0, 2%3%1- %3#"0 2%3#0# %3%-$ %3,1. %3404 2%3"#% %34."
5#86W4 A)VDZ"+ ,14$## /"%0 2%30.1 %3%$$ 2%34$% %30,1 2%3#1- %3,%% %3,.0 %3#04 %3%4$ %3104
5#86W4 A)VDZ"+ ,14$## /-" 2%3,0# %30,- 2%34"% %3$%% 2%3"-% %3$,1 %3"44 %3.." %3,$4 %3#."
!"1,40 A)VDZ,+ -".,- /",0 2%3,"1 %3"-, 2%34"1 %34." 2%3""1 %3404 2%34$0 %3%,1 2%3"$0 %3$,1
5#86.- \U)H+ A& /10. %3%4# %3104 %30-4 %3#"0 2%30"0 %3$-$ %3%"$ "3%%% 2%3--, %3"."
5#86.- \U)H+ A& /0%" 2%3%,# %3-.- %3,.. %3,,1 2%34,$ %3""0 %3,,0 %34." 2%34.- %3,%%
M,FG%$ \Q';"+ A& /0-% 2%3,%0 %30#, 2%3%4$ %3-#. 2%34., %3%-$ 2%3,#1 %3$%% 2%3#1# %3"."
M,FG%$ \Q';"+ A& /,.0 2%3,0# %3%1" 2%3""- %3."0 2%34.4 %3%,1 %3%". %31"0 2%3,4- %3"."
M,FG%$ \Q';"+ A& /,1$ 2%30," %3"-4 2%3#,, %30,1 2%34," %3,#. 2%3%#" %3104 %3"#% %3-#.
5$-L@- !'':+ ,0$,0 /"%4 2%34", %300, %3"00 %3-%% 2%3.$- %3""0 %3.-- %3,,1 2%3",4 %31."
51,%[, R)H(+ "#.%.0 /#4% 2%314" %3"#. 2%30%. %3$-$ 2"30## %3%-$ 2%3#0% %3.04 2"3#-- %3""0
51,%[, R)H(+ "#.%.0 /01% 2%3,-0 %301" 2%3%"$ %31." 2%3##4 %3"." 2%3,"4 %31"0 2%3.#% %3%#.
51,%[, R)H(+ "#.%.0 /0., 2%3,%0 %3,-% 2%3"44 %3#." 2%3,.$ %30#. 2%3",4 %3."0 2%3,$. %34"0
51,%[, R)H(+ "#.%.0 /"." 2%3#$0 %3%%, 2%30$# %3,%% 2%3$$, %3%,1 %3%"$ %3104 2%3"-, %30%%
51,%[, R)H(+ "#.%.0 /$%% 2%3",. %34,# 2%3""" %3$,1 2%3"04 %3#"0 2%3""0 %3#." 2%3"0. %34."
51,%[, R)H(+ "#.%.0 /4,. 2%30%% %3%%% 2%341. %3%,1 2%30%0 %3%#. 2%3%#% %3.04 2%3%#. %3#04
51,%[, R)H(+ "#.%.0 /$,- 2%3"10 %34%# 2%3""4 %3.04 2%3,.# %30%% %3"1% %3$%% %3%,- %3104
!,"1"4 R)H:+ ,1-#1$ /,.% 2%3%1. %3-.1 %3"$- %3--$ 2%34$, %3$,1 2%3.-" %30-$ 2"34", %3""0
!,"1"4 R)H:+ ,1-#1$ /#. 2%34#4 %3"#0 2%3,14 %3#"0 2%30"0 %3"." 2%3%#% %3104 2%3"." %3$%%
!,"1"4 R)H:+ ,1-#1$ /#4 2%340" %3%.$ 2%34## %3,-$ 2%34,- %34"0 2%3%"$ %3104 %3%"% %31."
!,"1"4 R)H:+ ,1-#1$ /$0 2%341. %3%,. 2%304. %3""0 2%34#- %3""0 %3"%$ %3-%% %3"-# %34."
F4G.0" R*',#(4+ A& /,%% 2%3"$1 %30.# %3%0$ %3--$ 2%34-0 %30,1 %3%10 %31"0 2%344$ %3,#.
F4G.0" R*',#(4+ A& /,-1 2%3,.4 %30"$ 2%30". %3#04 2%3",1 %3."0 2%30-, %30#. 2%3"10 %34."
F4G.0" R*',#(4+ A& /,%4 2%3,#1 %3"4% 2%3"0" %3$-$ 2%34.- %3,%% %3"$# %3$#. 2%3%.4 %3#"0
F4G.0" R*',#(4+ A& /14 2%34$- %3"14 2%300# %30-$ 2%3,1" %34"0 2%3"14 %3-#. 2%3%41 %31"0
F4G.0" R*',#(4+ A& /,,- 2%3-"" %3%0" 2"3"1. %3""0 2%30,# %3,,1 2%3,00 %3--$ %3#,- %3%#.
!%.-1# R>),+ ,0.-. /",, 2%3,%0 %34". 2%3%4% %31." 2%34.1 %3%-$ %3%0- %31"0 2%34%% %30%%
!%.-1# R>),+ ,0.-. /""0 2%3"1% %3,%# %3%"" %31." 2%341" %3""0 %3".$ %3404 2%3,,$ %30,1
!%.-1# R>),+ ,0.-. /"4% 2%3"4" %30," %3%00 %3."0 2%34%# %34." %3,"1 %30%% 2%3"4" %3$-$
!%.-1# R>),+ ,0.-. /$- 2%3,,1 %3%#. 2%3",0 %3#04 2%3444 %3%-$ %3%-4 %30-$ 2%3",$ %3#04
L"[70. RV'*(,+ A& /00% 2%3040 %3%0% 2%30.% %3,%% 2%341. %3,%% 2%3,#, %30%% 2%3".1 %30-$
!"4%-$ RV'*U"+ ""0#1. /"%# 2%30%. %3%,# 2%3,," %30-$ 2%3#1, %3%#. %3""% %3-,1 2%3,$% %3,,1
!"4%-$ RV'*U"+ ""0#1. /#0 2%3"#1 %34%$ 2%3%#4 %3-,1 2%3,$# %3,,1 %3"-% %30%% 2%3%44 %3--$
5$-L]% O^'S'"+ 4%"%"" /"4- 2%3%0$ %3$01 %3%4" %3-#. 2%3",4 %34." %3%,1 %3-%% 2%3",# %30-$
!4,##" O^'S',+ A& /1. 2%3,$" %3",# 2%34," %3,#. 2%3,%" %3#." %3%,1 %31"0 %3"01 %3#."
!4,##" O^'S',+ A& /"#- 2%3"#. %34,, 2%3"-0 %3404 2%3"4% %3$#. %3"#" %3$%% %3,%# %3,,1
!4,##" O^'S',+ A& /1" %3"%4 %3$%1 2%3"44 %3$%% %340% %3,-$ %3%#$ %3-#. %3#,1 %3""0
5._5"$ O^'S^+ A& /.. 2%3414 %3#40 2%3"%, %31." 2%3$-0 %3,,1 2%34,, %3-,1 2%31%0 %3,#.
5._5"$ O^'S^+ A& /44 2%3,1" %3,,# 2%34$. %3,,1 2%3,"0 %3$,1 %3"4# %3-%% %3,-- %3,-$
!-""## G)(',+ -4#4" /.4 %3,4" %3,-, %34-, %3,,1 %3%.1 %3-%% %3",1 %3$-$ 2%3".# %3$#.
!-""## G)(',+ -4#4" /.# %3"44 %3044 %3"## %3#"0 %3""% %3.04 2%3%04 %3-#. 2%3%-- %3$%%
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